Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ADAMTS17	"FLJ16363, FLJ32769"	ENSG00000140470	"ADAM metallopeptidase with thrombospondin type 1 motif 17"	Q8TE56	15	99971437-100342005	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Deafness, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 10.7"	"Group enriched"	"Detected in many"	8	"Astrocytes: 116.9;Early spermatids: 108.4;Inhibitory neurons: 275.7;Late spermatids: 91.0;Oligodendrocyte precursor cells: 337.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEK 293: 6.4;JURKAT: 19.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA062487			Approved	Nucleoplasm	"Secreted to extracellular matrix"	NA	NA				"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA062487: AB_2684780"	"unprognostic (7.73e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.03e-3)"	"unprognostic (2.56e-1)"	"unprognostic (9.90e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.18e-3)"	"unprognostic (5.03e-3)"	"unprognostic (4.70e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.35e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.43e-3)"	"unprognostic (6.43e-2)"	0.8	1.2	1.6	0.5	1.1	0.6	0.6	0.3	2.7	1.4	6.0	0.9	0.6	1.2	0.6	2.1	1.8	0.3	1.3	1.3	0.6	1.1	7.5	1.5	0.5	1.2	0.7	1.7	5.0	0.2	1.2	0.5	0.8	1.0	0.4	0.7	2.6	0.5	5.6	2.2	1.2	0.5	0.7	0.9	1.0	2.7	1.0	10.7	0.7	0.1	0.5	1.6	1.4	1.1	0.0	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	1.2	0.3	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.7	2.0	0.5	0.2	0.9	1.0	0.0	0.3	2.3	0.0	0.2	1.7	0.2	0.2	2.2	2.7	0.4	0.0	0.2	0.3	0.0	0.6	0.6	0.0	0.2	0.0	0.0	0.0	0.4	2.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.1	0.3	2.7	1.3	0.6	1.2	0.7	0.8	0.7	1.0	1.1	0.7	0.0	0.0	116.9	0.3	1.0	0.9	0.1	3.4	0.8	1.5	1.3	4.3	1.5	0.9	0.0	0.0	0.1	2.6	0.4	1.9	0.1	108.4	1.2	2.8	0.9	0.0	0.0	8.2	0.9	0.0	1.6	5.1	1.8	0.0	0.1	0.4	4.4	8.2	21.9	275.7	0.7	0.0	0.6	0.3	91.0	2.1	0.4	0.0	22.5	0.0	1.3	1.0	337.3	9.5	0.3	0.2	0.0	0.8	1.6	0.5	0.1	0.0	0.7	0.0	3.2	0.9	1.7	1.9	2.1	0.6	0.1	3.7	2.5	0.4	0.9
ANXA2R	"AXIIR, C5orf39"	ENSG00000177721	"Annexin A2 receptor"	Q3ZCQ2	5	43039233-43043170	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.8;lymphoid tissue: 26.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.2;B-cells: 23.8;dendritic cells: 36.4;Endothelial cells: 24.8;Hepatic stellate cells: 38.2;NK-cells: 47.4;T-cells: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"gdT-cell: 53.9;MAIT T-cell: 63.5;memory B-cell: 34.3;memory CD4 T-cell: 56.1;memory CD8 T-cell: 59.9;naive B-cell: 32.9;naive CD4 T-cell: 96.3;naive CD8 T-cell: 72.1;NK-cell: 24.8;T-reg: 66.5"	"Group enriched"	"Detected in all"	6	"B-cells: 34.3;NK-cells: 24.8;T-cells: 96.3"	"Cell line enhanced"	"Detected in many"		"HSkMC: 27.7;JURKAT: 33.1;MOLT-4: 30.0;REH: 30.9;U-937: 117.7"									HPA051482	Uncertain		Approved	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"HPA051482: AB_2681500"	"unprognostic (3.38e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.92e-3)"	"unprognostic (5.65e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.34e-1)"	"prognostic unfavorable (6.36e-8)"	"unprognostic (2.68e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.68e-1)"	4.7	1.3	3.2	12.1	3.2	19.8	3.9	3.0	3.8	3.5	3.5	2.5	3.3	2.4	1.7	1.8	3.3	3.5	2.9	2.8	2.9	2.0	1.3	4.6	26.1	3.4	3.3	1.2	0.8	0.6	1.1	3.2	3.2	2.7	2.7	0.1	1.7	1.2	2.5	2.1	8.2	2.1	3.5	15.8	3.3	1.5	3.3	25.2	2.7	3.0	17.2	3.2	3.8	4.0	2.1	2.1	1.6	1.2	2.6	8.0	0.4	0.5	0.3	0.5	0.6	3.9	1.9	6.8	6.5	1.6	2.2	0.8	5.0	0.5	0.5	13.3	4.0	2.2	5.9	1.8	4.1	2.6	0.8	27.7	0.2	2.4	0.2	0.1	16.2	33.1	1.5	8.9	2.1	3.1	30.0	4.1	0.0	1.7	14.8	30.9	3.6	3.9	0.7	1.1	5.7	0.0	2.7	0.7	0.7	0.2	0.7	4.9	9.9	0.5	0.0	0.8	2.5	4.4	6.7	3.3	3.6	117.7	1.4	5.6	3.5	1.7	53.9	2.5	63.5	34.3	56.1	59.9	3.5	32.9	96.3	72.1	3.2	24.8	8.1	5.2	66.5	26.6	3.2	3.2	3.0	3.8	2.8	2.9	3.4	3.3	3.2	3.5	3.3	4.0	32.2	0.0	9.9	0.0	23.8	3.7	1.4	0.3	2.2	0.1	1.9	2.2	1.3	4.3	1.5	0.0	0.0	0.4	36.4	0.5	0.0	0.1	4.0	1.1	5.0	24.8	1.8	8.2	0.0	0.0	1.1	7.2	1.5	0.8	15.2	4.1	38.2	1.4	8.7	0.0	0.0	0.1	2.0	18.2	5.6	1.5	1.5	7.5	7.2	0.0	7.1	0.2	47.4	0.0	0.0	0.1	0.0	0.4	7.8	1.2	1.0	0.4	2.0	0.0	0.0	3.4	3.7	0.7	1.6	1.2	2.3	0.4	66.0	0.3	0.5	1.4
APBB1IP	"INAG1, RIAM"	ENSG00000077420	"Amyloid beta precursor protein binding family B member 1 interacting protein"	Q7Z5R6	10	26438341-26567803	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 145.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 88.2;dendritic cells: 149.1;Kupffer cells: 117.7;Macrophages: 93.4;Microglial cells: 381.3;NK-cells: 134.9;T-cells: 125.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 182.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 101.0;MOLT-4: 87.7;REH: 195.4;U-698: 204.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA017009, HPA063903"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA017009: AB_2669505, HPA063903: AB_2685147"	"unprognostic (1.31e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.79e-3)"	"prognostic favorable (7.48e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.77e-3)"	"unprognostic (2.68e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.38e-2)"	30.7	4.7	7.0	47.8	8.0	45.5	14.5	10.4	7.6	3.5	5.7	6.1	7.1	2.2	1.6	3.4	5.9	11.6	5.7	7.6	10.4	5.0	38.3	15.5	50.0	16.4	12.5	1.5	4.3	1.6	2.8	8.8	18.0	2.6	6.7	0.6	5.1	2.1	1.4	3.4	17.8	7.5	16.0	56.6	9.2	0.8	15.5	145.4	3.5	2.7	44.3	10.5	3.6	27.3	0.1	1.8	0.0	0.0	12.8	21.2	11.3	37.0	7.2	20.8	19.8	0.0	0.0	101.0	0.5	24.9	22.2	0.1	0.0	0.0	28.6	0.0	0.0	73.3	0.2	0.0	0.0	13.9	0.1	30.3	0.0	0.7	0.0	2.6	0.0	40.5	0.1	62.0	0.0	0.0	87.7	19.5	0.1	7.9	0.0	195.4	0.1	72.4	5.8	0.0	0.1	0.0	3.4	0.3	0.1	0.3	0.1	47.6	0.1	0.0	0.5	6.8	0.1	16.8	0.0	204.7	16.9	71.0	0.0	81.5	23.8	58.5	30.2	23.6	24.9	32.6	25.8	25.9	15.4	39.5	29.3	28.8	182.9	19.1	38.9	50.3	27.2	13.4	7.0	8.0	10.4	7.6	7.6	10.4	16.4	12.5	18.0	16.0	15.5	27.3	3.2	0.0	25.3	1.6	88.2	1.1	0.1	0.1	0.6	0.1	1.6	3.2	1.0	8.6	2.6	3.7	0.0	2.2	149.1	0.1	0.0	3.9	0.4	0.7	12.8	4.7	0.0	28.2	1.1	0.0	20.7	15.0	3.6	0.4	23.4	0.1	6.8	28.9	59.9	0.0	2.9	0.2	0.0	117.7	18.4	0.3	0.0	93.4	3.6	381.3	65.2	0.0	134.9	4.0	1.5	0.1	0.1	0.0	41.7	0.1	0.0	5.1	3.7	0.2	0.0	0.9	11.3	0.1	1.1	0.4	0.1	1.4	125.9	0.4	0.1	0.1
ARHGAP15	BM046	ENSG00000075884	"Rho GTPase activating protein 15"	Q53QZ3	2	143091362-143768352	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 79.8;lymphoid tissue: 75.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 126.3;Early spermatids: 132.3;granulocytes: 88.5;Microglial cells: 250.1;NK-cells: 89.6;T-cells: 149.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 59.4;HEL: 75.8;HL-60: 124.3;MOLT-4: 82.0;NB-4: 100.4;THP-1: 131.0;U-698: 89.5;U-937: 63.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032125			Uncertain	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA		38000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA032125: AB_10671370"	"unprognostic (1.59e-2)"	"unprognostic (2.40e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.62e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (6.95e-5)"	"unprognostic (4.40e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.58e-2)"	"unprognostic (6.94e-2)"	6.9	5.9	1.4	27.1	1.3	79.8	7.6	2.3	2.3	4.1	1.9	7.3	6.8	2.6	9.7	4.0	2.8	11.4	5.6	1.2	2.2	4.4	10.2	9.8	59.3	3.0	1.9	1.8	1.3	1.7	1.0	4.0	2.7	4.3	7.7	1.3	4.2	5.1	1.2	2.0	15.1	3.9	1.9	44.9	7.5	7.4	2.1	75.2	4.5	2.2	46.3	11.4	4.3	4.0	0.3	0.1	4.9	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	59.4	0.2	0.1	0.1	0.1	0.2	0.1	0.3	14.6	0.0	75.8	0.5	0.1	0.0	124.3	1.2	0.0	0.0	0.2	0.2	0.1	0.0	47.0	0.3	4.4	0.0	0.1	82.0	100.4	0.3	0.0	0.1	44.7	0.6	22.7	0.0	0.1	0.2	0.4	0.3	0.2	1.0	0.1	4.5	131.0	0.6	0.4	1.2	0.1	0.2	1.0	0.3	89.5	0.7	63.9	3.9	181.8	32.0	140.1	97.7	34.3	161.6	94.3	172.8	125.7	56.3	86.2	119.0	101.7	207.2	121.4	40.5	54.3	147.7	99.9	1.4	1.3	2.3	2.3	1.2	2.2	3.0	1.9	2.7	1.9	2.1	4.0	8.2	0.0	9.6	2.0	126.3	5.6	0.1	0.0	0.0	0.3	1.8	2.0	3.9	1.5	2.5	0.0	0.0	0.2	78.9	0.3	0.0	0.1	132.3	1.8	2.3	4.3	0.0	26.3	12.2	0.0	0.3	9.7	8.6	3.5	88.5	0.0	8.6	0.8	21.3	1.7	6.8	0.0	0.0	39.9	30.9	17.5	14.9	43.0	8.8	250.1	34.9	0.4	89.6	20.6	3.2	0.0	0.0	3.4	65.8	0.2	0.0	0.7	2.2	0.3	46.0	2.7	31.6	68.4	1.2	0.4	4.5	0.3	149.2	0.1	0.2	0.2
ARHGAP19	"FLJ00194, MGC14258"	ENSG00000213390	"Rho GTPase activating protein 19"	Q14CB8	10	97222173-97292673	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.3"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA035777, HPA043231"	Uncertain		Enhanced	"Plasma membrane"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane"		"HPA035777: AB_2674777, HPA043231: AB_10796791"	"unprognostic (5.88e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.00e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.97e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (7.47e-5)"	"unprognostic (1.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.29e-2)"	3.2	2.1	2.4	7.1	3.9	18.8	7.6	2.9	2.0	3.7	0.6	4.3	3.6	5.5	2.6	4.0	4.7	3.4	3.3	1.6	3.2	3.9	2.4	4.7	13.3	4.3	3.2	9.3	1.6	5.5	0.5	5.3	4.4	3.6	4.5	3.2	3.2	3.0	1.8	3.6	5.3	4.5	3.3	7.9	3.6	18.5	2.9	21.3	3.2	4.2	13.2	2.9	2.0	5.9	18.5	6.0	31.9	56.0	2.1	8.3	9.8	9.0	9.1	13.9	9.9	11.2	16.1	40.9	7.4	6.2	8.3	12.3	27.1	11.2	17.8	20.4	14.7	27.0	7.8	7.8	2.1	42.1	27.8	4.2	3.9	9.8	22.3	4.7	19.6	57.3	27.1	21.0	12.1	8.9	39.3	9.1	16.9	12.2	5.5	45.5	27.1	11.4	4.2	7.8	2.5	14.5	6.7	3.1	14.5	11.9	19.4	22.2	9.1	5.7	6.8	8.9	23.6	18.6	20.7	54.3	7.0	48.7	6.4	21.5	7.2	11.1	5.0	6.8	4.7	5.5	4.9	4.7	5.4	5.3	5.6	5.0	15.8	4.4	6.1	3.0	6.3	5.5	2.4	3.9	2.9	2.0	1.6	3.2	4.3	3.2	4.4	3.3	2.9	5.9	5.8	3.2	3.2	0.0	4.1	0.9	1.4	2.8	3.4	2.8	3.6	8.8	1.9	2.8	1.6	0.0	0.0	2.0	3.6	2.2	0.0	1.3	9.1	2.4	2.6	5.4	0.0	6.7	0.0	1.6	3.5	3.9	1.5	3.6	5.1	5.6	11.7	2.6	3.5	6.7	0.0	1.9	2.0	9.3	1.9	6.3	3.4	6.1	1.8	0.0	5.4	1.7	5.2	0.0	0.0	1.4	2.9	4.1	5.8	2.6	2.6	0.7	4.8	1.3	0.0	3.1	2.2	13.7	10.4	5.3	2.4	1.0	3.5	3.4	3.5	1.6
ARHGDIB	"GDIA2, GDID4, Ly-GDI, RAP1GN1, RhoGDI2"	ENSG00000111348	"Rho GDP dissociation inhibitor beta"	P52566	12	14942031-14961728	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 1579.9;lymphoid tissue: 1075.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 703.8;Extravillous trophoblasts: 667.6;granulocytes: 700.2;Hofbauer cells: 915.2;Kupffer cells: 742.6;Macrophages: 672.9;NK-cells: 999.0;T-cells: 895.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 1636.5;HL-60: 1927.3;HMC-1: 2070.0;JURKAT: 1421.7;MOLT-4: 2313.6;REH: 1912.5;U-698: 1750.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018584, HPA051235"	Enhanced		Supported	Cytosol		NA	NA		61000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB018584: AB_647972, HPA051235: AB_2681398"	"unprognostic (2.29e-3)"	"unprognostic (8.10e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (1.74e-1)"	"unprognostic (4.42e-3)"	"unprognostic (4.97e-2)"	"prognostic favorable (3.42e-4)"	188.8	74.1	48.7	521.0	51.2	1579.9	170.4	56.0	77.6	85.4	57.9	112.9	79.6	68.0	48.4	82.9	85.3	165.9	110.7	49.4	56.4	95.9	139.0	280.3	905.3	68.5	65.4	27.6	32.2	54.1	35.4	143.8	68.4	68.8	142.4	5.3	122.3	66.3	56.3	74.2	201.6	144.3	61.8	592.6	108.1	19.5	65.6	1075.8	110.6	79.0	1036.8	290.4	67.4	79.6	147.8	5.5	5.8	327.3	23.7	17.6	2.1	6.0	1.8	2.3	1.6	19.3	156.9	1210.9	74.3	28.0	1.9	171.1	0.0	270.8	17.9	2.3	0.0	1636.5	3.5	0.7	5.2	1927.3	2070.0	2.5	37.5	0.8	24.2	5.6	929.0	1421.7	8.7	454.5	28.8	0.8	2313.6	1382.4	7.1	3.3	1.7	1912.5	21.3	540.3	52.7	845.5	1.3	1.4	1.8	205.7	2.5	14.1	10.9	1385.1	1171.8	4.6	11.5	2.2	36.2	74.5	13.0	1750.9	5.3	1339.7	2.4	5890.8	2659.3	6464.2	2731.2	3085.1	2695.1	2676.3	3099.3	3090.3	2210.1	2532.9	2986.0	3120.5	5422.5	2408.4	3802.9	955.6	5589.7	9860.2	48.7	51.2	56.0	77.6	49.4	56.4	68.5	65.4	68.4	61.8	65.6	79.6	189.6	60.9	143.0	0.7	575.2	68.2	51.9	11.1	5.7	0.6	99.7	64.5	14.0	11.5	79.5	58.8	0.0	89.6	703.8	5.3	17.6	21.9	1.5	3.2	6.1	175.6	1.2	182.1	0.7	342.7	667.6	47.3	42.3	3.6	700.2	0.4	342.3	11.1	915.2	0.0	0.2	2.2	8.2	742.6	487.7	4.1	53.4	672.9	90.7	26.2	451.3	3.3	999.0	0.5	0.1	53.5	16.3	58.6	292.5	6.9	0.2	9.2	39.0	1.2	243.3	10.3	187.9	1.2	2.3	5.5	56.1	68.0	895.2	14.9	6.7	94.7
ARID1A	"B120, BAF250, BAF250a, C10rf4, C1orf4, P270, SMARCF1"	ENSG00000117713	"AT-rich interaction domain 1A"	O14497	1	26693236-26782104	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005456, CAB016334"	Supported		Enhanced	Nucleoplasm		NA	Yes			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB016334: AB_673396, HPA005456: AB_1078205"	"unprognostic (2.83e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (4.18e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.69e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.54e-2)"	16.4	16.3	10.1	22.7	9.4	37.0	16.4	12.9	24.3	16.2	0.0	18.0	15.4	20.4	15.8	22.2	18.3	14.0	17.4	6.3	35.8	13.3	16.8	16.8	25.8	20.8	6.8	20.8	23.2	19.3	14.3	18.6	9.9	15.1	15.3	20.1	19.3	14.4	21.6	20.5	20.3	17.5	3.0	24.3	19.5	16.7	17.9	46.4	22.6	17.6	23.7	18.4	17.8	9.0	53.2	49.5	68.6	71.5	19.6	18.5	32.3	24.4	21.1	32.7	23.0	36.3	34.1	74.3	20.7	31.8	20.7	31.6	60.3	26.9	37.9	92.7	22.6	63.6	33.0	24.7	16.1	95.2	19.6	21.7	18.8	38.7	27.5	18.2	28.6	52.5	77.7	81.1	21.5	25.1	80.1	36.8	72.4	34.5	22.9	82.2	45.3	42.1	20.3	35.3	62.9	50.7	42.7	35.7	29.0	37.8	10.6	53.4	50.6	34.9	33.5	32.4	39.9	38.0	54.9	34.1	21.2	59.8	31.5	0.2	1.5	1.5	1.6	1.2	2.1	1.8	1.3	2.1	1.4	1.6	1.7	1.9	3.3	2.1	1.3	2.4	0.7	1.9	10.1	9.4	12.9	24.3	6.3	35.8	20.8	6.8	9.9	3.0	17.9	9.0	49.9	60.9	40.4	99.9	66.6	73.4	21.0	32.5	90.0	68.0	77.2	61.5	33.0	38.6	35.9	38.6	52.1	36.5	56.1	46.5	1.9	35.3	23.3	48.8	59.3	46.3	47.5	56.6	47.1	37.6	40.2	35.9	35.7	72.3	61.2	68.4	49.6	65.6	51.0	74.0	59.8	50.2	28.5	89.0	47.5	9.0	38.5	73.2	40.9	89.9	86.4	30.8	53.5	78.9	116.1	49.7	36.4	41.8	48.5	50.0	32.4	16.7	36.1	42.3	52.6	38.2	47.3	44.1	52.2	101.8	94.3	36.7	57.0	45.8	52.1	43.2
ARL4C	"ARL7, LAK"	ENSG00000188042	"ADP ribosylation factor like GTPase 4C"	P56559	2	234493041-234497081	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 74.0"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 610.9;Langerhans cells: 474.5;NK-cells: 437.7;T-cells: 349.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 149.4;RPTEC TERT1: 284.8;U-2197: 168.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028927	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	Cytosol	"HPA028927: AB_10602387"	"unprognostic (1.93e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.20e-3)"	"prognostic unfavorable (2.90e-7)"	"unprognostic (8.01e-3)"	"unprognostic (3.35e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (3.69e-8)"	"unprognostic (8.57e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (6.99e-5)"	15.1	10.6	15.4	31.7	14.6	65.0	17.3	17.8	18.6	11.4	45.3	9.1	6.6	5.8	9.5	23.2	11.9	31.8	5.1	13.1	21.9	12.2	12.8	16.1	55.3	21.9	17.1	2.1	5.5	10.8	7.4	16.5	21.3	10.3	11.2	9.7	21.6	5.4	1.5	24.1	13.2	5.9	12.8	51.0	13.6	1.2	18.5	74.0	3.7	1.7	32.1	25.5	18.0	13.8	32.3	97.4	12.0	1.6	10.4	3.0	31.6	3.2	13.8	3.8	6.6	45.4	60.4	0.1	8.0	7.7	109.0	23.5	12.0	66.4	4.1	30.4	4.2	0.0	0.6	0.6	10.7	0.1	2.8	6.4	42.2	36.6	21.2	149.4	6.4	78.4	0.4	102.4	16.4	4.4	93.7	0.3	12.6	22.5	21.9	0.3	54.1	18.0	284.8	35.2	44.1	8.1	1.1	7.1	4.7	18.2	0.9	1.9	14.8	60.0	23.2	168.2	61.6	51.1	19.7	1.6	101.9	0.1	32.0	79.8	1.2	27.4	86.7	1.6	85.6	18.1	60.0	69.5	10.3	18.3	53.5	59.1	2.2	61.2	0.9	55.2	83.8	30.0	15.4	14.6	17.8	18.6	13.1	21.9	21.9	17.1	21.3	12.8	18.5	13.8	12.3	73.7	15.9	8.8	63.6	124.8	120.7	18.4	145.1	156.6	40.4	64.6	10.9	67.2	27.0	14.7	8.4	30.0	610.9	2.3	0.0	19.6	7.8	73.9	19.2	23.4	1.8	6.1	15.5	5.7	5.4	23.7	19.9	186.3	27.8	1.1	11.0	3.4	31.4	107.7	103.0	2.5	0.0	208.4	474.5	6.5	0.3	182.1	42.7	6.5	41.8	32.2	437.7	6.0	2.5	16.5	0.1	0.0	132.6	60.4	0.1	0.9	4.7	13.1	0.0	7.0	19.3	0.7	1.9	65.4	42.9	14.6	349.8	0.4	1.2	46.6
ARPC3	"ARC21, p21-Arc"	ENSG00000111229	"Actin related protein 2/3 complex subunit 3"	O15145	12	110434823-110450422	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006550	Approved		Uncertain	Nucleoplasm		NA	NA		3800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA006550: AB_1854869"	"unprognostic (1.83e-1)"	"unprognostic (4.21e-3)"	"unprognostic (4.15e-1)"	"unprognostic (4.26e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.10e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (9.96e-2)"	"prognostic unfavorable (2.22e-11)"	"unprognostic (3.00e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.79e-3)"	196.5	205.3	160.2	365.7	167.7	774.3	213.5	160.2	228.2	205.5	165.9	324.0	259.5	151.6	298.3	367.1	162.2	253.1	153.0	167.3	171.5	241.6	262.4	264.7	578.8	172.9	166.9	107.2	171.6	174.8	163.6	276.6	170.8	166.9	344.1	60.4	205.0	152.1	106.7	156.5	258.2	206.6	169.4	366.3	263.3	106.9	165.1	343.3	184.2	102.5	573.7	355.8	206.5	180.5	452.0	360.8	307.0	196.4	318.3	600.2	411.5	476.0	550.1	594.6	578.6	392.9	350.1	654.7	359.3	559.7	354.4	340.1	343.9	520.7	647.7	377.7	415.6	562.1	146.6	385.1	519.7	565.6	842.4	422.6	555.3	375.3	347.8	736.2	756.3	434.5	366.2	170.3	746.3	365.6	661.6	1390.3	302.7	525.8	428.6	510.9	181.5	559.4	1050.5	581.0	346.6	342.2	334.0	464.7	427.1	453.8	757.8	933.8	630.0	350.5	195.7	312.9	349.9	332.7	507.0	914.8	458.0	568.1	425.1	1313.6	1022.6	1660.3	352.4	1182.3	322.2	692.3	361.1	398.7	987.2	604.5	267.0	349.5	1607.5	418.3	1417.4	632.7	619.8	1547.5	160.2	167.7	160.2	228.2	167.3	171.5	172.9	166.9	170.8	169.4	165.1	180.5	316.2	189.1	239.5	16.6	619.4	159.5	315.8	810.1	145.1	36.1	222.3	252.2	52.2	208.8	555.8	268.5	12.5	538.2	582.4	473.2	579.2	636.3	131.2	373.6	241.1	269.0	274.1	244.0	32.4	535.1	824.0	199.0	190.6	459.6	491.8	245.8	227.7	165.5	1432.0	53.8	25.1	538.9	537.1	918.9	781.2	45.3	172.4	935.9	240.1	45.9	1221.8	184.1	545.8	23.6	41.6	630.2	665.2	157.6	352.5	313.5	422.2	777.0	407.3	35.6	249.8	108.4	329.6	209.8	200.1	365.5	171.9	721.6	462.6	323.3	401.1	629.3
BACH2	BTBD25	ENSG00000112182	"BTB domain and CNC homolog 2"	Q9BYV9	6	89926528-90296908	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.7;lymphoid tissue: 17.0"	"Group enriched"	"Detected in many"	4	"Astrocytes: 81.3;B-cells: 93.1;Excitatory neurons: 95.2;Horizontal cells: 198.5;Inhibitory neurons: 293.9;Oligodendrocyte precursor cells: 169.9;Oligodendrocytes: 253.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 14.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Daudi: 139.5;U-698: 78.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051384, HPA058384"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA051384: AB_2681462, HPA058384: AB_2683700"	"unprognostic (4.00e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.12e-3)"	"unprognostic (4.22e-1)"	"unprognostic (9.87e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.87e-4)"	1.3	0.8	2.0	4.9	3.7	11.7	1.7	3.2	4.0	1.9	0.1	0.9	0.3	2.6	0.6	0.6	1.1	0.9	1.2	2.3	3.3	0.6	2.5	2.4	17.0	4.9	2.9	3.3	1.6	1.6	0.6	1.0	3.2	1.3	0.5	1.3	1.3	0.8	3.2	2.2	2.7	1.1	1.9	4.4	0.6	1.7	2.7	12.3	0.6	2.3	12.8	1.4	1.3	7.7	1.0	0.1	5.1	0.5	0.2	0.0	0.8	0.0	0.2	0.1	0.6	0.0	0.2	139.5	0.2	0.0	0.1	0.1	0.8	1.7	0.4	0.0	1.7	0.0	0.1	0.0	0.0	0.2	0.4	1.1	0.4	0.1	3.0	0.0	0.1	8.6	5.8	11.6	0.0	0.4	3.0	0.0	1.4	0.0	1.1	19.3	3.6	2.5	0.0	0.3	4.5	12.8	0.5	0.1	0.9	1.7	0.2	0.1	0.4	0.0	1.9	0.0	0.1	8.9	0.4	78.8	0.6	1.4	1.0	2.4	0.0	0.8	0.3	0.0	0.8	2.5	0.8	0.7	0.2	14.1	3.6	2.5	0.0	1.7	0.0	0.2	0.1	0.5	2.0	3.7	3.2	4.0	2.3	3.3	4.9	2.9	3.2	1.9	2.7	7.7	4.0	0.0	0.5	81.3	93.1	7.5	11.4	1.7	15.9	5.9	5.4	7.7	2.2	0.0	2.2	3.7	41.7	0.2	10.2	0.1	0.0	6.2	19.9	2.9	7.2	2.9	0.0	2.5	95.2	2.8	0.3	8.4	1.5	11.4	0.0	0.7	2.2	3.1	0.5	198.5	293.9	0.2	0.0	0.3	11.8	10.6	5.9	3.0	3.6	38.4	2.5	0.7	20.6	169.9	253.9	3.4	0.0	4.5	7.6	20.0	0.0	0.3	0.7	1.8	0.0	13.5	4.2	0.1	2.4	3.8	7.7	0.0	23.6	0.5	0.1	3.5
BATF3	"JDP1, JUNDM1, SNFT"	ENSG00000123685	"Basic leucine zipper ATF-like transcription factor 3"	Q9NR55	1	212686417-212699840	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 9.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 41.0;Langerhans cells: 50.4;Macrophages: 24.4;monocytes: 65.7;Smooth muscle cells: 20.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 65.9;myeloid DC: 55.3;non-classical monocyte: 99.3"	"Group enriched"	"Detected in many"	34	"dendritic cells: 55.3;monocytes: 99.3"	"Cell line enriched"	"Detected in many"	11	"HDLM-2: 497.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA075858			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA075858: "	"unprognostic (3.87e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.29e-2)"	"unprognostic (6.85e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.84e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.08e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.43e-10)"	"unprognostic (9.88e-2)"	"unprognostic (5.19e-2)"	"unprognostic (3.90e-1)"	"unprognostic (7.08e-2)"	5.9	1.1	1.9	3.6	2.9	3.0	3.0	1.4	2.8	1.8	9.1	1.7	0.6	1.3	0.0	1.1	2.0	2.0	2.1	2.2	1.9	5.1	1.1	5.8	5.9	1.8	1.8	0.6	1.7	0.4	0.9	2.5	1.9	1.8	0.6	0.0	0.9	0.4	0.5	0.9	2.3	1.8	2.3	7.3	1.5	0.5	1.7	4.2	1.6	0.6	2.6	4.9	1.4	2.0	2.4	6.6	0.7	0.0	0.2	3.1	4.3	2.3	7.4	6.5	7.0	0.0	1.7	0.0	0.9	0.4	10.6	0.0	7.0	1.1	4.5	497.4	12.5	0.1	1.9	0.0	1.2	22.6	3.9	0.5	0.0	12.5	1.8	1.0	0.1	43.5	1.1	6.5	1.3	0.0	17.8	9.3	2.7	0.0	8.4	3.5	2.4	0.3	6.0	0.0	1.4	0.9	1.6	0.0	0.5	2.3	0.0	17.8	0.0	2.7	11.1	0.5	13.4	0.5	1.4	2.7	8.7	21.3	6.2	0.0	13.6	0.0	0.0	65.9	0.0	0.7	0.2	0.3	55.3	0.0	0.0	0.0	2.2	1.5	99.3	0.2	1.8	8.8	1.9	2.9	1.4	2.8	2.2	1.9	1.8	1.8	1.9	2.3	1.7	2.0	9.6	3.2	0.6	0.3	2.4	5.7	2.3	0.9	0.0	0.2	5.2	5.5	0.5	0.0	1.6	0.0	0.0	2.1	0.7	0.0	0.0	0.7	0.7	1.5	3.1	8.2	0.0	0.4	4.5	0.4	41.0	6.8	0.0	2.3	5.1	1.0	6.1	0.4	5.8	0.0	0.6	0.1	0.0	14.4	50.4	0.8	0.9	24.4	1.8	7.5	65.7	0.1	0.0	0.5	0.9	1.1	0.0	0.0	0.0	18.9	0.0	0.4	2.7	0.4	0.0	5.2	20.0	1.0	4.1	0.1	2.8	4.5	1.9	0.1	0.0	1.4
C17orf49	"BAP18, HEPIS, MGC49942"	ENSG00000258315	"Chromosome 17 open reading frame 49"	Q8IXM2	17	7014495-7017525	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 62.0;Smooth muscle cells: 41.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA022961, HPA024457"	Supported		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA022961: AB_1845592, HPA024457: AB_1845593"	"unprognostic (1.48e-2)"	"unprognostic (1.67e-3)"	"unprognostic (9.09e-2)"	"unprognostic (5.15e-2)"	"unprognostic (4.54e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.06e-9)"	"unprognostic (5.68e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.62e-2)"	62.3	42.6	54.9	61.5	54.6	122.1	55.5	55.6	60.4	42.1	49.3	37.8	34.9	36.0	53.1	52.8	49.3	38.2	53.1	53.7	55.4	47.2	47.1	55.3	97.5	54.6	54.0	35.6	50.8	37.7	40.1	36.9	54.1	35.3	42.3	39.2	42.2	26.8	69.6	63.1	37.0	34.0	54.6	73.0	35.5	28.2	57.2	97.6	52.9	55.1	105.4	53.9	39.5	55.9	68.2	88.3	136.8	106.6	95.4	134.5	47.0	36.1	58.7	70.8	57.5	43.6	54.5	64.6	97.1	86.8	23.0	55.1	34.5	69.8	53.7	227.6	91.6	58.4	27.9	85.3	71.6	37.7	74.8	85.4	92.4	52.9	106.0	50.7	112.0	51.6	21.9	179.3	87.5	77.7	62.3	125.1	45.9	77.1	51.2	38.3	40.0	95.1	80.9	44.6	37.2	105.3	63.4	32.3	67.5	49.1	41.0	47.9	61.7	40.8	50.3	69.7	93.5	63.8	39.5	22.5	63.6	55.6	59.9	259.3	159.7	157.7	190.8	225.8	122.3	238.7	195.9	193.8	251.3	221.0	128.9	143.0	148.1	391.4	177.4	346.7	215.3	193.1	54.9	54.6	55.6	60.4	53.7	55.4	54.6	54.0	54.1	54.6	57.2	55.9	9.6	3.2	10.3	0.0	18.2	10.5	5.9	8.2	13.1	1.2	8.9	11.2	1.1	2.8	7.2	1.8	0.0	10.9	18.1	8.2	17.6	17.7	0.2	2.3	4.1	12.3	30.6	8.6	0.0	23.1	16.5	6.0	2.6	4.2	18.9	3.1	9.3	2.1	11.1	0.0	0.0	12.5	14.2	7.8	32.3	1.4	4.1	12.0	24.9	0.0	62.0	2.1	16.5	0.0	0.0	24.2	14.3	1.5	14.1	6.6	8.8	6.0	4.1	3.5	6.6	6.1	41.9	5.4	18.5	11.9	11.8	10.4	17.6	3.3	14.0	6.2
C21orf58		ENSG00000160298	"Chromosome 21 open reading frame 58"	P58505	21	46300181-46323875	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.4;pituitary gland: 20.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 141.9;Enteroendocrine cells: 69.4;Erythroid cells: 80.2;Respiratory ciliated cells: 164.1;Spermatocytes: 80.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"basophil: 4.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 4.4"	"Cell line enhanced"	"Detected in many"		"REH: 62.0"	"Not detected"	"Not detected"							"HPA035110, HPA035111"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 14: REH - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nuclear bodies"	"HPA035110: AB_10603683, HPA035111: AB_2674468"	"unprognostic (2.19e-1)"	"unprognostic (6.74e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.08e-2)"	"prognostic favorable (7.00e-4)"	"unprognostic (4.74e-3)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.20e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.01e-10)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.07e-2)"	1.5	1.7	1.9	3.6	2.4	13.1	2.0	2.6	2.3	3.5	3.0	3.2	4.7	2.0	0.7	3.9	26.4	1.0	1.3	1.8	1.9	1.5	1.7	4.8	6.3	2.8	4.6	2.6	2.5	1.2	20.7	2.0	2.0	2.9	2.6	2.5	2.3	1.5	1.7	5.3	4.4	1.3	1.8	3.4	3.5	7.1	2.5	12.8	2.1	0.7	3.8	2.1	2.7	3.2	26.0	11.6	30.2	19.0	2.9	4.0	16.7	15.7	5.7	10.8	10.5	5.4	18.6	18.6	3.8	4.4	12.5	20.3	8.1	6.7	3.2	19.9	17.8	29.9	35.2	3.1	0.7	8.6	16.6	1.7	1.4	7.7	1.9	4.0	6.8	45.4	17.4	48.1	8.9	10.6	42.7	11.6	13.0	7.2	5.7	62.0	13.6	16.6	3.4	4.8	24.7	15.4	11.7	8.3	3.7	6.4	20.5	17.1	4.7	6.6	18.4	6.6	9.6	19.3	9.3	8.8	11.6	37.1	17.4	4.4	0.2	0.6	0.4	0.1	0.2	0.1	0.5	0.6	0.0	0.9	0.9	0.7	0.3	0.3	0.1	1.0	0.8	0.5	1.9	2.4	2.6	2.3	1.8	1.9	2.8	4.6	2.0	1.8	2.5	3.2	2.1	3.2	2.6	4.2	3.1	0.9	1.6	7.0	2.8	19.5	6.2	8.8	3.0	0.0	16.6	1.8	27.1	7.7	9.4	13.9	0.0	1.7	17.3	141.9	7.7	2.3	69.4	80.2	2.7	1.0	5.9	5.9	11.7	4.5	2.5	21.4	2.2	1.5	4.0	5.0	2.5	12.8	14.2	1.6	1.9	32.5	5.3	6.2	0.0	0.0	1.3	5.9	5.2	1.5	4.2	1.2	4.1	2.6	4.8	2.0	3.0	0.7	164.1	28.2	0.0	2.6	5.5	80.8	45.3	8.5	1.4	1.4	3.7	3.9	16.8	0.9
CCDC18	NY-SAR-41	ENSG00000122483	"Coiled-coil domain containing 18"	Q5T9S5	1	93179919-93278730	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.6;lymphoid tissue: 8.9;testis: 9.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 50.5;Spermatocytes: 137.2;Spermatogonia: 47.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA028035	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA028035: AB_10601795"	"unprognostic (8.79e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.89e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.49e-4)"	"unprognostic (4.36e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.64e-13)"	"unprognostic (4.94e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.44e-1)"	1.9	1.0	1.3	4.3	1.4	10.6	1.1	1.6	1.1	1.0	1.0	1.9	1.7	1.2	0.8	1.6	0.7	1.1	1.0	1.1	1.3	0.6	2.0	1.7	8.9	1.4	1.3	1.3	0.4	0.3	0.8	1.3	1.4	0.6	2.7	0.6	0.7	0.3	2.0	2.1	1.6	1.2	1.1	3.5	1.5	9.5	1.3	6.5	0.7	0.9	5.9	1.6	0.9	1.4	24.8	8.1	18.7	5.9	4.5	4.7	9.7	15.1	7.9	15.1	15.3	4.3	8.3	31.9	8.2	8.1	14.7	11.5	8.2	11.8	21.9	15.9	10.7	21.9	18.5	7.6	1.6	23.1	9.8	3.1	1.0	11.5	11.1	4.2	10.0	14.0	23.8	23.9	20.4	3.5	11.1	9.3	17.1	6.7	10.0	14.0	22.3	9.4	7.4	10.9	8.2	5.2	21.4	10.8	6.1	8.3	5.1	13.3	7.7	17.7	12.4	11.5	17.5	10.2	14.5	18.8	3.7	20.1	4.8	5.1	3.6	5.8	2.3	4.1	2.7	10.2	2.1	2.2	1.7	11.6	1.7	1.9	6.0	1.2	3.8	12.5	2.5	0.5	1.3	1.4	1.6	1.1	1.1	1.3	1.4	1.3	1.4	1.1	1.3	1.4	5.0	19.2	9.6	16.6	17.6	4.1	7.9	4.5	8.0	2.4	3.8	4.2	9.5	0.0	3.6	3.7	4.2	5.7	18.4	3.6	0.0	2.3	50.5	6.6	7.6	4.6	0.0	40.2	13.2	2.9	6.7	8.8	8.2	6.1	19.0	13.5	5.0	4.5	8.2	1.7	12.6	3.2	6.1	14.2	10.4	16.3	6.2	17.5	3.6	15.0	12.9	0.7	7.2	7.5	15.7	2.0	4.4	6.4	22.7	4.6	2.1	1.5	5.6	0.7	6.6	9.8	8.1	137.2	47.7	8.2	7.2	2.9	15.7	5.1	6.9	8.9
CCND3		ENSG00000112576	"Cyclin D3"	P30281	6	41934934-42050357	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 256.6"	"Cell type enhanced"	"Detected in all"		"NK-cells: 555.1;Syncytiotrophoblasts: 236.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 696.3;REH: 651.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000116, HPA042871"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 10: Basophils - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"CAB000116: , HPA042871: "	"unprognostic (4.53e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.45e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.25e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.45e-1)"	"unprognostic (9.17e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.45e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (8.08e-6)"	"unprognostic (2.11e-1)"	74.3	137.6	84.8	63.1	84.6	220.2	64.8	80.0	94.5	36.9	78.4	45.6	40.6	35.4	15.3	39.6	43.2	34.4	68.1	86.2	88.6	42.4	22.1	102.5	143.3	87.4	82.5	36.0	31.6	23.7	33.3	55.4	84.0	50.4	27.0	10.3	50.4	25.6	18.2	52.3	78.5	28.6	79.7	170.4	66.1	11.1	86.4	256.6	58.7	32.5	83.6	45.4	44.3	80.8	67.7	242.2	24.6	54.8	43.7	88.6	286.1	77.1	43.7	77.7	57.1	45.9	29.7	288.9	127.8	51.9	68.9	40.5	65.8	93.4	39.2	49.2	43.4	458.8	106.6	37.3	94.9	75.9	385.2	84.7	59.8	76.0	27.9	23.5	96.6	188.3	236.7	27.2	111.6	92.0	696.3	354.6	10.9	202.8	51.5	651.8	96.3	32.2	179.1	44.9	83.8	21.8	65.8	83.3	38.6	30.6	51.5	288.4	162.9	86.2	47.9	74.7	88.1	17.9	15.2	458.5	50.4	157.6	53.3	1281.3	246.3	725.1	390.4	294.4	276.5	127.1	266.4	318.1	343.3	180.8	306.4	328.3	339.3	333.2	405.6	221.4	193.0	635.4	84.8	84.6	80.0	94.5	86.2	88.6	87.4	82.5	84.0	79.7	86.4	80.8	102.2	60.9	67.9	31.0	102.9	27.0	95.8	52.3	48.9	19.6	49.9	45.1	26.2	64.3	27.8	20.2	6.2	201.0	227.3	66.4	29.4	20.3	12.8	12.1	10.8	68.3	9.6	133.6	37.1	24.3	82.4	32.3	19.9	11.2	26.6	7.7	70.6	7.2	45.3	11.8	23.7	19.5	50.8	115.7	51.7	9.4	41.3	152.2	37.4	47.8	79.0	40.8	555.1	18.1	9.3	29.9	30.5	51.9	48.7	40.3	18.6	19.8	22.5	16.2	46.0	19.2	31.9	4.3	6.3	21.7	22.6	236.6	195.0	141.6	32.7	52.8
CKLF	"C32, CKLF1, CKLF3, CKLF4, HSPC224, UCK-1"	ENSG00000217555	"Chemokine like factor"	Q9UBR5	16	66552563-66566251	"Predicted membrane proteins, Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 345.1;Spermatocytes: 300.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1384.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA062779			Approved	Vesicles	"Secreted to blood"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA062779: AB_2684867"	"unprognostic (1.64e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (2.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.79e-2)"	"unprognostic (8.05e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.06e-9)"	"unprognostic (2.36e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (2.22e-4)"	"unprognostic (1.07e-1)"	36.5	31.1	26.3	54.8	26.2	68.2	36.0	27.4	29.8	27.7	25.9	42.1	31.8	23.8	27.4	19.2	31.1	40.3	16.5	25.7	28.8	21.0	29.6	36.2	61.5	28.1	27.6	25.6	17.9	58.0	19.7	29.7	28.9	15.5	42.5	9.7	19.7	18.4	14.8	16.9	38.7	33.5	27.9	67.0	25.6	56.8	26.4	90.0	23.7	20.1	51.2	46.1	20.0	29.6	194.6	169.2	34.7	101.5	92.7	76.1	25.5	95.2	72.4	101.7	150.9	158.8	231.4	75.8	116.6	81.8	106.4	102.5	70.5	57.2	142.1	94.2	35.3	55.5	145.0	197.3	56.0	175.7	144.1	52.0	45.3	126.9	44.9	122.1	122.8	229.4	90.8	212.8	129.2	64.8	169.9	172.1	11.5	114.0	273.1	287.5	184.2	215.6	343.2	106.3	48.8	58.8	290.5	19.3	93.0	23.3	55.5	116.5	76.6	146.5	131.8	51.0	113.5	100.3	224.0	393.0	123.5	151.5	121.1	807.1	380.9	773.3	187.6	203.9	238.9	100.6	174.8	186.6	317.6	97.7	92.7	126.4	1384.5	187.6	199.2	161.6	236.0	401.2	26.3	26.2	27.4	29.8	25.7	28.8	28.1	27.6	28.9	27.9	26.4	29.6	65.7	19.2	49.0	0.0	68.7	27.3	24.7	84.2	12.0	8.4	80.8	94.0	1.8	87.2	50.8	57.0	0.0	54.8	109.7	57.1	17.6	141.4	67.7	34.8	21.5	52.4	33.0	63.5	0.0	130.0	117.7	38.6	21.4	17.5	345.1	17.7	67.5	38.4	247.4	1.7	0.0	73.6	61.1	138.2	238.4	31.4	49.4	244.2	40.9	0.0	157.8	28.1	188.4	0.0	0.0	224.2	51.3	30.1	94.6	10.0	95.9	83.4	79.3	9.0	32.9	24.5	38.1	300.0	77.1	30.8	23.0	17.4	192.6	23.9	79.0	25.8
CMTM7	"CKLFSF7, FLJ30992"	ENSG00000153551	"CKLF like MARVEL transmembrane domain containing 7"	Q96FZ5	3	32391698-32483067	"Predicted membrane proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 102.3;Ductal cells: 105.6;Hofbauer cells: 120.3;Kupffer cells: 110.7;Langerhans cells: 102.8;monocytes: 108.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 135.4;hTERT-RPE1: 135.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077409			Approved	"Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"		"HPA077409: AB_2686838"	"unprognostic (2.27e-3)"	"unprognostic (3.16e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (3.03e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (1.00e-6)"	"unprognostic (5.86e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.12e-2)"	22.8	10.4	7.5	20.7	7.7	43.7	32.6	8.6	12.9	15.2	8.7	8.4	5.3	11.1	10.9	3.9	38.7	16.0	10.1	7.3	8.2	22.1	10.1	33.0	32.2	8.9	8.3	5.5	19.9	4.0	3.7	19.2	9.2	12.1	9.3	0.6	13.1	19.9	4.0	10.1	18.3	10.5	8.7	49.3	13.4	8.6	9.5	46.1	20.5	3.1	31.4	24.1	7.2	10.8	0.4	15.8	32.8	40.2	29.8	29.0	93.4	15.5	18.0	26.5	24.3	18.0	135.4	0.1	46.7	18.1	33.0	17.4	40.6	69.1	23.2	0.0	32.8	18.5	0.1	40.6	120.8	4.7	29.0	31.0	9.0	27.2	42.6	135.1	60.0	0.2	15.8	40.9	19.6	0.4	0.2	42.9	39.7	7.0	71.7	90.5	12.3	85.0	37.7	30.9	1.6	33.9	2.0	2.6	80.8	13.9	21.3	48.7	36.2	25.3	25.5	27.9	54.4	11.6	4.6	0.2	9.3	57.9	54.2	32.4	198.7	110.8	21.3	196.8	12.7	44.2	72.1	44.2	106.8	34.7	76.5	54.1	77.3	21.6	173.6	45.0	164.1	112.6	7.5	7.7	8.6	12.9	7.3	8.2	8.9	8.3	9.2	8.7	9.5	10.8	10.3	25.6	16.7	1.0	65.5	9.8	20.2	102.3	1.8	0.5	63.4	86.0	2.1	28.6	51.9	18.4	0.0	22.2	25.0	2.0	0.0	105.6	0.2	17.4	12.8	24.2	17.3	11.6	0.5	15.5	10.0	15.2	26.0	33.1	29.8	29.0	20.7	1.3	120.3	1.7	1.4	4.4	40.7	110.7	102.8	1.2	1.5	77.2	24.9	20.6	108.1	1.4	12.3	1.0	0.3	91.8	8.1	1.2	62.9	42.0	1.2	27.5	23.3	0.2	6.6	1.2	13.5	1.2	10.4	0.9	5.5	6.8	57.4	6.1	2.8	16.3
CNOT9	"CAF40, CT129, RCD1, RCD1+, RQCD1"	ENSG00000144580	"CCR4-NOT transcription complex subunit 9"	Q92600	2	218568580-218597080	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046622	Approved		Approved	"Cytoplasmic bodies"	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Cytoplasmic bodies"		"HPA046622: AB_10962694"	"unprognostic (7.70e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.58e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (8.41e-9)"	"unprognostic (8.08e-3)"	"unprognostic (1.91e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.02e-2)"	"unprognostic (6.89e-2)"	"prognostic unfavorable (4.69e-9)"	"unprognostic (1.87e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.67e-2)"	17.2	21.9	18.3	26.0	19.7	40.2	16.6	20.8	19.4	17.8	18.9	17.7	18.1	17.6	19.4	21.4	18.8	16.1	20.1	18.7	19.4	16.3	21.0	18.2	31.3	18.6	19.2	18.7	15.8	21.0	25.2	18.0	18.6	18.4	22.6	26.1	15.1	15.0	22.4	20.5	17.3	20.2	19.4	22.6	17.1	27.0	18.9	33.6	15.4	17.1	36.2	21.8	17.6	22.1	49.9	38.2	62.2	82.2	35.2	33.8	79.8	55.5	57.4	69.6	67.4	68.2	40.4	55.4	33.7	64.3	60.9	57.2	88.1	61.6	81.4	79.8	55.6	110.6	72.1	81.1	48.9	120.2	61.7	31.0	48.5	73.1	74.2	32.7	53.1	74.0	67.1	121.1	56.3	40.0	117.2	72.8	94.5	38.4	60.4	97.8	88.7	57.1	37.1	71.5	79.2	64.8	54.5	47.5	52.2	59.1	38.1	66.5	43.2	75.5	55.8	55.3	69.0	57.6	62.6	128.3	53.7	73.1	55.0	36.9	25.6	29.1	41.5	31.7	36.4	29.9	34.0	35.4	30.4	26.6	31.8	35.0	10.5	35.5	34.0	35.1	30.8	37.9	18.3	19.7	20.8	19.4	18.7	19.4	18.6	19.2	18.6	19.4	18.9	22.1	22.1	22.4	20.7	0.0	10.0	0.0	0.0	0.0	0.0	0.0	20.4	15.1	0.0	0.0	9.9	12.9	0.0	28.4	27.1	0.0	27.4	21.2	0.0	32.2	21.2	10.3	0.0	0.0	0.0	20.7	40.7	10.9	0.0	22.4	16.4	18.9	0.0	0.0	28.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	20.7	0.0	0.0	0.0	0.0	25.6	0.0	0.0	7.0	0.0	0.0	16.1	10.2	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	28.3	11.0	16.9	0.0	0.0
CNTRL	"CEP1, CEP110"	ENSG00000119397	Centriolin	Q7Z7A1	9	121074753-121177610	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 28.0;testis: 35.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 131.7;Spermatocytes: 385.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 81.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020468, HPA020480, HPA051583"	Approved		Approved	"Centriolar satellite,Centrosome,Cytosol"		NA	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Centrosome, Cytosol"	"Centriolar satellite"	"HPA020468: AB_2670455, HPA020480: AB_2670457, HPA051583: AB_2681542"	"unprognostic (4.33e-3)"	"unprognostic (2.89e-3)"	"unprognostic (2.09e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (9.21e-5)"	"unprognostic (1.05e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.60e-3)"	"unprognostic (9.83e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.13e-2)"	5.3	3.7	2.5	13.8	3.6	28.0	5.0	4.0	3.2	4.4	6.9	4.6	4.0	6.7	2.7	4.1	7.8	5.4	2.8	2.1	3.3	2.8	4.1	6.7	23.3	5.4	5.5	7.5	3.9	2.8	3.1	6.3	4.1	4.5	5.6	7.5	3.6	3.8	1.1	4.9	5.2	4.9	3.7	12.6	7.8	35.3	3.4	23.9	4.8	1.8	21.7	6.5	2.8	5.3	12.6	8.3	22.5	16.4	3.3	4.9	4.2	8.4	6.2	6.6	5.6	4.7	13.2	55.7	3.3	6.3	11.8	25.2	7.6	5.2	10.4	34.3	5.5	29.4	15.2	6.1	4.5	81.0	34.1	3.1	3.8	6.9	16.5	2.8	14.6	22.7	19.2	31.0	6.5	7.9	31.2	21.5	8.1	16.0	6.6	30.1	33.4	17.4	3.1	5.7	8.5	12.9	28.4	5.2	6.3	3.9	11.0	36.0	10.3	6.7	11.6	10.8	15.8	22.0	25.6	37.8	5.6	32.2	16.1	16.2	7.0	17.0	7.2	4.3	5.5	11.7	7.5	5.5	3.7	11.9	9.0	6.4	2.7	5.0	6.5	10.6	11.5	2.8	2.5	3.6	4.0	3.2	2.1	3.3	5.4	5.5	4.1	3.7	3.4	5.3	19.8	28.9	32.8	34.9	78.7	3.3	13.8	6.8	9.1	33.5	7.4	12.2	8.9	10.0	29.5	3.7	37.5	2.7	58.2	2.7	3.9	5.1	131.7	61.8	12.3	14.8	8.4	33.2	35.4	6.0	3.0	15.1	14.8	10.9	53.0	20.6	14.6	3.9	27.2	30.3	43.8	8.4	4.1	33.9	16.5	44.3	13.7	50.7	8.8	52.5	55.2	8.2	49.4	37.2	53.1	6.3	4.5	12.0	39.1	4.3	2.2	1.4	114.6	59.6	39.5	33.8	14.5	385.0	114.1	10.9	5.7	0.8	57.0	13.1	6.4	6.2
CORO1A	"coronin-1, HCORO1, p57"	ENSG00000102879	"Coronin 1A"	P31146	16	30182827-30189076	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 568.8;lymphoid tissue: 583.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 523.9;dendritic cells: 588.7;Hofbauer cells: 494.4;Kupffer cells: 395.8;Macrophages: 342.7;monocytes: 583.7;NK-cells: 968.1;T-cells: 663.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 924.0;HL-60: 645.7;HMC-1: 1086.7;JURKAT: 603.0;MOLT-4: 632.5;NB-4: 771.8;RPMI-8226: 980.9;U-698: 618.2;U-937: 829.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046473, HPA051132"	Enhanced		Approved	Cytosol		NA	NA		45000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB046473: AB_10602363, HPA051132: AB_2681355"	"unprognostic (4.17e-3)"	"unprognostic (3.64e-3)"	"unprognostic (3.86e-2)"	"prognostic favorable (6.91e-4)"	"unprognostic (2.41e-1)"	"prognostic favorable (4.42e-4)"	"unprognostic (1.99e-2)"	"unprognostic (8.27e-3)"	"unprognostic (8.26e-3)"	"unprognostic (4.30e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (5.74e-7)"	"unprognostic (2.55e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.01e-1)"	29.1	20.8	34.4	306.4	37.1	568.8	11.2	24.9	52.0	10.6	23.6	26.8	44.3	10.0	3.1	22.5	17.9	45.0	11.3	36.9	31.9	11.5	13.1	49.5	583.8	37.6	32.0	6.4	8.4	4.3	9.3	18.4	32.2	11.4	15.3	0.9	32.9	7.3	6.7	17.6	111.0	22.2	35.8	321.4	49.0	4.8	33.9	257.6	12.7	8.8	309.1	57.6	10.4	50.0	3.1	3.6	10.9	21.5	0.1	0.1	6.1	2.6	0.7	5.4	3.0	0.7	6.9	924.0	6.1	0.9	1.5	4.4	5.2	10.8	1.3	302.3	2.5	97.9	0.5	15.0	1.7	645.7	1086.7	2.8	0.0	4.3	0.5	0.4	2.0	603.0	1.5	467.6	3.4	80.7	632.5	771.8	4.0	3.1	6.4	340.0	17.5	980.9	1.3	5.1	17.3	13.0	2.2	110.7	2.0	0.2	1.9	373.0	1.6	4.0	9.0	2.7	3.1	348.5	497.7	618.2	3.0	829.6	6.3	797.2	773.6	2671.1	637.5	859.7	597.8	505.5	567.3	625.6	843.2	512.0	537.1	566.2	1318.9	531.0	898.0	482.1	858.7	1647.2	34.4	37.1	24.9	52.0	36.9	31.9	37.6	32.0	32.2	35.8	33.9	50.0	6.3	22.4	32.5	0.3	523.9	11.3	1.2	3.2	2.2	1.2	4.7	5.5	1.5	17.2	6.0	1.8	0.0	4.6	588.7	2.3	0.0	3.5	0.5	1.1	2.0	12.3	6.0	60.2	3.3	0.9	17.4	9.5	18.8	1.3	83.7	0.6	21.8	4.8	494.4	0.0	1.7	2.2	6.1	395.8	197.9	1.2	0.6	342.7	32.0	4.7	583.7	0.8	968.1	1.5	0.4	11.1	47.5	0.0	201.4	0.8	1.0	4.8	3.5	0.9	6.6	2.9	5.1	0.1	0.9	2.4	9.1	4.9	663.0	2.7	3.3	0.9
CTNNBL1	"C20orf33, FLJ21108, NAP, NYD-SP19, P14, P14L"	ENSG00000132792	"Catenin beta like 1"	Q8WYA6	20	37693955-37872129	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 372.9;granulocytes: 263.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 308.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004742, HPA027906, HPA027907"	Approved		Enhanced	Nucleoplasm,Centrosome,Cytosol		No	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	"Centrosome, Cytosol"	"HPA004742: AB_1847323, HPA027906: , HPA027907: AB_10601362"	"unprognostic (2.81e-1)"	"unprognostic (3.42e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.31e-2)"	26.9	16.8	20.9	27.3	22.8	41.8	23.8	21.6	24.8	23.7	23.4	31.8	21.7	27.7	31.1	23.4	25.3	19.8	32.3	22.0	22.4	22.9	46.8	25.3	39.3	22.8	22.3	27.1	17.3	19.7	18.2	22.1	21.7	23.4	23.1	18.8	18.5	30.6	33.3	25.3	25.1	30.6	21.6	54.0	34.8	43.3	22.1	40.1	17.1	20.9	41.2	25.8	20.4	23.6	66.7	60.3	56.7	44.6	40.3	32.8	89.2	41.9	43.7	98.0	86.0	224.8	52.4	73.9	59.6	42.7	94.4	69.8	77.1	98.6	105.3	36.1	38.0	243.0	33.2	110.2	41.8	77.4	308.0	35.1	58.9	55.6	54.8	34.1	59.8	103.8	66.8	29.6	53.5	54.9	127.0	101.4	51.4	74.9	85.8	87.9	109.1	56.3	42.9	55.0	45.1	53.6	72.5	102.3	75.4	52.3	50.6	61.1	44.5	97.4	58.0	64.9	68.8	34.1	46.6	85.5	68.5	48.6	52.7	267.9	77.7	103.3	51.0	103.0	49.1	88.9	49.9	53.8	110.3	83.4	49.8	53.6	16.9	79.9	109.6	86.9	66.2	71.3	20.9	22.8	21.6	24.8	22.0	22.4	22.8	22.3	21.7	21.6	22.1	23.6	28.6	28.9	26.4	21.2	40.0	22.8	32.9	40.7	13.1	26.1	13.0	13.2	39.8	17.2	34.1	18.4	18.8	147.8	40.4	21.1	37.2	34.8	372.9	24.2	24.9	32.5	20.9	43.7	31.6	34.7	69.4	28.7	48.4	21.6	263.6	34.4	44.3	45.2	49.3	18.5	35.6	27.3	42.7	36.0	35.5	131.2	34.2	44.5	26.6	14.0	89.8	32.1	40.2	30.7	39.8	31.9	21.5	33.4	21.6	22.3	34.7	43.1	26.1	25.8	19.7	25.4	48.0	79.4	45.2	10.7	22.4	52.9	38.8	23.7	24.2	20.6
CWF19L1	"FLJ10998, hDrn1"	ENSG00000095485	"CWF19 like cell cycle control factor 1"	Q69YN2	10	100232298-100267680	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA036889, HPA036890"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Golgi apparatus"		"HPA036889: AB_10670928, HPA036890: AB_10696789"	"unprognostic (2.76e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (3.04e-1)"	"unprognostic (9.17e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.50e-3)"	"unprognostic (5.61e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.10e-1)"	8.1	6.9	5.9	11.4	6.3	18.8	11.6	7.5	7.6	7.9	5.1	7.2	6.8	8.2	5.7	6.9	8.7	6.7	7.4	5.9	6.5	7.8	8.2	7.5	16.4	6.0	5.8	10.3	8.0	9.0	6.1	9.0	6.3	6.8	8.6	10.3	8.6	6.5	10.1	11.2	8.1	9.3	6.3	11.8	6.6	14.3	6.0	14.8	8.1	10.2	16.9	8.5	6.6	8.4	29.1	18.8	18.7	29.2	9.1	10.8	20.7	17.2	23.8	37.5	30.6	21.5	22.6	30.5	19.4	16.6	16.3	27.9	42.2	24.9	39.6	19.4	20.8	17.5	15.8	20.6	15.8	44.7	19.6	15.2	10.4	28.0	26.2	14.2	26.6	30.8	20.7	26.8	21.9	18.3	36.2	32.4	14.7	15.0	23.2	12.6	29.2	21.2	15.0	16.5	9.4	16.8	20.6	10.3	26.0	12.6	37.3	19.1	18.6	15.8	21.5	18.3	32.8	23.9	29.6	17.9	20.1	39.1	11.4	10.0	17.0	22.7	12.8	15.9	16.3	14.0	13.3	14.4	14.9	13.0	14.9	15.0	9.6	18.1	14.7	6.8	17.7	13.8	5.9	6.3	7.5	7.6	5.9	6.5	6.0	5.8	6.3	6.3	6.0	8.4	8.0	19.2	10.8	14.0	16.2	4.5	7.7	6.8	4.6	9.5	4.8	3.9	8.0	5.7	11.3	5.5	4.2	10.4	13.5	4.3	7.9	6.0	23.6	6.8	6.4	8.3	4.2	11.2	26.8	7.7	11.0	6.7	4.6	6.3	17.7	8.3	7.5	5.9	9.5	10.1	24.3	4.2	10.2	13.1	5.7	5.3	6.8	11.3	8.8	14.0	15.5	5.1	19.6	18.6	24.0	7.2	6.7	4.1	11.3	5.3	4.5	6.2	12.5	12.3	0.0	8.4	6.9	18.4	12.2	5.8	7.7	10.9	12.8	6.7	5.3	4.4
CXCR4	"CD184, D2S201E, fusin, HM89, HSY3RR, LESTR, NPY3R, NPYR, NPYY3R"	ENSG00000121966	"C-X-C motif chemokine receptor 4"	P61073	2	136114349-136118149	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 1175.1;lymphoid tissue: 549.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 1446.9;dendritic cells: 1015.1;Langerhans cells: 486.2;Macrophages: 513.6;Plasma cells: 534.2;T-cells: 1436.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 580.8;JURKAT: 323.6;Karpas-707: 302.1;MOLT-4: 538.9;REH: 281.0;U-266/70: 648.5;U-698: 677.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"				"unprognostic (1.19e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.99e-2)"	"unprognostic (9.25e-2)"	"unprognostic (6.06e-2)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (1.41e-7)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.57e-1)"	"unprognostic (3.47e-2)"	"unprognostic (9.33e-2)"	51.8	184.5	11.8	297.9	11.4	1175.1	39.6	14.6	23.8	36.1	20.1	33.2	12.6	35.2	5.5	34.9	64.9	84.5	21.8	10.6	19.7	29.0	52.4	95.5	383.8	24.3	12.8	12.9	10.0	12.3	32.6	57.5	18.2	34.1	48.6	7.8	30.2	11.8	5.2	9.8	246.5	28.1	16.7	346.5	64.0	4.0	15.2	491.2	36.7	12.0	549.3	99.3	26.9	32.3	0.8	0.3	9.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	580.8	1.8	0.0	0.4	0.7	1.7	0.0	0.0	29.6	6.9	35.1	84.3	0.0	0.0	81.5	60.7	0.0	0.0	0.0	0.0	0.0	54.5	323.6	1.0	302.1	0.0	1.5	538.9	72.8	9.3	45.4	2.9	281.0	62.6	102.5	4.5	0.0	30.9	26.1	0.6	2.0	0.3	2.9	0.7	156.7	8.1	0.0	2.0	0.5	0.4	648.5	116.7	677.4	0.1	131.8	0.1	87.0	28.5	117.8	83.8	15.6	67.3	115.6	76.5	79.6	25.7	166.2	113.1	109.5	143.3	17.2	9.1	63.7	76.1	51.9	11.8	11.4	14.6	23.8	10.6	19.7	24.3	12.8	18.2	16.7	15.2	32.3	32.0	16.0	42.2	8.5	1446.9	41.0	5.7	0.3	9.6	8.6	46.1	42.2	5.2	11.5	4.4	3.7	0.0	1.5	1015.1	1.1	13.7	5.1	1.2	20.0	8.9	67.6	1.8	67.5	0.0	0.9	4.2	28.9	52.0	71.0	12.6	9.0	29.6	9.1	159.9	0.0	0.2	2.0	10.2	270.0	486.2	2.9	1.5	513.6	113.8	3.7	189.2	1.0	153.5	0.0	2.0	2.3	1.1	2.6	534.2	3.2	0.0	3.2	2.4	0.8	46.0	99.1	23.1	0.5	7.8	8.5	35.7	6.3	1436.5	4.6	1.8	4.5
DCP2	NUDT20	ENSG00000172795	"Decapping mRNA 2"	Q8IU60	5	112976702-113022195	"Enzymes, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011677, HPA057676"	Approved		Approved	"Nucleoplasm,Cell Junctions,Cytoplasmic bodies"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytoplasmic bodies"	"Cell Junctions"	"CAB011677: AB_731858, HPA057676: AB_2683500"	"unprognostic (2.76e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.86e-3)"	"prognostic unfavorable (4.84e-4)"	"unprognostic (1.87e-1)"	"unprognostic (3.64e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.30e-2)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (8.39e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.75e-2)"	4.6	4.0	5.9	8.1	6.0	14.0	6.9	9.8	5.7	6.0	6.6	3.9	3.7	4.3	3.4	4.1	4.7	3.5	3.4	5.9	7.2	4.8	4.7	6.9	12.6	5.5	4.9	6.7	3.3	3.1	3.7	12.1	5.8	4.4	4.1	7.4	5.3	3.5	4.8	5.8	5.1	3.3	4.5	10.2	4.0	3.8	8.5	17.9	3.7	3.9	12.3	4.4	5.2	5.1	6.4	5.6	24.1	19.0	4.5	5.3	37.0	6.7	4.3	7.2	9.8	25.0	13.1	32.2	8.5	3.2	5.6	7.9	27.6	7.1	8.8	9.0	11.0	29.5	4.6	9.9	5.4	20.1	15.3	4.8	5.3	8.4	9.0	6.9	12.5	24.8	22.7	12.0	6.1	8.1	29.6	19.6	20.8	4.0	2.9	27.0	22.7	12.2	10.5	15.4	5.6	11.4	8.3	8.8	11.3	24.1	25.3	24.4	7.7	7.8	13.9	4.4	8.8	8.8	19.8	23.6	4.7	26.0	6.3	14.0	4.9	3.7	3.0	6.1	4.2	3.8	3.7	3.0	5.1	2.5	3.4	3.7	9.4	3.5	7.3	2.9	4.3	2.6	5.9	6.0	9.8	5.7	5.9	7.2	5.5	4.9	5.8	4.5	8.5	5.1	30.0	19.2	16.8	16.0	50.7	27.8	19.9	22.3	31.9	24.7	43.5	26.4	12.4	8.6	24.1	20.2	79.2	66.7	65.0	11.6	19.6	11.2	24.3	21.7	38.1	28.9	16.2	41.9	25.5	11.8	49.6	25.7	17.3	25.7	19.6	66.7	28.5	7.0	31.7	28.6	34.1	8.9	20.3	78.1	41.5	53.8	19.0	57.4	26.6	56.2	90.7	36.9	35.0	26.7	28.8	17.3	10.6	10.9	27.1	33.3	13.8	14.4	22.7	34.6	6.6	16.5	32.3	36.6	29.5	20.0	26.6	64.4	50.1	52.0	13.1	48.8
DDX39A	"BAT1L, DDX39, DDXL, URH49"	ENSG00000123136	"DExD-box helicase 39A"	O00148	19	14408798-14419383	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 147.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 308.4;Late spermatids: 283.3;Spermatocytes: 307.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055334	Approved		Approved	"Nuclear speckles"		NA	NA		200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles"		"HPA055334: AB_2682787"	"unprognostic (1.31e-1)"	"prognostic favorable (6.86e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (1.50e-10)"	"unprognostic (1.55e-3)"	"unprognostic (8.57e-2)"	"unprognostic (3.92e-1)"	"unprognostic (7.38e-3)"	28.2	21.6	17.1	49.6	20.7	105.5	24.7	21.9	23.0	22.1	18.0	26.4	28.6	21.9	8.7	39.3	18.2	13.6	24.9	17.0	18.6	21.0	21.9	25.1	76.2	21.9	19.8	14.9	15.7	10.2	15.5	18.1	22.0	16.8	20.2	4.7	19.0	8.8	20.7	24.4	33.8	15.1	19.0	55.7	27.2	147.8	20.5	80.4	20.5	12.7	65.1	25.9	22.7	25.2	198.8	175.9	87.8	147.2	32.4	22.4	73.5	84.8	48.0	176.1	105.7	183.3	98.7	375.0	87.5	71.1	101.0	114.8	215.7	135.9	74.3	129.0	127.3	408.5	201.0	133.1	55.1	225.1	164.0	30.1	30.6	113.1	47.0	25.4	89.1	134.4	253.4	150.3	95.7	270.9	375.4	320.1	147.9	208.8	280.4	248.9	139.7	212.0	62.5	179.6	181.5	98.2	64.3	127.8	98.6	54.3	138.0	216.5	83.1	144.5	92.7	245.7	192.6	156.0	313.0	399.3	167.1	232.2	148.9	33.2	92.8	29.6	120.1	107.9	106.2	132.5	96.0	96.3	131.1	125.8	83.1	90.1	27.0	84.1	94.3	82.7	153.0	135.5	17.1	20.7	21.9	23.0	17.0	18.6	21.9	19.8	22.0	19.0	20.5	25.2	55.6	16.0	21.4	4.9	90.0	76.0	43.6	53.0	50.1	10.5	30.0	24.8	10.9	21.5	27.4	5.5	0.0	60.6	75.1	60.5	37.2	55.3	308.4	26.6	30.6	53.0	25.7	88.1	3.1	67.2	117.9	33.3	87.7	44.5	93.0	32.7	26.0	12.9	90.5	11.8	3.5	55.4	26.4	48.6	85.2	283.3	26.4	62.7	49.8	4.7	56.7	16.2	50.4	4.0	9.2	53.5	42.7	18.8	115.6	44.5	41.7	26.0	21.1	4.9	19.7	24.8	62.0	307.5	95.4	69.4	71.0	59.9	78.7	32.1	63.8	34.2
DOCK2	KIAA0209	ENSG00000134516	"Dedicator of cytokinesis 2"	Q92608	5	169637268-170083382	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 61.6;lung: 16.4;lymphoid tissue: 51.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 53.3;dendritic cells: 78.1;Kupffer cells: 93.2;Macrophages: 78.0;Microglial cells: 173.3;monocytes: 72.5;T-cells: 50.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 123.4;HDLM-2: 172.7;HL-60: 132.7;HMC-1: 135.8;MOLT-4: 94.5;U-698: 112.4;U-937: 85.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036469	Enhanced					NA	NA		46000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA036469: AB_2675140"	"unprognostic (3.45e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.92e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.95e-2)"	"unprognostic (7.24e-2)"	7.7	3.6	1.4	34.4	2.4	61.6	3.6	1.9	2.6	3.1	2.8	7.6	5.0	2.3	1.3	3.3	2.4	9.6	1.6	1.8	2.5	1.2	5.5	16.4	42.5	6.4	3.7	1.6	1.9	1.5	0.8	7.3	4.6	1.8	7.8	0.2	2.6	1.9	0.9	1.2	9.6	7.0	4.6	36.5	8.1	1.7	6.3	51.4	1.5	1.4	46.9	9.9	1.1	8.4	0.4	0.3	0.0	0.0	0.0	0.4	0.0	3.3	0.0	8.2	14.3	0.0	0.0	123.4	4.5	13.0	3.9	0.1	0.1	0.6	19.5	172.7	0.3	71.0	3.4	0.0	0.2	132.7	135.8	0.4	0.0	6.3	0.0	5.5	0.5	65.1	1.4	60.3	8.7	0.0	94.5	27.0	0.2	0.0	0.0	59.9	4.8	49.3	3.0	0.0	0.4	0.0	0.5	0.1	0.0	0.0	0.1	64.8	0.4	5.9	6.8	4.1	9.1	18.6	40.9	112.4	7.3	85.1	0.2	19.7	28.6	22.0	12.3	48.6	12.6	13.2	11.3	12.6	29.8	9.7	7.8	9.5	29.4	13.5	72.1	10.9	11.7	24.0	1.4	2.4	1.9	2.6	1.8	2.5	6.4	3.7	4.6	4.6	6.3	8.4	1.4	0.0	3.9	2.0	53.3	0.9	0.2	0.0	0.0	0.0	0.7	2.3	1.7	0.0	2.5	0.0	0.0	0.3	78.1	0.2	0.0	0.0	5.9	0.3	0.3	1.5	0.0	15.1	9.6	0.0	0.3	1.3	1.5	0.3	33.6	0.8	1.8	1.3	42.6	0.0	4.9	0.0	0.0	93.2	31.1	5.6	0.3	78.0	5.4	173.3	72.5	0.0	47.4	4.0	21.7	0.2	0.1	0.0	39.6	0.1	0.0	0.2	0.7	0.1	6.6	0.7	0.6	2.8	1.4	0.2	2.0	0.8	50.8	0.3	0.1	0.1
DUT	dUTPase	ENSG00000128951	"Deoxyuridine triphosphatase"	P33316	15	48331011-48343373	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 508.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054422, HPA060360"	Enhanced		Supported	Nucleoplasm		No	Yes		31000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA054422: AB_2682483, HPA060360: AB_2684262"	"unprognostic (1.82e-1)"	"unprognostic (3.49e-2)"	"unprognostic (7.89e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.16e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.87e-2)"	"unprognostic (4.25e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.71e-2)"	73.0	65.3	54.7	61.7	58.9	162.9	76.4	57.1	77.2	90.7	60.0	69.5	29.3	76.9	49.7	72.1	77.6	33.6	68.9	53.9	59.6	67.6	53.6	58.1	97.8	58.2	55.5	86.1	53.2	48.3	80.0	45.1	58.3	77.8	47.1	49.1	66.5	48.3	57.9	71.6	66.5	40.4	57.7	82.1	61.5	57.3	57.5	111.4	89.2	53.0	87.8	69.1	78.0	63.5	196.1	60.2	143.9	137.1	98.4	104.0	85.3	202.1	128.1	182.8	224.6	69.8	131.0	539.3	106.0	112.0	149.4	262.1	152.4	138.4	177.6	383.4	157.2	442.2	151.8	96.1	54.8	469.0	202.0	64.4	92.1	123.9	65.0	117.8	123.3	316.6	244.0	297.6	136.5	79.3	422.4	548.7	90.7	197.4	114.5	338.6	313.9	570.0	120.8	130.4	207.2	210.1	150.0	119.6	184.4	145.5	169.6	368.6	103.0	190.1	183.1	228.3	269.7	238.1	534.3	532.5	143.6	789.4	213.4	32.5	50.3	46.8	52.9	53.1	68.7	94.8	94.7	84.6	74.0	90.0	97.4	64.3	30.9	60.5	68.4	85.3	94.3	71.4	54.7	58.9	57.1	77.2	53.9	59.6	58.2	55.5	58.3	57.7	57.5	63.5	153.6	54.5	38.9	39.8	126.8	179.6	212.0	222.4	131.5	48.3	158.0	205.5	120.1	95.8	118.5	104.8	14.6	221.8	103.9	62.8	203.5	94.3	36.8	67.2	123.5	123.0	96.1	418.8	36.5	46.5	286.8	147.9	76.5	86.0	84.4	118.3	101.4	77.6	174.5	82.4	32.1	98.4	105.8	87.7	112.6	31.5	184.8	92.0	154.7	23.4	89.5	106.3	95.8	23.6	45.1	45.4	58.8	177.6	192.3	133.2	27.2	256.4	59.6	40.9	157.8	167.1	154.0	508.7	270.0	206.4	168.5	97.1	124.4	82.3	195.4	181.2
EAF2	"BM040, TRAITS, U19"	ENSG00000145088	"ELL associated factor 2"	Q96CJ1	3	121835183-121886526	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 71.8;lymphoid tissue: 53.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 73.7;Plasma cells: 144.1;Proximal tubular cells: 128.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"memory B-cell: 104.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 73.5;HL-60: 114.9;THP-1: 59.9;U-698: 93.5;U-937: 64.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA008411	Enhanced					NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA008411: AB_1847950"	"unprognostic (3.43e-1)"	"prognostic favorable (2.25e-9)"	"unprognostic (1.48e-1)"	"prognostic favorable (2.66e-4)"	"unprognostic (1.00e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.89e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.04e-2)"	"unprognostic (8.34e-2)"	4.3	2.6	2.3	19.5	2.0	71.8	10.0	2.1	3.1	5.5	1.5	10.3	8.9	2.0	4.9	2.7	1.4	5.0	1.7	2.7	2.4	30.2	3.5	4.3	53.6	2.1	2.4	1.0	4.2	3.1	3.3	2.9	2.2	21.0	11.6	1.7	7.6	8.4	0.8	1.0	7.7	3.5	1.4	16.9	8.2	4.6	3.0	7.7	1.7	1.3	43.4	7.8	1.4	2.0	3.5	3.0	2.0	2.5	0.7	2.1	6.0	1.3	0.8	2.4	4.4	5.8	2.0	73.5	1.5	0.3	7.7	5.7	5.0	3.0	6.0	35.8	2.9	42.4	3.0	11.1	1.0	114.9	44.7	1.0	6.9	2.8	2.6	0.0	2.3	10.0	5.0	14.2	1.1	1.0	16.3	15.1	2.9	13.8	2.5	17.1	6.4	11.2	2.4	4.3	2.5	0.6	2.1	2.0	5.7	5.5	1.8	59.9	0.7	1.5	2.4	1.4	3.4	25.4	12.2	93.5	2.8	64.0	4.7	11.9	18.8	42.8	1.4	41.2	2.8	104.4	2.2	1.5	22.5	97.4	2.9	1.6	3.5	1.8	54.7	30.5	2.7	13.1	2.3	2.0	2.1	3.1	2.7	2.4	2.1	2.4	2.2	1.4	3.0	2.0	4.5	3.2	4.2	48.0	73.7	2.4	6.9	25.0	6.2	1.3	5.9	6.6	4.3	0.0	16.5	1.8	4.2	15.5	15.3	2.9	17.6	4.4	36.4	4.3	2.0	2.5	1.2	10.3	17.3	17.6	2.2	4.9	7.7	7.7	10.1	2.5	3.9	1.6	16.5	0.0	28.6	5.7	16.2	32.4	15.7	4.6	5.0	29.8	16.0	8.4	29.5	9.4	6.2	12.1	7.7	4.2	4.7	3.0	144.1	11.1	2.4	128.0	9.1	5.3	0.0	4.5	4.6	37.6	18.1	2.3	2.4	7.7	11.1	2.2	3.5	5.9
EDEM1	"EDEM, KIAA0212"	ENSG00000134109	"ER degradation enhancing alpha-mannosidase like protein 1"	Q92611	3	5187646-5219958	"Plasma proteins, Predicted intracellular proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 79.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 100.7;Langerhans cells: 194.0;Plasma cells: 135.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 184.4;U-698: 162.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029565	Uncertain		Enhanced	"Endoplasmic reticulum,Aggresome"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum"	Aggresome	"HPA029565: AB_10602032"	"unprognostic (3.03e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.57e-3)"	"unprognostic (4.30e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.60e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.49e-2)"	"unprognostic (5.72e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-1)"	11.2	11.3	5.5	31.3	6.6	66.5	14.4	3.7	6.2	11.6	4.4	15.6	14.1	11.9	12.6	16.7	10.7	12.2	7.2	5.2	5.6	12.5	59.3	29.8	41.4	6.5	5.2	13.1	24.9	17.2	9.4	14.0	4.9	12.4	16.9	5.6	13.3	10.7	5.7	17.2	18.7	12.5	5.4	24.4	17.7	10.5	6.7	79.1	17.6	5.4	42.5	16.7	13.2	6.4	18.0	17.8	11.1	11.1	14.3	31.6	35.1	28.8	38.8	19.5	25.5	8.2	23.4	95.9	15.2	28.6	42.3	13.9	12.1	39.8	29.6	184.4	7.1	32.7	16.9	18.7	66.2	39.0	91.8	28.7	47.4	41.6	45.5	26.4	39.2	122.1	8.7	128.2	24.4	10.6	78.9	14.9	5.6	8.2	13.4	113.2	19.6	90.0	22.4	37.0	1.4	14.5	20.8	29.6	44.4	9.8	15.2	123.3	38.7	37.2	25.7	32.1	33.6	75.1	49.4	162.3	61.8	37.1	31.8	2.9	2.6	3.1	4.0	3.7	5.7	6.7	5.9	4.4	3.3	4.4	5.2	4.1	3.0	2.1	4.6	7.5	6.7	2.0	5.5	6.6	3.7	6.2	5.2	5.6	6.5	5.2	4.9	5.4	6.7	6.4	11.8	60.9	100.7	10.7	51.1	20.6	7.0	15.5	10.2	5.3	17.2	11.0	3.1	20.0	19.9	16.5	10.4	10.0	29.1	23.8	0.0	7.0	14.4	11.4	14.8	12.6	8.4	12.6	17.4	12.2	32.8	11.3	20.9	20.0	23.5	8.1	12.8	76.2	17.0	1.7	15.4	26.4	14.2	32.9	194.0	63.1	8.4	44.3	16.0	14.0	43.1	3.3	12.3	11.1	10.3	15.2	4.7	9.1	135.5	12.5	16.1	8.5	11.0	4.0	0.0	9.4	13.6	7.8	5.5	23.1	27.3	40.9	25.5	5.1	12.3	20.7
ELK4	SAP1	ENSG00000158711	"ETS transcription factor ELK4"	P28324	1	205597556-205632011	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 104.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 6.6"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028863	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA028863: AB_10602492"	"unprognostic (2.08e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (4.65e-4)"	"unprognostic (2.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (2.94e-6)"	"unprognostic (2.21e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.58e-3)"	9.0	4.9	7.4	11.5	11.0	11.7	8.1	12.2	7.5	8.2	7.0	6.9	6.1	7.7	7.2	8.0	6.7	9.2	7.0	6.0	6.4	7.8	13.2	9.7	17.5	8.5	8.8	6.7	8.1	7.8	5.5	7.9	9.9	26.0	6.8	9.3	8.2	5.7	10.6	13.5	9.6	6.1	9.1	15.8	7.7	7.3	8.5	14.1	6.9	8.7	16.8	9.6	9.3	14.1	14.9	13.2	5.1	13.3	11.9	15.2	12.9	9.8	10.1	7.6	8.9	5.7	14.6	31.3	9.0	12.2	5.7	18.0	10.9	12.0	13.1	35.9	7.7	13.6	22.0	12.2	16.1	25.7	51.8	13.4	14.5	12.0	24.4	14.7	32.3	14.8	12.7	25.6	10.7	20.1	21.3	9.5	8.5	3.4	7.8	15.7	31.2	25.4	10.2	32.0	5.9	7.0	25.2	13.7	17.3	8.9	12.7	8.5	23.5	15.3	17.8	13.7	18.8	19.1	18.9	21.1	13.3	10.3	18.2	6.6	0.4	0.7	0.8	0.5	1.1	0.7	0.9	1.1	0.6	1.1	1.1	1.6	0.2	0.6	0.3	0.8	1.0	0.4	7.4	11.0	12.2	7.5	6.0	6.4	8.5	8.8	9.9	9.1	8.5	14.1	50.7	9.6	16.2	7.2	39.3	39.4	35.3	19.0	9.6	104.8	15.1	11.9	20.8	34.3	17.8	31.3	12.5	15.6	34.0	13.8	3.9	14.7	17.4	37.7	37.4	40.1	13.1	21.4	22.8	17.8	6.2	23.2	18.3	82.5	28.5	12.8	36.4	30.2	10.0	25.2	11.7	18.3	14.2	23.5	39.1	19.5	25.4	22.3	30.2	27.2	22.3	11.2	39.1	17.6	28.0	17.5	9.0	15.4	18.6	71.3	14.4	17.5	24.9	26.9	26.3	28.5	21.4	24.6	11.6	19.2	48.6	18.3	32.6	16.7	17.5	103.1
EXOSC9	"p5, p6, PM/Scl-75, PMSCL1, RRP45, Rrp45p"	ENSG00000123737	"Exosome component 9"	Q06265	4	121801318-121817021	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 154.0;Spermatocytes: 170.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041838, HPA048257, CAB070171"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoli	Nucleoplasm	"CAB070171: AB_11026964, HPA041838: AB_10794492, HPA048257: AB_2680331"	"unprognostic (7.36e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (7.89e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.25e-2)"	"unprognostic (9.85e-3)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (3.28e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.21e-2)"	14.7	14.3	9.2	16.7	9.9	37.9	14.4	10.5	15.3	11.9	8.4	11.7	9.3	12.9	14.4	12.3	12.9	8.1	15.7	9.4	9.9	11.8	16.0	13.6	25.8	9.3	9.2	12.9	11.2	14.7	11.0	14.1	9.3	10.4	12.6	9.9	11.9	9.3	21.6	13.9	12.0	10.2	9.0	15.8	11.7	43.4	9.2	32.8	10.1	18.6	21.1	14.8	11.9	10.4	66.3	29.9	76.7	44.4	10.7	20.6	39.2	83.7	45.4	114.6	84.5	32.5	53.2	113.9	20.1	50.5	35.7	23.2	83.1	38.1	95.6	51.1	39.9	56.8	43.4	43.0	26.0	98.5	51.1	16.1	20.1	77.8	20.3	23.7	56.0	72.6	102.2	42.3	110.0	38.9	154.6	78.6	42.7	25.2	34.7	80.6	134.4	52.4	41.4	21.0	51.3	53.7	28.8	45.5	52.3	38.9	38.2	64.2	35.2	50.4	76.5	44.4	80.9	63.0	49.7	132.5	52.4	67.8	34.2	15.8	14.5	23.4	17.6	21.1	18.5	20.7	20.9	25.4	17.9	22.4	22.1	22.6	3.8	14.4	21.3	15.9	24.9	14.0	9.2	9.9	10.5	15.3	9.4	9.9	9.3	9.2	9.3	9.0	9.2	10.4	20.4	44.8	19.1	4.9	20.8	12.7	15.5	31.7	18.8	10.7	6.7	10.7	13.2	17.2	25.4	3.7	10.4	31.4	21.5	5.7	1.9	23.7	154.0	10.9	15.6	17.6	6.0	27.0	10.4	30.5	31.3	15.8	7.7	11.8	31.0	25.4	10.0	5.5	24.5	16.8	8.8	9.8	28.5	11.9	10.1	21.8	13.1	16.3	8.8	11.2	22.2	15.3	16.5	6.6	10.9	20.2	9.2	10.9	22.9	8.4	6.5	8.5	16.8	17.7	6.6	23.4	21.8	170.4	62.8	14.1	14.8	10.9	26.2	16.5	11.6	12.1
FGD3	"FLJ00004, ZFYVE5"	ENSG00000127084	"FYVE, RhoGEF and PH domain containing 3"	Q5JSP0	9	92947523-93036236	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.4;lymphoid tissue: 32.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 41.8;Early spermatids: 66.1;Late spermatids: 99.0;NK-cells: 69.0;T-cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 43.9;Karpas-707: 61.4;RT4: 33.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA020963, HPA021018"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		11000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA020963: AB_2670542, HPA021018: AB_2670564"	"unprognostic (5.66e-3)"	"prognostic favorable (5.51e-4)"	"unprognostic (5.05e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (2.23e-7)"	"unprognostic (2.26e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.56e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.22e-2)"	4.7	1.3	1.8	21.9	1.6	39.4	3.5	1.8	4.9	1.5	2.5	3.0	3.1	1.1	0.4	2.4	2.1	4.6	2.0	1.6	2.7	4.9	2.0	10.2	30.8	3.4	2.6	1.4	7.6	0.4	0.7	3.5	3.5	1.7	2.3	0.0	4.9	1.5	1.1	3.2	11.3	2.7	2.7	29.5	4.3	6.5	3.5	32.4	3.3	2.2	17.6	8.1	3.5	4.0	13.3	0.2	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	16.0	9.1	11.3	0.6	0.0	0.1	8.4	0.6	0.0	0.0	19.7	0.1	17.4	0.1	0.6	0.0	4.8	43.9	0.0	0.3	0.0	0.0	0.0	0.0	18.8	0.7	61.4	0.0	22.8	20.7	20.4	0.4	4.3	1.1	20.1	0.0	16.3	0.1	33.5	1.2	0.4	0.0	14.4	0.4	0.4	5.8	21.4	0.0	0.0	0.6	0.1	0.1	6.2	6.6	5.4	3.1	10.3	0.0	142.9	50.6	139.6	49.5	63.4	49.9	28.6	51.4	46.6	37.5	36.9	50.1	44.7	178.2	39.1	99.2	16.8	48.4	74.0	1.8	1.6	1.8	4.9	1.6	2.7	3.4	2.6	3.5	2.7	3.5	4.0	1.7	22.4	9.2	0.0	25.3	0.8	0.6	0.4	0.6	0.1	5.8	1.8	2.5	4.3	2.3	9.2	0.0	2.9	41.8	0.4	0.0	7.2	66.1	1.2	0.2	2.1	1.8	11.8	0.6	0.2	3.2	0.9	0.0	0.6	19.6	3.7	1.8	0.8	15.5	0.0	1.6	0.6	0.0	22.3	6.2	99.0	0.3	20.7	1.8	12.2	20.1	0.4	69.0	5.0	0.5	0.4	0.1	0.4	15.8	0.1	0.0	0.7	0.3	3.9	0.0	0.3	0.8	1.6	2.4	0.5	1.0	4.5	47.3	0.1	0.4	0.5
FLT3	"CD135, FLK2, STK1"	ENSG00000122025	"Fms related receptor tyrosine kinase 3"	P36888	13	28003274-28100592	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, RAS pathway related proteins"	"Host-virus interaction"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.3;brain: 4.9;lymphoid tissue: 6.5"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 24.4;Inhibitory neurons: 59.9;Kupffer cells: 29.1;Langerhans cells: 21.4;Macrophages: 16.9;monocytes: 39.5"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.8"	"Region enhanced"	"Detected in some"		"cerebellum: 4.9"	"Group enriched"	"Detected in many"	13	"myeloid DC: 68.7;plasmacytoid DC: 26.2"	"Lineage enriched"	"Detected in many"	19	"dendritic cells: 68.7"	"Group enriched"	"Detected in some"	11	"REH: 42.5;THP-1: 26.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047539			Approved	"Endoplasmic reticulum"		NA	NA		210000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 14: REH - Unknown function"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum"		"HPA047539: AB_2680080"	"unprognostic (2.19e-3)"	"unprognostic (3.16e-3)"	"unprognostic (6.54e-3)"	"unprognostic (9.96e-2)"	"unprognostic (3.88e-1)"	"unprognostic (3.96e-7)"	"unprognostic (7.99e-3)"	"unprognostic (1.65e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.22e-1)"	0.5	0.1	0.3	3.0	0.2	5.3	1.5	4.9	0.8	0.5	0.1	0.7	0.3	0.2	0.1	0.6	0.4	1.6	0.1	0.2	0.5	1.5	0.5	0.7	6.5	1.3	0.9	0.1	2.8	0.0	0.0	0.0	1.7	0.1	0.8	0.0	0.4	0.2	0.0	0.7	1.6	0.8	0.8	5.7	0.6	0.6	0.8	4.7	0.1	0.3	3.6	1.3	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.2	0.6	0.0	0.0	42.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	3.6	3.4	0.0	0.8	0.0	0.2	0.0	0.0	68.7	0.0	0.0	0.0	0.1	2.0	0.0	26.2	0.0	2.7	0.3	0.2	4.9	0.8	0.2	0.5	1.3	0.9	1.7	0.8	0.8	0.8	0.0	0.0	0.0	2.3	1.5	0.3	0.0	0.0	0.0	0.0	1.5	1.0	0.4	1.5	0.0	0.0	0.0	0.0	24.4	0.0	0.0	2.7	3.7	0.3	0.1	0.2	0.0	8.2	7.4	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.7	0.1	0.5	0.0	59.9	0.0	0.0	29.1	21.4	2.3	0.0	16.9	1.8	1.9	39.5	0.0	0.0	1.5	4.2	0.1	0.0	0.0	2.2	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.2	0.6	0.0	0.6	0.0	1.7	0.0	0.0	0.0
GEN1	"FLJ40869, Gen"	ENSG00000178295	"GEN1 Holliday junction 5' flap endonuclease"	Q17RS7	2	17753858-17788946	"Predicted intracellular proteins"	"DNA damage, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA020078, HPA021141"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA020078: AB_2670352, HPA021141: AB_2670599"	"unprognostic (2.25e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (8.64e-2)"	"unprognostic (1.67e-3)"	"unprognostic (7.90e-4)"	"unprognostic (4.53e-2)"	"unprognostic (1.70e-3)"	"unprognostic (8.60e-3)"	"unprognostic (8.04e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.89e-12)"	"unprognostic (3.97e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.49e-3)"	1.6	1.8	1.1	4.8	1.0	15.1	3.2	0.7	1.2	2.3	15.4	5.2	3.2	1.8	9.3	5.6	1.4	4.4	2.3	1.5	1.7	1.7	8.6	2.0	10.8	2.1	2.4	0.9	2.2	1.1	3.0	3.9	1.8	2.7	6.9	2.5	5.6	2.7	1.7	7.5	4.5	1.4	1.7	5.1	3.0	8.5	1.6	5.4	1.9	1.5	11.8	1.5	3.7	1.8	29.4	15.0	14.0	9.9	3.2	4.1	23.9	21.3	6.7	9.9	9.6	19.6	13.0	27.4	8.2	7.3	10.4	18.4	16.4	12.8	13.7	21.4	9.1	15.7	16.3	9.5	1.9	20.2	17.0	3.1	4.7	16.8	7.7	3.0	8.0	13.7	21.0	19.6	16.4	14.1	15.2	16.4	9.5	9.4	6.8	17.7	36.3	10.9	5.6	19.6	15.3	20.8	11.5	14.3	7.5	9.5	9.8	10.6	10.7	22.4	9.8	12.2	21.8	13.1	26.0	45.1	9.6	18.3	16.0	0.1	0.4	0.3	0.3	0.3	0.2	1.7	0.3	0.6	0.6	0.7	0.4	0.4	0.1	0.4	0.4	0.6	0.5	0.3	1.1	1.0	0.7	1.2	1.5	1.7	2.1	2.4	1.8	1.7	1.6	1.8	3.6	6.4	3.6	12.1	16.9	2.8	2.7	5.2	5.7	5.7	4.5	3.0	4.4	1.5	8.1	3.7	12.5	4.4	6.9	9.3	0.0	2.1	4.6	4.9	8.5	4.0	1.8	15.3	14.1	2.3	4.8	4.2	17.3	6.6	1.3	14.5	2.2	5.4	3.8	3.3	13.0	7.3	0.0	3.1	1.0	3.7	1.8	4.0	1.8	6.5	2.9	3.8	1.0	12.5	11.0	2.9	4.0	0.7	11.2	3.2	5.3	2.5	5.0	3.6	6.6	15.0	5.3	14.2	11.4	8.1	1.8	3.3	3.7	8.0	7.2	2.9
GIT2	"KIAA0148, PKL"	ENSG00000139436	"GIT ArfGAP 2"	Q14161	12	109929802-109996389	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB004681	Approved		Approved	Microtubules		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	Microtubules		"CAB004681: AB_425820"	"unprognostic (1.07e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.67e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.41e-2)"	16.6	18.0	12.1	25.5	18.1	60.2	13.0	20.3	17.0	14.0	9.8	15.0	11.2	14.1	10.8	11.5	12.1	15.4	17.4	16.4	12.1	11.7	11.8	16.9	33.1	16.2	13.9	17.8	17.2	14.1	13.8	22.9	16.5	12.8	13.8	9.1	13.5	12.8	14.7	13.1	19.0	19.8	12.1	36.0	10.7	13.9	15.3	37.0	16.4	15.6	32.1	16.3	12.8	16.2	20.6	24.6	16.6	18.4	28.6	26.3	11.9	42.1	41.3	37.0	23.2	12.5	10.8	49.8	16.3	51.7	14.6	14.9	14.5	18.8	38.1	42.1	14.3	32.7	15.0	14.6	18.1	47.7	49.6	22.0	17.4	34.9	18.7	34.0	39.5	28.5	17.2	12.4	46.0	13.1	42.0	66.4	11.7	11.7	17.7	34.5	41.7	27.9	18.2	17.1	10.1	14.9	27.1	12.5	16.6	17.0	17.9	39.3	37.3	25.0	12.6	20.0	22.0	25.0	22.8	49.3	21.5	34.9	21.2	85.6	76.4	172.9	42.7	72.0	41.6	42.4	42.3	43.9	74.7	49.4	36.0	32.2	165.1	49.3	71.3	30.6	46.5	63.7	12.1	18.1	20.3	17.0	16.4	12.1	16.2	13.9	16.5	12.1	15.3	16.2	26.3	19.2	15.3	24.8	44.8	9.6	6.4	11.3	11.4	24.7	10.8	10.0	7.8	14.3	12.2	27.6	8.4	13.1	37.7	9.9	3.9	16.0	6.5	7.6	16.9	24.0	7.8	19.4	73.2	14.0	11.3	15.3	14.8	11.1	14.5	36.1	24.7	13.7	35.1	33.7	82.2	6.7	8.2	65.5	32.0	5.2	18.6	45.1	14.2	66.5	64.5	9.3	61.8	28.6	39.8	18.4	8.6	19.9	26.1	4.3	22.8	7.2	12.4	18.7	13.1	29.4	14.5	36.1	20.1	11.8	11.4	6.2	36.5	19.1	9.9	7.4
GMFG		ENSG00000130755	"Glia maturation factor gamma"	O60234	19	39328353-39342372	"Plasma proteins, Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 577.4;lymphoid tissue: 460.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 304.3;Hofbauer cells: 467.5;Kupffer cells: 523.4;Langerhans cells: 343.2;Macrophages: 409.6;monocytes: 409.4;NK-cells: 423.3;T-cells: 370.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 356.7;HMC-1: 602.6;JURKAT: 464.5;Karpas-707: 494.4;NB-4: 361.6;REH: 409.8;THP-1: 641.5;U-937: 482.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002954	Uncertain	Approved	Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		810000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA002954: AB_1078997"	"unprognostic (1.22e-2)"	"prognostic favorable (7.35e-4)"	"unprognostic (2.37e-2)"	"unprognostic (1.21e-3)"	"unprognostic (9.93e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (9.11e-6)"	"unprognostic (3.01e-1)"	"unprognostic (8.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.27e-3)"	111.6	26.3	27.1	188.6	27.4	577.4	71.3	26.9	41.6	26.0	29.3	45.6	33.8	20.7	19.6	19.7	29.0	60.8	25.1	27.9	29.1	36.8	65.9	117.7	299.5	30.7	30.1	9.2	14.4	15.6	10.8	102.4	30.5	18.5	53.2	2.0	18.9	15.0	11.4	16.2	75.0	47.8	29.1	325.3	41.5	7.4	28.6	460.7	37.6	23.6	262.7	93.5	18.3	32.6	1.4	0.0	2.0	0.4	0.0	0.0	0.7	1.1	0.3	0.3	0.2	0.3	33.1	309.6	2.4	0.3	0.1	1.5	0.0	0.7	1.2	99.7	0.5	329.7	0.4	3.5	5.1	356.7	602.6	0.7	0.6	0.5	0.8	0.8	19.2	464.5	12.3	494.4	2.4	0.0	316.6	361.6	0.6	0.1	0.2	409.8	3.2	196.8	0.5	40.9	0.8	0.5	1.3	1.9	2.1	0.6	0.8	641.5	175.7	0.2	3.2	0.8	1.1	26.9	107.3	340.0	1.7	482.4	2.7	4389.0	1574.5	3622.3	720.9	1447.6	773.8	812.5	1058.2	894.4	1139.9	742.7	1044.5	858.2	5262.9	908.0	1686.2	459.6	1840.4	2617.7	27.1	27.4	26.9	41.6	27.9	29.1	30.7	30.1	30.5	29.1	28.6	32.6	304.3	28.9	97.6	0.0	211.7	18.6	4.4	0.3	2.8	0.0	4.2	9.4	3.2	11.5	17.3	0.0	0.0	3.6	273.5	0.9	0.0	1.1	11.8	0.6	2.2	176.4	0.0	119.4	0.5	0.7	4.0	18.2	9.7	0.8	238.0	0.3	272.4	11.8	467.5	0.0	0.4	0.3	2.0	523.4	343.2	30.4	1.8	409.6	74.7	1.9	409.4	0.7	423.3	0.5	0.3	0.3	0.0	0.4	216.8	1.1	0.3	4.6	8.9	0.3	46.0	4.2	26.4	8.6	3.3	1.4	14.8	5.5	370.6	2.3	1.1	4.1
GP5	CD42d	ENSG00000178732	"Glycoprotein V platelet"	P40197	3	194394821-194398354	"CD markers, Plasma proteins, Predicted membrane proteins"	"Blood coagulation, Cell adhesion, Hemostasis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.1"	"Cell type enhanced"	"Detected in single"		"Paneth cells: 1.1"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"HEL: 16.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA072646			Approved	Cytosol		NA	NA		270000000	"Cluster 32: T-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 58: T-cells - T-cell receptor"	Cytosol		"HPA072646: "	"unprognostic (3.74e-2)"	"unprognostic (3.40e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.94e-1)"	0.1	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.3	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
HMHB1	"HB-1, HB-1Y"	ENSG00000158497	"Histocompatibility minor HB-1"	O97980	5	143812161-143820719	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.4;testis: 1.3"	"Group enriched"	"Detected in some"	4	"Early spermatids: 10.8;Late spermatids: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	25	"plasmacytoid DC: 19.8"	"Lineage enriched"	"Detected in single"	25	"dendritic cells: 19.8"	"Group enriched"	"Detected in some"	7	"Karpas-707: 3.2;REH: 4.6;RPMI-8226: 1.2"															NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 14: REH - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (1.99e-1)"				"unprognostic (6.19e-2)"						"unprognostic (2.67e-2)"		"unprognostic (6.33e-5)"	"unprognostic (7.45e-2)"	"unprognostic (1.44e-1)"		"unprognostic (4.86e-3)"	0.3	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	2.4	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.6	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	10.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ICOS	"AILIM, CD278"	ENSG00000163600	"Inducible T cell costimulator"	Q9Y6W8	2	203936763-203961577	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"bone marrow: 16.5;lymphoid tissue: 20.2"	"Cell type enriched"	"Detected in some"	12	"T-cells: 81.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 29.1"	"Lineage enriched"	"Detected in single"	54	"T-cells: 29.1"	"Group enriched"	"Detected in some"	8	"HEL: 4.6;MOLT-4: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB032575, HPA034865"	Approved		Approved	"Plasma membrane,Actin filaments"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Actin filaments"	"CAB032575: AB_2122593, HPA034865: "	"unprognostic (2.66e-2)"	"unprognostic (2.13e-3)"	"unprognostic (4.19e-4)"	"unprognostic (2.35e-5)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.80e-4)"	"unprognostic (9.38e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.51e-4)"	"unprognostic (7.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.86e-5)"	"unprognostic (7.05e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.82e-3)"	0.5	0.1	0.0	7.7	0.0	16.5	0.3	0.0	0.0	0.2	0.0	0.7	0.7	0.2	0.1	0.5	0.3	1.4	0.2	0.0	0.0	0.2	0.4	2.6	14.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	1.3	0.0	0.4	0.0	0.0	0.2	2.3	0.4	0.0	3.3	1.3	0.2	0.0	20.2	0.4	0.0	16.2	2.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	4.2	0.0	15.1	6.8	0.0	0.0	15.7	7.2	0.1	0.5	0.0	0.0	29.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.3	0.0	3.1	2.9	0.0	0.0	0.0	0.0	1.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.1	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	1.1	2.0	0.2	6.3	0.0	0.4	0.1	0.1	0.0	0.0	0.2	0.0	0.8	4.7	0.1	0.0	3.1	3.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.3	0.0	1.8	0.1	81.2	0.0	0.0	0.1
IKZF1	"hIk-1, Hs.54452, IKAROS, LyF-1, PPP1R92, ZNFN1A1"	ENSG00000185811	"IKAROS family zinc finger 1"	Q13422	7	50304068-50405101	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"bone marrow: 173.0;lymphoid tissue: 112.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 120.5;dendritic cells: 221.4;Erythroid cells: 89.8;Microglial cells: 91.8;monocytes: 106.6;NK-cells: 150.4;Plasma cells: 128.9;T-cells: 182.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 140.4;HDLM-2: 258.6;HMC-1: 220.4;JURKAT: 128.9;MOLT-4: 184.3;REH: 192.3;U-698: 342.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009247, HPA035221, HPA035222"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Cytosol	"CAB009247: AB_2124699, HPA035221: AB_2674524, HPA035222: AB_2674525"	"prognostic favorable (4.28e-4)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.49e-3)"	"unprognostic (2.41e-3)"	"unprognostic (5.59e-1)"	"prognostic favorable (8.63e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.67e-2)"	5.0	3.2	3.5	53.0	3.4	173.0	4.4	4.0	3.9	3.6	3.3	7.6	7.0	2.5	2.3	4.8	2.2	7.7	1.5	3.0	4.0	1.4	4.9	11.6	87.1	7.7	5.2	1.6	0.8	0.8	0.6	3.6	7.5	2.3	6.8	0.2	4.6	1.9	1.0	2.0	15.6	4.0	7.3	48.6	12.0	1.7	8.7	112.5	2.1	1.2	73.8	9.6	1.8	10.3	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	140.4	0.4	0.0	0.0	0.2	0.0	0.0	0.0	258.6	0.2	52.1	0.0	0.0	0.0	84.5	220.4	0.0	0.0	0.0	0.0	0.0	0.0	128.9	72.4	15.4	0.0	0.0	184.3	80.9	2.4	0.0	0.0	192.3	0.3	39.6	0.0	0.0	1.6	2.0	0.8	1.0	0.8	0.4	0.2	112.1	0.2	0.0	1.9	0.2	0.4	80.8	49.4	342.7	0.5	89.5	0.5	21.2	14.2	25.0	35.4	43.9	29.1	46.7	36.3	35.0	15.1	40.7	48.2	35.7	20.2	24.3	43.3	23.4	32.6	26.4	3.5	3.4	4.0	3.9	3.0	4.0	7.7	5.2	7.5	7.3	8.7	10.3	2.8	3.2	12.2	0.7	120.5	2.8	0.1	0.0	0.0	0.0	2.8	1.9	1.5	2.8	1.8	1.8	0.0	0.4	221.4	0.3	0.0	0.4	3.8	0.5	0.4	2.6	0.0	89.8	0.2	0.0	0.4	2.5	4.6	0.6	23.4	0.2	3.9	2.0	30.6	0.0	0.3	0.0	0.0	64.3	61.0	5.3	0.0	72.1	19.6	91.8	106.6	0.0	150.4	1.0	0.3	0.1	0.4	0.0	128.9	0.1	0.0	1.0	1.5	0.1	0.0	1.5	1.6	0.1	2.1	0.5	2.7	0.7	182.8	0.1	0.1	0.1
INTS6L	"DDX26B, FLJ41215"	ENSG00000165359	"Integrator complex subunit 6 like"	Q5JSJ4	X	135520659-135582510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Breast myoepithelial cells: 14.0;dendritic cells: 15.9;Endometrial ciliated cells: 16.0;Glandular and luminal cells: 11.1;granulocytes: 25.2;Theca cells: 11.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 20.7;U-937: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001552, HPA013200, HPA013335, HPA030747"	Uncertain		Approved	"Nuclear bodies,Centrosome,Mitochondria"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Centrosome	"Nuclear bodies, Mitochondria"	"HPA001552: AB_1078659, HPA013200: AB_2668801, HPA013335: AB_1847553, HPA030747: AB_2673589"	"unprognostic (2.03e-1)"	"prognostic favorable (5.39e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.33e-3)"	"prognostic favorable (5.54e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.28e-8)"	"unprognostic (2.87e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.37e-2)"	"prognostic favorable (2.94e-4)"	3.4	7.5	3.3	6.3	2.9	13.1	3.8	8.7	3.7	6.7	2.6	7.7	2.6	4.6	2.8	4.7	6.5	3.8	4.4	3.0	3.0	3.8	1.1	4.4	12.6	3.5	3.6	8.2	2.1	1.8	6.7	3.3	3.4	5.0	7.1	5.1	12.0	3.6	1.1	6.1	7.3	3.7	3.3	10.2	3.4	6.3	3.4	8.4	3.3	0.8	11.3	5.7	5.1	3.7	0.1	0.0	7.5	8.9	2.2	2.5	0.0	1.9	4.0	2.2	6.6	0.7	3.2	7.5	6.3	1.6	5.4	5.6	8.4	2.5	1.5	5.8	3.0	6.5	0.7	0.0	1.9	6.8	0.5	3.3	2.4	2.5	2.5	3.8	2.8	4.9	4.3	11.8	1.6	5.5	6.5	20.7	3.5	8.0	3.1	5.3	2.4	6.4	1.8	3.0	1.2	2.7	2.6	2.6	0.2	3.2	2.8	12.5	1.6	5.6	3.2	0.0	2.2	13.5	11.2	11.3	1.9	19.0	1.1	0.0	1.6	1.4	2.9	1.4	3.8	3.3	3.4	3.5	2.3	3.5	5.2	3.4	0.8	1.9	1.8	2.2	2.0	2.5	3.3	2.9	8.7	3.7	3.0	3.0	3.5	3.6	3.4	3.3	3.4	3.7	6.8	12.8	5.8	0.0	7.3	0.0	0.0	0.0	0.0	0.0	7.2	14.0	0.0	0.0	3.7	3.7	0.0	2.1	15.9	0.0	0.0	1.3	0.0	16.0	5.3	3.3	0.0	0.0	0.0	1.6	0.3	3.3	0.0	11.1	25.2	7.3	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	6.3	0.0	0.0	1.0	6.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.8	6.9	11.1	0.0	0.0
ITGA4	CD49D	ENSG00000115232	"Integrin subunit alpha 4"	P13612	2	181457202-181538940	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 47.1;lymphoid tissue: 74.1"	"Group enriched"	"Detected in many"	4	"B-cells: 86.3;dendritic cells: 151.5;Erythroid cells: 169.3;Macrophages: 72.0;monocytes: 73.8;NK-cells: 126.7;Plasma cells: 141.6;T-cells: 129.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 164.0;HEL: 308.1;JURKAT: 142.3;MOLT-4: 373.6"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 12.9"	HPA074961			Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA		120000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"HPA074961: AB_2732273"	"unprognostic (5.31e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.76e-1)"	"prognostic favorable (8.29e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (3.08e-5)"	"unprognostic (2.26e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.57e-2)"	3.3	2.3	1.2	31.5	0.5	47.1	3.8	4.1	1.5	12.7	3.0	8.7	8.7	3.3	1.4	2.3	1.5	9.8	1.5	4.1	1.3	2.7	5.7	12.7	37.2	1.4	1.6	1.4	1.5	0.9	0.4	14.7	2.9	3.5	10.3	8.6	2.9	2.5	0.6	1.2	11.7	5.2	0.9	45.5	10.4	0.8	2.4	74.1	2.0	0.9	26.1	9.5	1.4	1.3	0.3	1.3	4.6	0.1	38.9	55.0	0.0	42.3	46.7	19.5	42.0	0.0	0.0	32.4	0.2	164.0	17.4	23.4	14.0	0.7	22.3	0.0	3.4	308.1	1.1	0.0	4.0	123.4	6.8	39.2	0.0	1.2	0.0	20.5	2.3	142.3	0.1	45.5	12.7	0.0	373.6	117.9	3.7	0.0	0.2	78.1	20.3	5.1	0.0	0.0	8.2	2.6	0.1	0.4	1.4	1.6	0.0	82.9	23.2	6.5	4.1	0.7	8.5	90.9	77.5	18.6	3.7	59.5	90.3	29.5	55.0	137.4	42.0	131.3	32.1	37.3	46.9	52.4	66.0	33.0	26.5	33.1	7.1	32.2	139.6	17.5	13.4	65.2	1.2	0.5	4.1	1.5	4.1	1.3	1.4	1.6	2.9	0.9	2.4	1.3	2.8	0.0	6.7	0.0	86.3	0.3	0.2	1.2	0.0	2.3	1.1	1.4	1.2	2.8	1.8	0.0	6.2	0.1	151.5	0.1	0.0	0.0	0.0	4.4	6.5	1.4	0.0	169.3	9.4	0.0	0.3	6.3	7.1	6.4	18.9	0.3	1.8	0.2	5.9	0.0	0.5	0.1	0.0	24.5	4.4	0.0	0.6	72.0	0.0	7.5	73.8	0.2	126.7	15.6	0.3	0.0	0.4	0.0	141.6	0.3	0.0	0.2	0.8	6.4	0.0	0.7	8.3	0.7	1.2	0.3	0.6	0.4	129.9	0.4	0.2	0.2
KTI12	"MGC20419, SBBI81, TOT4"	ENSG00000198841	"KTI12 chromatin associated homolog"	Q96EK9	1	52032103-52033810	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031203, HPA031204, HPA031205"	Approved		Approved	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear speckles, Cytoplasmic bodies"		"HPA031203: AB_2732464, HPA031204: AB_10600110, HPA031205: AB_10611380"	"unprognostic (6.14e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.36e-3)"	"unprognostic (4.18e-1)"	"unprognostic (1.83e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.72e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.08e-3)"	"unprognostic (6.59e-2)"	"unprognostic (3.36e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.64e-2)"	7.5	10.2	4.2	6.9	4.0	16.7	5.9	4.5	4.4	4.5	4.9	6.5	4.9	7.3	4.7	5.8	6.9	3.8	5.1	4.0	5.0	4.9	6.8	4.2	8.7	4.5	4.1	9.2	6.8	3.9	6.4	4.2	4.1	4.0	4.0	2.5	4.0	4.7	4.6	5.5	7.6	4.7	4.1	8.5	7.1	7.2	4.9	6.6	4.0	3.5	7.6	5.5	3.8	4.4	14.0	13.4	5.3	12.5	17.8	14.8	16.6	13.9	17.0	20.1	17.1	15.2	6.7	16.0	15.3	14.5	29.8	15.6	18.7	16.4	13.9	16.5	20.9	16.6	14.6	14.9	12.3	23.8	15.7	13.9	12.5	16.0	8.6	8.7	13.8	14.0	25.2	7.7	17.1	11.1	17.5	26.7	10.3	12.2	14.9	16.3	14.6	21.5	19.4	10.0	9.3	13.5	13.4	23.3	25.8	12.0	4.5	37.2	10.4	16.2	10.1	19.4	26.3	28.6	25.8	25.4	17.9	25.2	12.1	17.0	21.6	16.4	22.1	24.5	24.9	29.8	24.7	27.0	29.4	22.7	29.0	20.7	4.5	24.2	19.3	44.6	26.9	18.8	4.2	4.0	4.5	4.4	4.0	5.0	4.5	4.1	4.1	4.1	4.9	4.4	10.8	3.2	5.1	0.0	14.3	7.1	13.2	14.1	5.7	6.1	5.3	6.1	3.1	8.6	6.3	3.7	0.0	12.1	17.5	1.8	5.9	11.3	2.3	4.4	10.6	8.4	2.4	8.6	0.0	10.9	17.0	8.6	3.1	3.9	6.3	26.3	9.3	5.9	10.0	10.1	0.0	3.9	6.1	6.6	6.4	1.2	11.5	6.0	5.4	0.0	13.6	9.7	10.3	0.0	0.0	10.5	3.4	10.1	9.5	7.8	3.1	11.6	4.7	4.9	19.7	8.1	10.7	20.3	9.3	6.7	7.4	18.3	10.6	28.1	4.7	11.5
LCP2	"SLP-76, SLP76"	ENSG00000043462	"Lymphocyte cytosolic protein 2"	Q13094	5	170246233-170297815	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 163.9;lymphoid tissue: 115.1"	"Cell type enhanced"	"Detected in many"		"granulocytes: 129.6;Kupffer cells: 154.4;Macrophages: 158.2;NK-cells: 91.6;T-cells: 104.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 147.0;HL-60: 152.5;HMC-1: 375.9;Karpas-707: 80.4;MOLT-4: 91.4;THP-1: 80.8;U-937: 99.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004574, HPA036396, HPA036397"	Enhanced					NA	NA		2900000	"Cluster 52: Eosinophils - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"			"CAB004574: AB_628259, HPA036396: AB_10671840, HPA036397: AB_10670436"	"unprognostic (1.33e-2)"	"unprognostic (3.88e-2)"	"unprognostic (7.52e-3)"	"prognostic favorable (5.08e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.10e-1)"	"prognostic unfavorable (6.22e-5)"	"unprognostic (1.87e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.07e-1)"	23.0	14.1	5.0	75.7	5.7	163.9	8.4	5.9	22.9	10.3	6.3	14.6	15.8	8.2	4.9	9.6	6.8	28.6	5.7	5.1	6.9	5.6	26.3	31.5	77.5	12.2	8.4	3.7	7.7	3.3	2.2	21.9	11.6	8.0	16.4	0.8	6.6	6.5	3.2	3.9	24.4	16.6	7.9	81.1	17.6	3.9	10.2	115.1	4.7	6.2	47.3	28.2	3.7	12.7	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.4	0.0	147.0	0.0	0.0	0.0	152.5	375.9	0.0	0.0	0.0	0.0	0.0	0.1	49.7	1.1	80.4	0.0	0.0	91.4	53.2	0.5	0.0	0.0	14.0	0.0	45.5	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.3	0.0	80.8	0.1	0.0	0.1	0.2	0.1	1.4	14.6	0.2	0.3	99.9	1.7	56.8	20.4	76.6	40.5	42.5	40.2	2.7	32.4	38.6	26.6	1.0	29.8	31.0	68.9	41.7	65.8	5.3	39.8	22.9	5.0	5.7	5.9	22.9	5.1	6.9	12.2	8.4	11.6	7.9	10.2	12.7	13.4	16.0	29.2	0.7	12.2	3.2	0.2	0.1	0.0	0.2	0.9	2.8	4.8	1.5	5.6	1.8	0.0	0.5	35.2	0.1	0.0	0.2	1.6	0.4	2.4	14.2	0.0	24.0	2.8	0.0	0.8	9.5	5.1	0.7	129.6	0.0	18.9	2.4	57.9	0.0	7.9	0.7	0.0	154.4	49.4	0.9	2.5	158.2	1.8	31.9	48.2	0.0	91.6	0.5	0.5	0.0	0.0	3.0	12.6	0.4	0.0	0.3	2.9	0.0	26.3	1.3	3.1	0.0	0.2	1.0	1.8	0.8	104.6	0.5	0.0	0.3
LSM5	YER146W	ENSG00000106355	"LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated"	Q9Y4Y9	7	32485338-32495283	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019054	Uncertain					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA019054: AB_10960217"	"unprognostic (1.92e-1)"	"unprognostic (5.36e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.92e-2)"	"unprognostic (3.51e-2)"	"prognostic unfavorable (7.53e-5)"	"unprognostic (2.22e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (1.84e-4)"	"unprognostic (3.08e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.18e-1)"	35.8	41.9	26.2	35.8	27.0	77.6	62.6	27.0	40.3	33.7	25.4	58.1	42.4	34.0	35.5	46.6	34.5	28.1	50.1	26.2	26.9	46.8	76.0	28.1	61.7	26.0	26.6	36.4	54.7	30.0	29.1	28.8	26.5	34.3	60.0	28.8	31.4	27.8	57.6	33.8	39.4	36.5	26.7	41.0	47.0	22.5	26.3	67.9	44.4	51.1	72.2	37.6	34.4	27.0	204.6	121.9	162.8	229.4	56.0	62.2	80.9	94.9	79.9	119.3	125.6	168.9	170.0	118.8	49.0	67.7	290.9	119.1	121.1	118.7	161.2	84.6	132.7	124.6	193.5	233.7	49.6	267.4	123.3	52.4	85.1	116.7	137.4	79.2	132.9	203.4	261.0	90.5	169.2	246.3	140.3	598.9	267.9	296.7	139.4	122.3	128.4	200.9	107.3	97.8	140.5	206.4	84.9	237.0	114.6	243.5	148.4	331.6	63.9	102.5	252.6	95.8	246.2	149.2	339.9	354.5	96.9	314.9	296.6	17.9	35.0	34.2	38.6	57.4	58.2	69.2	62.9	50.7	50.7	60.2	89.3	68.9	6.0	44.9	49.5	100.1	57.4	45.2	26.2	27.0	27.0	40.3	26.2	26.9	26.0	26.6	26.5	26.7	26.3	27.0	68.9	32.1	50.6	13.7	135.3	146.4	152.0	254.1	109.8	52.5	201.8	262.4	109.7	94.4	116.7	114.0	22.9	211.9	93.4	95.6	277.8	137.0	16.1	91.1	68.2	81.0	50.5	184.5	15.9	216.6	286.2	98.8	98.8	74.6	72.2	148.2	79.6	285.6	189.8	43.7	20.4	164.9	175.0	117.9	158.2	21.2	75.8	100.1	122.7	13.1	163.9	94.3	78.2	10.1	13.9	146.3	118.2	82.4	187.0	146.9	107.6	343.4	137.5	59.7	65.7	81.9	141.9	88.5	133.2	167.7	177.6	100.6	111.8	123.2	233.2	152.8
LSM6	YDR378C	ENSG00000164167	"LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated"	P62312	4	146175703-146200000	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, rRNA processing, tRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045079	Approved		Approved	"Actin filaments"		NA	NA		30000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	"Actin filaments"		"HPA045079: AB_10961320"	"unprognostic (5.04e-3)"	"unprognostic (4.91e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (3.88e-4)"	"unprognostic (2.28e-2)"	"unprognostic (4.36e-1)"	"unprognostic (8.20e-2)"	"prognostic unfavorable (6.65e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.08e-3)"	11.2	6.2	6.2	10.0	6.7	11.4	6.9	9.6	13.5	5.3	4.5	10.1	5.8	5.5	5.8	5.2	5.4	4.6	4.4	5.4	7.1	7.9	9.9	6.2	18.3	6.9	7.3	6.8	6.4	3.9	4.3	9.1	6.8	7.4	7.6	8.3	6.8	4.5	4.3	4.8	8.2	4.9	6.9	10.4	8.9	7.5	6.9	12.5	4.2	5.7	14.2	8.5	4.4	6.6	21.1	11.1	28.0	11.3	9.4	9.7	19.2	17.7	17.8	17.2	18.9	12.1	23.7	27.9	6.3	10.3	16.3	8.8	22.7	10.8	27.5	35.1	15.7	18.4	8.9	32.2	16.0	50.1	16.1	7.0	15.9	17.2	7.8	10.5	16.6	19.7	25.4	31.0	13.7	17.5	56.4	37.0	21.7	21.9	14.3	29.9	14.8	14.3	13.4	23.2	23.8	11.3	9.7	12.6	22.0	15.3	9.8	37.1	12.2	16.2	17.9	11.8	29.9	17.7	23.5	32.9	20.2	16.0	18.6	3.5	27.4	18.4	18.2	43.9	24.1	32.3	23.8	21.6	26.6	33.3	26.6	24.1	16.2	26.8	59.6	21.3	28.3	30.8	6.2	6.7	9.6	13.5	5.4	7.1	6.9	7.3	6.8	6.9	6.9	6.6	143.3	22.4	34.1	11.8	86.7	69.3	91.2	141.8	56.9	22.5	55.3	88.0	25.1	51.5	55.9	27.6	2.1	132.7	53.5	38.2	68.4	67.2	3.6	53.4	44.9	68.7	23.4	82.6	12.3	67.1	183.4	65.6	30.1	33.1	56.4	52.1	54.7	65.8	124.9	18.5	13.3	66.2	61.1	96.2	98.0	13.8	76.1	98.2	51.6	7.5	171.2	33.7	74.2	16.6	13.1	53.1	83.6	57.9	60.6	162.8	92.7	111.5	64.3	25.0	32.9	47.5	82.2	107.3	196.2	78.0	71.7	73.7	77.1	71.6	85.5	99.8
MOB1A	"C2orf6, FLJ10788, FLJ11595, Mats1, MOB1, Mob4B, MOBK1B, MOBKL1B"	ENSG00000114978	"MOB kinase activator 1A"	Q9H8S9	2	74152528-74178898	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 350.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047088, HPA071690"	Supported		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA047088: AB_2679927, HPA071690: AB_2686432"	"unprognostic (5.32e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (3.34e-4)"	"unprognostic (9.36e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.20e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.11e-3)"	36.6	24.7	12.6	64.2	11.8	90.5	31.4	12.9	13.5	36.4	18.6	41.0	42.3	35.0	25.5	40.2	33.2	35.5	25.3	11.4	15.6	48.1	30.7	38.9	91.9	15.8	13.6	31.9	16.0	28.6	9.1	35.8	16.7	30.3	42.7	10.2	19.5	29.4	13.2	38.9	41.7	40.5	15.8	61.1	34.2	19.8	12.8	56.1	33.6	19.4	93.1	46.6	26.0	17.9	78.2	43.9	53.9	58.5	86.9	94.0	63.5	61.3	82.0	78.1	76.6	60.2	55.4	159.0	51.3	77.4	58.2	63.7	69.6	70.2	117.7	113.0	41.5	143.7	28.0	64.3	69.1	126.1	222.1	80.2	67.1	62.6	52.5	58.6	83.3	60.4	62.5	57.2	76.8	42.1	159.4	106.9	50.3	66.4	35.6	108.2	185.2	85.2	67.3	96.1	27.3	35.6	87.1	63.6	56.4	40.4	51.0	59.1	79.6	100.9	53.0	71.4	98.7	42.2	40.5	119.5	68.0	105.3	55.3	103.7	65.3	91.5	37.3	106.1	40.3	57.8	33.3	40.3	60.5	46.1	30.2	36.4	65.6	56.4	126.0	42.1	37.2	79.7	12.6	11.8	12.9	13.5	11.4	15.6	15.8	13.6	16.7	15.8	12.8	17.9	82.6	51.3	58.0	3.9	173.0	136.9	96.5	107.4	60.9	13.3	66.8	45.1	40.0	35.8	79.5	82.8	6.2	63.8	170.1	114.1	92.0	60.9	11.1	88.3	91.3	73.1	37.7	48.8	7.4	52.6	101.9	67.2	55.0	102.2	110.4	58.5	61.1	43.0	169.5	26.9	7.9	67.4	65.1	196.6	246.9	11.8	62.4	226.1	67.6	14.0	350.8	25.2	117.4	6.0	10.1	83.4	85.7	68.4	106.4	127.8	80.4	170.2	116.6	14.5	72.3	60.6	75.3	99.5	44.6	86.6	132.0	66.4	124.4	79.3	74.0	155.3
MSL2	"FLJ10546, KIAA1585, msl-2, MSL2L1, RNF184"	ENSG00000174579	"MSL complex subunit 2"	Q9HCI7	3	136148917-136197241	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003413	Uncertain		Approved	Nucleoplasm,Cytosol		NA	No			"Cluster 32: T-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA003413: AB_1848659"	"unprognostic (9.86e-2)"	"prognostic favorable (4.80e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.41e-2)"	"unprognostic (8.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.62e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.79e-3)"	"unprognostic (4.54e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.76e-3)"	11.9	9.4	6.0	21.3	8.7	57.9	13.8	18.8	8.6	14.7	5.0	12.9	13.3	15.2	9.2	12.7	15.5	12.8	9.5	6.3	7.3	11.3	14.1	14.5	33.1	6.5	7.2	20.9	11.5	15.3	8.0	13.1	9.2	12.0	12.7	14.8	13.0	11.5	12.6	11.4	14.8	12.1	6.0	25.8	14.7	17.4	7.2	60.3	17.0	17.2	31.7	13.3	10.1	12.1	26.5	7.5	20.8	23.2	14.4	15.6	33.1	16.1	16.0	14.9	14.9	19.4	15.0	52.1	21.2	14.3	17.0	20.4	24.6	16.2	23.5	25.3	11.9	59.6	19.8	11.0	14.8	51.7	26.1	12.6	17.7	11.7	34.0	14.2	15.1	48.1	22.0	47.7	12.5	15.8	93.8	26.7	25.3	14.7	13.1	40.5	33.5	35.3	7.1	21.2	25.2	16.8	37.7	16.1	26.5	16.2	14.7	28.5	20.6	19.0	15.0	17.4	15.1	47.5	28.0	78.7	15.9	20.2	13.2	5.1	2.5	4.1	5.1	2.9	6.2	3.1	4.7	6.0	2.7	5.4	9.6	6.4	5.9	5.1	2.2	1.5	3.9	4.2	6.0	8.7	18.8	8.6	6.3	7.3	6.5	7.2	9.2	6.0	7.2	12.1	15.0	19.2	11.2	18.9	30.4	28.0	15.6	5.6	23.3	12.9	15.8	9.5	15.2	8.6	7.0	12.9	4.2	8.9	47.1	9.3	3.9	5.1	4.1	9.6	15.3	13.9	18.0	23.1	28.0	5.6	6.3	14.7	9.2	12.9	7.0	12.6	16.8	23.4	8.5	16.8	31.6	14.1	2.0	24.2	25.4	3.7	9.3	18.9	21.4	37.5	21.4	8.0	30.9	39.2	55.1	6.4	5.6	8.6	27.8	14.5	7.7	7.4	5.7	9.7	6.6	18.6	12.3	16.0	12.5	22.8	26.7	4.8	36.2	8.5	12.2	14.0
MTF2	"M96, PCL2, TDRD19A"	ENSG00000143033	"Metal response element binding transcription factor 2"	Q9Y483	1	93079235-93139079	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 117.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069047, HPA069066"			Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA069047: AB_2686073, HPA069066: AB_2686078"	"unprognostic (1.84e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.56e-2)"	"unprognostic (7.88e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.26e-3)"	"prognostic unfavorable (8.90e-7)"	"unprognostic (1.26e-2)"	"unprognostic (9.22e-3)"	"unprognostic (3.98e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (1.05e-4)"	"prognostic unfavorable (2.47e-7)"	"unprognostic (7.19e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.26e-2)"	5.5	6.5	5.6	10.4	6.2	23.5	9.3	10.0	7.9	7.5	5.0	7.5	7.6	8.1	7.3	5.7	6.7	6.2	4.4	5.7	5.7	7.4	6.7	7.2	20.1	4.9	5.0	10.1	5.4	5.5	5.8	12.3	5.2	5.5	7.6	8.8	5.2	4.1	7.2	7.5	7.9	5.9	5.3	11.5	6.8	16.9	5.8	29.2	7.1	5.9	18.8	6.7	6.6	6.5	20.8	9.8	33.7	22.8	5.7	5.5	38.8	12.8	10.3	21.9	27.3	17.3	11.0	66.9	23.3	8.2	19.2	10.4	31.1	13.4	32.5	25.8	22.7	45.7	15.7	22.4	8.5	61.4	19.4	7.0	7.2	21.2	12.4	10.1	21.3	50.9	53.2	20.0	13.9	9.2	88.1	49.5	57.4	8.9	13.0	70.4	40.8	17.9	20.5	22.1	20.8	24.8	21.1	25.1	26.5	34.8	15.2	42.1	12.1	14.7	21.4	14.1	19.8	15.3	19.2	117.7	2.8	35.4	9.8	9.1	7.3	11.8	7.9	8.1	9.3	7.2	8.3	10.3	9.4	8.6	9.8	8.9	5.4	10.6	5.1	8.7	10.1	4.9	5.6	6.2	10.0	7.9	5.7	5.7	4.9	5.0	5.2	5.3	5.8	6.5	36.4	28.9	29.7	52.2	53.8	46.5	28.5	37.0	26.2	0.0	33.2	25.0	13.6	18.6	32.6	38.6	0.0	68.3	64.5	26.2	7.9	33.8	5.0	24.7	29.2	40.2	32.2	51.6	70.3	19.3	67.4	23.9	23.4	36.0	60.1	56.4	43.5	15.0	34.1	0.0	58.0	31.1	40.7	27.4	54.0	7.4	32.6	34.5	17.8	54.4	50.4	0.0	90.6	68.9	68.1	30.9	28.5	23.7	39.6	41.2	39.2	15.5	21.0	0.0	39.5	24.2	39.4	125.5	89.3	24.1	43.2	60.7	54.0	45.8	33.7	48.1
MYBL2	"B-MYB, BMYB"	ENSG00000101057	"MYB proto-oncogene like 2"	P10244	20	43667019-43716495	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 91.8;lymphoid tissue: 55.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 33.0;dendritic cells: 32.6;Erythroid cells: 82.3;Extravillous trophoblasts: 32.3;Plasma cells: 139.6;Spermatogonia: 33.6"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 295.8"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	34	"plasmacytoid DC: 91.5"	"Lineage enriched"	"Detected in many"	34	"dendritic cells: 91.5"	"Cell line enhanced"	"Detected in many"		"MCF7: 763.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017114, HPA030530, HPA055416"	Uncertain		Supported	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Cytosol	"CAB017114: , HPA030530: AB_2673515, HPA055416: AB_2682811"	"unprognostic (9.75e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.20e-1)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.11e-7)"	"unprognostic (2.66e-3)"	"unprognostic (9.23e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.42e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.84e-1)"	1.6	0.6	0.1	24.2	0.1	91.8	1.6	0.1	0.2	1.1	0.2	8.6	7.0	1.4	0.1	10.1	0.4	1.0	0.4	0.1	0.1	0.6	1.1	1.8	55.5	0.1	0.1	0.3	11.2	0.1	0.2	5.7	0.1	0.5	6.9	0.0	1.6	0.2	0.1	4.2	7.8	2.1	0.1	27.8	6.1	15.6	0.4	33.3	0.5	0.0	53.5	3.5	2.5	0.1	195.8	121.8	105.4	109.6	1.0	3.5	136.2	87.0	29.0	265.6	194.6	600.2	118.8	393.6	49.2	37.8	55.8	116.1	192.1	59.6	98.8	74.2	124.1	183.2	118.7	164.2	0.2	168.6	121.7	2.4	5.1	101.6	22.9	5.9	72.2	189.6	188.1	470.3	23.8	763.7	346.0	236.3	121.8	155.4	105.4	237.3	216.3	222.1	49.6	39.7	96.7	140.6	255.6	253.3	26.1	110.4	167.2	183.1	34.0	16.3	264.3	118.3	151.5	162.1	363.8	606.5	34.2	142.3	103.9	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.3	0.0	1.4	0.0	0.0	0.1	0.2	0.0	91.5	1.3	0.8	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.2	0.0	0.0	0.0	33.0	4.2	0.8	0.8	0.0	0.0	2.5	3.4	2.0	1.5	0.1	0.0	0.0	14.4	32.6	3.4	0.0	0.4	5.9	0.9	1.3	1.8	0.0	82.3	0.4	0.9	32.3	4.8	10.2	2.9	0.0	18.9	0.7	1.4	13.5	0.0	0.3	5.1	0.0	2.4	2.6	14.1	0.0	3.2	1.8	0.0	0.0	0.0	1.0	0.0	0.5	0.7	1.1	0.0	139.6	0.3	0.5	0.0	0.0	0.0	0.0	0.1	3.9	7.0	33.6	8.2	2.4	3.7	3.0	1.2	8.6	2.4
MYO1G	HA-2	ENSG00000136286	"Myosin IG"	B0I1T2	7	44962662-44979088	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.6;lymphoid tissue: 27.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 81.3;Langerhans cells: 65.1;Macrophages: 74.2;monocytes: 392.2;NK-cells: 252.4;T-cells: 87.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 52.6;HEL: 64.1;HL-60: 39.9;JURKAT: 85.9;MOLT-4: 97.3;NB-4: 52.1;THP-1: 68.6;U-937: 57.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021252	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"	Nucleoplasm	"HPA021252: AB_1854254"	"unprognostic (2.74e-2)"	"prognostic favorable (8.26e-4)"	"unprognostic (5.20e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.54e-3)"	"unprognostic (6.47e-2)"	"unprognostic (6.40e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (8.71e-8)"	"unprognostic (3.20e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.92e-2)"	2.2	0.8	0.4	16.6	0.3	43.6	1.0	0.3	0.6	0.8	0.3	2.0	3.3	0.7	0.3	1.5	1.2	3.5	0.9	0.3	1.0	0.9	1.3	12.0	25.1	1.4	0.7	0.3	0.7	0.1	0.5	1.2	0.6	1.1	1.8	0.0	2.3	0.7	0.3	0.9	7.8	2.8	0.6	19.0	3.3	0.4	1.6	27.2	1.6	0.4	14.8	6.1	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	52.6	0.0	64.1	2.7	0.0	0.0	39.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	85.9	0.0	0.0	0.0	0.0	97.3	52.1	0.0	0.0	0.0	18.5	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.0	68.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	57.3	0.0	41.5	58.3	18.5	61.5	95.5	38.4	27.7	40.5	55.6	42.7	18.9	14.1	29.6	6.0	23.9	129.8	4.5	79.9	79.9	0.4	0.3	0.3	0.6	0.3	1.0	1.4	0.7	0.6	0.6	1.6	0.8	0.9	3.2	7.7	0.0	55.7	2.8	0.4	0.0	0.0	0.2	1.2	1.3	1.1	1.5	1.3	0.0	0.0	0.2	81.3	0.2	0.0	0.3	0.6	0.3	0.5	1.0	0.0	6.3	0.1	1.1	0.3	2.3	2.0	0.6	30.4	0.4	2.2	1.4	10.5	3.3	0.0	0.2	0.0	58.7	65.1	1.6	0.0	74.2	3.6	0.0	392.2	0.3	252.4	0.5	0.0	0.2	0.1	0.4	33.4	0.4	0.0	0.6	0.7	0.2	6.6	2.0	1.4	3.8	1.2	0.2	1.7	0.1	87.1	1.2	0.1	0.2
NASP	"DKFZp547F162, FLB7527, FLJ31599, FLJ35510, MGC19722, MGC20372, MGC2297, PRO1999"	ENSG00000132780	"Nuclear autoantigenic sperm protein"	P49321	1	45583846-45618904	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 476.2;Spermatogonia: 514.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028136, HPA030518, HPA030520"	Enhanced		Enhanced	Nucleoplasm		NA	Yes		170000	"Cluster 24: B-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA028136: AB_2672497, HPA030518: AB_2673509, HPA030520: AB_2673510"	"unprognostic (5.59e-2)"	"unprognostic (1.34e-3)"	"unprognostic (5.02e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.36e-3)"	"prognostic unfavorable (4.96e-6)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.78e-2)"	"prognostic unfavorable (1.91e-8)"	"unprognostic (1.62e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.73e-2)"	"unprognostic (5.32e-2)"	66.2	39.6	57.4	55.9	62.6	165.0	58.8	60.6	95.7	67.4	57.1	52.7	34.6	54.6	29.9	55.2	65.6	26.7	51.0	57.2	68.0	48.6	52.0	50.4	91.5	65.0	61.6	72.4	34.9	41.1	40.9	61.9	63.0	54.1	51.5	38.2	43.5	43.4	41.7	46.7	58.3	45.1	56.0	83.3	47.3	108.9	62.4	100.7	48.1	22.2	97.7	51.1	56.0	65.3	191.3	110.8	520.2	184.6	85.8	44.9	243.8	150.9	112.4	230.5	286.5	205.7	134.4	357.9	103.5	65.8	251.9	180.2	351.9	161.0	291.5	164.0	222.9	462.7	201.6	326.9	30.2	489.3	186.4	52.5	38.3	254.0	87.6	60.1	159.5	294.8	396.3	204.1	157.6	131.4	559.6	445.0	755.5	189.5	93.1	697.4	454.0	343.8	115.3	189.4	198.3	239.8	248.7	140.4	159.7	389.2	100.8	377.0	86.7	105.5	322.8	204.4	250.0	124.5	251.2	616.2	107.6	306.7	107.3	6.4	9.4	10.9	14.1	12.1	16.4	16.1	16.1	16.3	14.3	22.3	13.9	13.7	4.0	9.7	7.3	14.7	22.0	9.1	57.4	62.6	60.6	95.7	57.2	68.0	65.0	61.6	63.0	56.0	62.4	65.3	196.5	57.7	106.7	70.8	136.1	78.1	135.2	72.4	133.7	45.3	77.4	87.4	58.4	37.1	99.1	36.8	37.5	319.3	150.8	64.8	31.3	55.0	16.6	119.6	138.1	138.4	51.3	142.8	32.7	37.4	223.2	100.6	81.1	137.9	115.2	134.2	90.3	38.6	108.1	43.7	34.8	68.1	44.7	43.7	62.6	26.6	94.8	82.7	40.9	31.9	52.3	60.9	62.8	63.8	160.3	29.8	44.9	78.2	107.4	88.6	28.9	36.6	109.1	77.3	85.5	148.1	106.6	476.2	514.5	92.1	57.0	268.2	142.2	90.7	101.7	85.3
NOP58	"HSPC120, NOP5"	ENSG00000055044	"NOP58 ribonucleoprotein"	Q9Y2X3	2	202265736-202303661	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018472, HPA021062"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA018472: AB_1854564, HPA021062: AB_1854565"	"unprognostic (1.56e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (1.97e-6)"	"unprognostic (6.64e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (9.86e-4)"	"unprognostic (4.52e-3)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (3.38e-9)"	"unprognostic (1.79e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.60e-1)"	36.0	35.1	33.5	43.9	33.6	76.3	43.7	38.8	58.4	29.5	33.4	30.4	28.2	32.2	33.4	37.8	31.6	23.6	25.1	33.4	36.3	32.8	40.7	26.4	60.3	32.3	33.3	37.4	37.8	24.8	30.2	32.6	32.6	29.5	35.8	28.1	26.5	23.1	41.8	30.7	29.7	27.3	32.6	33.9	29.6	24.9	34.8	41.9	27.1	21.5	59.8	43.3	30.2	35.3	126.4	86.0	85.1	106.8	62.0	55.6	199.2	118.5	62.9	89.1	82.9	191.5	110.9	193.1	95.4	72.5	111.6	114.0	170.1	144.7	158.4	75.0	152.5	233.6	133.3	193.7	91.5	234.7	108.6	72.1	85.3	124.6	284.6	48.6	81.2	112.3	260.4	144.1	113.4	131.4	215.1	258.7	212.9	139.4	146.5	179.5	128.3	257.1	107.1	148.5	130.5	95.8	109.0	156.6	140.8	136.2	106.4	181.8	70.3	113.5	133.8	102.5	206.0	115.7	226.1	274.8	84.2	163.7	138.5	13.4	24.0	7.4	37.2	35.6	55.0	56.1	53.1	51.2	37.4	45.0	57.5	58.9	2.3	52.1	28.3	53.1	58.0	32.5	33.5	33.6	38.8	58.4	33.4	36.3	32.3	33.3	32.6	32.6	34.8	35.3	56.3	109.0	116.2	22.2	111.6	85.8	150.5	98.0	78.0	28.1	53.8	70.2	82.7	37.1	116.8	40.5	41.7	78.1	87.1	35.7	29.4	59.9	39.2	59.6	75.9	62.3	35.2	65.2	39.0	67.8	96.9	82.6	51.0	97.0	137.3	47.7	32.2	46.1	47.7	25.2	47.5	61.5	61.1	23.2	43.5	11.1	43.2	51.5	24.9	20.6	59.6	18.8	35.0	20.6	27.0	50.3	17.3	29.7	118.6	89.9	18.3	37.8	70.6	44.2	26.3	112.2	116.8	70.4	58.4	77.5	74.7	68.0	124.1	45.4	79.6	94.6
NUP210	"FLJ22389, GP210, KIAA0906, POM210"	ENSG00000132182	"Nucleoporin 210"	Q8TEM1	3	13316235-13420322	"Metabolic proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 53.4;lymphoid tissue: 41.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 57.7;Granulosa cells: 70.0;NK-cells: 69.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 232.7;U-266/84: 261.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066888	Approved					NA	NA		78000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 40: Granulosa cells - Unknown function"			"HPA066888: AB_2685741"	"unprognostic (3.17e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.72e-3)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (1.30e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.63e-2)"	2.0	5.2	5.3	23.2	5.8	53.4	5.4	7.8	6.5	2.3	4.8	6.4	7.3	2.6	8.4	7.1	4.1	4.6	2.3	5.0	6.2	8.8	19.8	7.6	41.3	6.1	6.7	1.2	13.0	9.7	13.5	6.4	5.5	5.4	5.6	4.8	6.4	2.8	5.2	5.6	22.2	2.4	5.2	32.5	8.5	9.2	5.8	41.7	8.1	1.8	29.0	5.8	2.2	7.3	41.5	72.0	34.8	90.8	0.0	0.0	138.1	0.6	0.0	8.6	0.4	37.2	66.3	167.7	55.6	0.1	3.9	23.8	77.5	0.0	3.2	135.9	57.9	65.2	81.1	39.6	0.0	210.8	22.7	0.0	0.0	0.0	0.0	6.3	0.1	124.1	102.5	174.9	0.0	103.8	112.6	83.4	40.2	12.8	14.8	0.2	0.2	232.7	16.9	38.4	39.8	39.8	51.3	67.7	21.0	15.5	64.8	172.6	0.5	0.1	11.7	0.2	31.8	176.1	261.0	144.9	0.1	116.0	0.3	0.0	2.5	0.9	7.3	3.2	5.8	5.4	5.2	7.2	5.4	3.1	4.3	5.8	0.1	5.5	2.0	5.6	4.8	3.7	5.3	5.8	7.8	6.5	5.0	6.2	6.1	6.7	5.5	5.2	5.8	7.3	0.7	16.0	5.4	16.6	37.3	1.7	1.3	0.5	0.0	25.4	9.6	5.3	11.6	8.6	4.1	5.5	14.6	17.6	57.7	2.9	3.9	5.7	19.2	4.3	1.0	1.0	8.3	41.8	17.9	4.4	5.6	1.1	3.6	8.3	5.1	70.0	3.6	17.0	16.7	35.3	23.4	8.8	4.1	11.3	4.9	23.5	0.6	14.9	1.8	10.3	16.7	3.0	69.0	30.2	17.7	2.6	0.8	0.4	43.7	2.6	2.1	4.5	3.0	19.4	0.0	2.1	1.1	6.4	10.0	3.5	2.4	4.9	37.2	17.8	11.5	1.9
NUP85	"FLJ12549, NUP75"	ENSG00000125450	"Nucleoporin 85"	Q9BW27	17	75205659-75235758	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061910, HPA062595"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA061910: AB_2684634, HPA062595: AB_2684801"	"unprognostic (2.30e-1)"	"unprognostic (5.10e-2)"	"unprognostic (5.12e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (1.73e-7)"	"unprognostic (3.46e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (3.32e-6)"	"unprognostic (1.03e-3)"	"unprognostic (2.16e-1)"	"unprognostic (9.10e-3)"	"unprognostic (2.11e-1)"	20.9	12.9	15.2	18.6	15.7	20.8	20.0	21.8	17.0	21.5	15.4	18.7	15.8	20.8	16.1	20.5	20.9	11.6	16.4	15.6	14.7	18.9	22.1	18.7	26.5	15.8	15.1	20.8	18.7	12.1	12.7	19.0	16.0	18.9	21.0	11.2	16.7	14.3	16.7	23.9	20.5	19.6	14.9	25.3	16.9	22.2	15.3	33.2	18.0	14.1	27.0	17.9	19.5	17.0	66.5	74.0	53.4	37.3	20.3	31.5	74.0	47.3	37.4	108.5	101.7	63.2	61.4	61.1	26.6	41.1	70.5	55.9	88.8	50.6	96.1	19.3	70.1	51.0	83.3	56.3	16.6	52.8	40.7	30.3	30.5	76.1	32.8	24.9	84.7	49.0	63.3	38.1	53.8	73.0	100.2	64.8	40.0	82.2	67.4	68.9	115.1	55.5	42.1	47.5	40.6	38.5	58.2	73.7	42.5	59.4	83.3	59.1	30.8	80.2	74.4	52.5	76.3	23.6	21.0	79.2	41.4	47.3	50.6	8.1	24.9	21.5	16.1	22.6	22.9	16.1	17.5	15.9	20.5	21.5	17.0	12.8	8.2	16.7	16.5	22.5	16.6	17.3	15.2	15.7	21.8	17.0	15.6	14.7	15.8	15.1	16.0	14.9	15.3	17.0	13.2	6.4	12.5	7.2	13.9	6.1	8.9	19.1	6.2	7.8	10.3	7.5	9.0	8.6	15.0	7.3	10.4	23.0	11.7	9.1	7.9	16.0	3.7	11.1	13.6	15.0	7.7	16.2	13.5	19.4	22.1	13.8	9.7	10.3	11.4	13.0	21.0	23.1	23.0	6.7	9.9	11.0	16.2	13.3	7.2	3.9	14.3	13.7	8.8	10.3	15.8	4.8	22.6	3.5	10.6	18.3	7.5	9.8	8.6	7.9	8.8	11.7	11.8	8.8	32.9	7.9	19.2	24.9	29.3	7.3	7.1	12.7	10.9	7.4	13.3	8.0
OSBPL8	"MST120, MSTP120, ORP8, OSBP10"	ENSG00000091039	"Oxysterol binding protein like 8"	Q9BZF1	12	76351797-76559809	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001309	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Vesicles, Cytosol"		"HPA001309: AB_1079530"	"unprognostic (2.55e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.84e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (9.79e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.19e-3)"	24.2	13.5	18.1	24.3	43.3	32.5	21.1	9.7	22.5	22.6	12.3	11.2	9.3	22.3	7.7	24.4	10.5	18.4	14.0	15.3	13.7	36.4	19.2	19.6	30.9	11.7	13.4	17.4	14.0	13.0	5.6	18.2	14.0	14.9	11.7	14.2	13.5	12.7	10.7	28.7	13.0	18.9	9.1	26.7	16.0	16.6	13.1	33.7	14.3	11.5	32.0	19.1	10.2	16.6	36.5	22.8	49.7	35.5	67.5	94.8	31.6	54.7	76.3	34.2	31.1	33.2	14.6	50.8	30.4	65.3	21.5	14.9	37.2	31.6	51.3	43.6	33.3	136.0	21.0	19.8	41.7	87.2	53.1	50.4	58.7	51.2	63.3	61.8	30.0	29.1	95.0	22.7	57.3	25.0	58.8	41.4	24.3	13.2	22.6	30.4	67.7	29.3	26.4	30.3	27.2	28.4	46.7	16.6	34.0	38.9	13.0	52.4	70.6	55.0	27.5	57.5	29.7	22.7	38.4	54.6	21.0	47.9	32.8	134.8	50.8	74.1	29.2	37.4	27.9	45.3	31.2	24.6	46.9	40.8	27.9	23.2	195.7	36.0	44.5	54.9	41.1	31.8	18.1	43.3	9.7	22.5	15.3	13.7	11.7	13.4	14.0	9.1	13.1	16.6	63.5	57.7	58.3	54.5	87.8	116.2	65.7	39.6	114.9	49.7	68.4	55.5	42.5	25.8	36.1	51.5	89.6	34.8	111.3	13.6	60.7	53.9	47.4	29.0	102.6	68.7	9.5	63.5	246.3	55.2	28.7	98.0	28.5	44.1	254.8	36.3	52.1	45.9	77.1	42.1	248.6	25.8	40.7	98.0	127.0	22.1	65.9	142.0	35.6	79.6	149.3	50.2	125.7	113.6	92.9	104.0	28.3	82.8	56.8	54.6	23.9	180.2	37.4	37.3	46.0	79.3	83.1	66.2	129.9	89.9	124.5	48.2	105.3	58.4	20.0	62.4
P2RY8	P2Y8	ENSG00000182162	"P2Y receptor family member 8"	Q86VZ1	X	1462581-1537185	"Cancer-related genes, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 31.2;lymphoid tissue: 40.1"	"Group enriched"	"Detected in some"	4	"B-cells: 42.0;dendritic cells: 56.2;monocytes: 26.1;NK-cells: 56.7;Plasma cells: 49.3;T-cells: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 119.2;MOLT-4: 60.6;NB-4: 59.6;RPMI-8226: 74.3;THP-1: 73.7;U-266/70: 96.8;U-698: 192.8;U-937: 60.6"					"Low region specificity"	"Detected in single"			HPA003631	Enhanced					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA003631: AB_1079543"	"unprognostic (4.32e-2)"	"unprognostic (3.22e-5)"	"unprognostic (6.31e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (7.80e-5)"	"prognostic favorable (1.73e-4)"	"unprognostic (5.27e-3)"	"unprognostic (5.76e-3)"	"unprognostic (5.52e-3)"	"prognostic favorable (6.54e-4)"	"unprognostic (4.29e-2)"	"unprognostic (8.45e-3)"	"unprognostic (2.90e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.80e-1)"	3.5	4.6	0.4	19.2	0.5	31.2	2.4	0.8	1.1	0.7	0.8	3.4	3.4	0.8	0.9	1.3	0.7	3.8	4.9	0.2	0.7	3.6	1.9	3.0	40.1	1.5	0.5	1.1	2.1	2.1	2.1	1.2	0.9	1.5	3.2	0.7	3.4	1.1	2.6	1.8	7.5	1.4	0.5	20.0	5.1	0.4	1.4	16.4	7.9	1.4	33.4	4.4	0.5	1.8	0.6	0.5	0.5	1.5	0.0	0.0	1.3	0.2	0.1	0.0	0.1	0.4	0.7	119.2	0.6	0.0	0.5	0.5	0.0	0.1	0.0	4.7	0.4	1.0	1.3	6.1	0.1	53.2	12.3	0.1	0.1	0.1	0.0	1.1	0.0	35.1	1.1	48.9	0.1	0.1	60.6	59.6	0.7	0.1	1.3	54.1	0.6	74.3	0.1	0.9	0.2	0.8	0.4	1.1	0.3	1.1	0.6	73.7	0.3	1.0	1.1	0.5	0.3	96.8	19.6	192.8	0.2	60.6	0.2	49.9	18.9	31.1	58.6	12.7	53.6	34.2	44.5	55.8	13.6	38.3	34.7	36.4	11.3	37.5	5.2	3.6	37.6	53.3	0.4	0.5	0.8	1.1	0.2	0.7	1.5	0.5	0.9	0.5	1.4	1.8	5.9	0.0	1.8	0.3	42.0	0.4	0.0	0.0	0.0	0.7	0.3	0.0	1.2	0.0	0.6	1.8	0.0	0.0	56.2	0.1	0.0	0.0	0.0	0.1	0.1	5.2	0.0	9.9	0.7	0.2	0.0	0.4	2.6	0.1	1.3	0.3	3.9	0.3	1.9	0.0	0.7	0.0	0.0	11.2	1.8	0.0	0.0	8.7	1.8	1.9	26.1	0.0	56.7	1.0	0.4	0.0	0.0	0.0	49.3	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.0	0.4	0.0	40.7	0.9	0.2	0.0
PPAT	"GPAT, PRAT"	ENSG00000128059	"Phosphoribosyl pyrophosphate amidotransferase"	Q06203	4	56393362-56435615	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Allosteric enzyme, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036091, HPA036092"	Approved		Approved	"Midbody ring"		Yes	No		11000	"Cluster 27: Non-specific - Gene expression"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Midbody ring"		"HPA036091: AB_2674936, HPA036092: AB_10603132"	"unprognostic (5.11e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.15e-5)"	"unprognostic (1.38e-1)"	"unprognostic (4.37e-3)"	"prognostic unfavorable (1.14e-8)"	"unprognostic (6.74e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.88e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (8.34e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.09e-1)"	2.8	6.1	3.8	5.4	4.0	5.6	7.1	3.7	4.7	4.3	3.6	3.9	4.0	4.6	3.4	4.5	4.4	3.0	2.3	4.1	4.0	6.0	6.1	2.2	8.4	3.4	4.0	7.4	5.9	3.9	2.5	6.7	4.3	3.9	4.8	4.4	5.6	3.1	2.9	4.3	3.2	3.6	3.7	4.3	3.5	8.6	4.1	8.3	5.9	2.9	8.0	6.7	2.6	4.2	23.1	19.0	38.0	18.7	12.2	15.7	31.0	25.2	11.1	20.4	21.6	38.1	27.5	80.6	33.4	11.9	19.0	16.8	74.0	25.4	40.7	21.1	32.8	32.6	22.6	42.2	18.4	65.0	19.5	13.6	19.4	29.0	32.4	12.6	21.8	32.5	83.5	43.3	23.2	20.9	80.6	49.1	50.6	52.0	22.4	67.2	24.9	56.9	34.2	16.2	64.0	31.2	20.1	36.3	23.0	35.4	24.5	13.8	15.3	21.2	36.6	21.4	45.0	32.2	34.5	82.9	23.6	40.7	20.1	4.7	1.8	0.9	3.8	2.7	5.9	7.4	5.1	5.2	2.5	6.1	7.7	7.1	0.5	10.2	3.9	3.2	4.3	3.5	3.8	4.0	3.7	4.7	4.1	4.0	3.4	4.0	4.3	3.7	4.1	4.2	4.8	0.0	5.5	16.6	10.7	31.0	16.0	5.6	28.5	8.4	10.1	9.7	3.8	4.3	8.0	3.7	2.1	29.7	10.3	1.5	9.8	3.7	2.6	5.5	14.1	7.8	4.2	14.9	22.9	2.7	25.2	9.4	4.1	6.9	7.0	66.2	5.3	7.1	7.9	38.7	15.8	4.3	4.1	1.6	6.0	2.6	7.8	5.2	8.8	5.6	3.1	6.4	2.1	5.5	9.1	3.3	2.7	5.7	15.3	15.0	0.8	12.7	6.2	4.7	0.0	9.3	10.8	16.4	27.5	18.3	31.8	7.7	10.7	21.9	9.0	8.7
PPM1M	"FLJ32332, PP2Ceta"	ENSG00000164088	"Protein phosphatase, Mg2+/Mn2+ dependent 1M"	Q96MI6	3	52245759-52250599	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 42.2;Kupffer cells: 39.0;Macrophages: 31.1;NK-cells: 30.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 54.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036905, HPA062291"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear bodies"		"HPA036905: AB_10602818, HPA062291: AB_2684740"	"unprognostic (4.26e-3)"	"prognostic favorable (7.73e-4)"	"unprognostic (2.55e-2)"	"unprognostic (4.85e-3)"	"unprognostic (5.64e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.70e-2)"	"prognostic favorable (6.69e-4)"	"unprognostic (4.63e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (1.49e-1)"	"unprognostic (4.14e-2)"	"unprognostic (9.27e-2)"	"unprognostic (4.37e-2)"	19.5	9.4	12.7	20.3	13.7	24.6	15.5	9.9	13.6	25.9	12.2	18.7	6.0	18.3	9.9	12.3	18.1	14.1	11.4	13.6	14.2	10.9	5.6	23.5	29.6	12.8	11.4	18.6	8.0	11.2	9.1	11.6	12.2	16.7	8.7	2.2	11.6	15.2	3.7	10.7	13.1	18.0	12.0	30.1	11.4	8.8	15.5	27.6	13.8	7.8	28.2	17.5	18.2	12.9	0.9	5.4	3.2	7.6	46.1	45.7	5.2	12.2	26.2	17.0	13.1	3.2	4.2	9.0	3.6	32.0	9.5	1.5	10.9	2.3	6.9	11.0	2.7	20.5	14.6	3.3	33.6	3.1	18.7	37.8	5.2	18.9	11.9	27.3	22.2	40.5	3.6	14.5	20.2	2.2	13.7	0.9	4.1	4.0	14.7	3.0	1.6	20.0	7.3	2.6	2.3	9.3	9.0	2.2	11.1	6.8	7.6	7.9	15.5	6.5	10.7	3.8	1.6	54.3	11.2	9.9	12.7	5.4	8.0	1.8	24.1	13.3	20.6	19.3	15.9	6.8	16.1	19.2	14.4	7.4	15.2	19.0	28.9	11.7	29.6	8.5	20.5	17.5	12.7	13.7	9.9	13.6	13.6	14.2	12.8	11.4	12.2	12.0	15.5	12.9	6.8	0.0	5.4	1.3	15.4	5.1	6.5	0.7	8.0	1.6	5.9	7.2	1.8	5.7	2.0	1.8	0.0	3.3	25.9	0.7	3.9	1.8	9.7	4.7	8.9	7.0	1.2	3.0	1.5	1.1	5.8	11.9	3.1	11.0	5.7	7.3	12.5	3.7	42.2	1.7	0.6	0.4	2.0	39.0	17.0	18.0	12.8	31.1	5.4	4.7	29.1	5.1	30.9	1.5	0.7	1.3	3.2	9.8	11.4	2.3	0.9	3.0	0.9	0.7	19.7	5.2	7.3	0.7	4.2	11.9	3.8	1.9	25.1	3.1	1.0	3.5
PTPN1	PTP1B	ENSG00000196396	"Protein tyrosine phosphatase non-receptor type 1"	P18031	20	50510321-50585241	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 227.6;monocytes: 207.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009329, HPA012542, CAB015217"	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Endoplasmic reticulum"		"CAB009329: AB_2174944, CAB015217: , HPA012542: AB_1855915"	"unprognostic (1.67e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.95e-2)"	"unprognostic (2.40e-2)"	"unprognostic (6.47e-3)"	"unprognostic (5.87e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.58e-2)"	26.3	30.8	13.0	44.5	14.0	55.4	22.1	12.3	14.7	23.2	28.6	24.8	13.9	23.0	18.7	29.6	22.0	23.1	31.9	17.5	13.0	46.7	21.0	55.2	52.9	16.1	14.4	25.6	15.9	48.3	19.7	34.2	13.7	25.0	18.8	9.9	18.9	18.2	35.4	23.9	28.3	21.9	13.7	46.5	21.0	18.3	14.2	35.5	18.7	21.6	52.6	35.8	23.5	14.1	66.1	32.4	38.4	26.6	24.6	33.6	54.5	43.2	40.8	123.8	44.9	96.1	134.3	32.5	74.8	40.0	48.7	56.9	30.8	123.8	78.2	48.5	27.6	45.9	30.9	51.3	49.0	48.2	60.2	39.6	84.9	55.9	68.2	54.3	72.3	38.5	81.5	28.9	68.3	36.5	52.1	38.1	20.4	36.2	44.2	45.6	44.6	31.1	71.2	48.4	30.8	35.3	62.0	77.6	71.3	32.1	50.4	50.9	108.2	107.3	43.1	48.8	54.2	31.4	27.3	38.9	67.1	32.3	40.6	19.8	7.1	25.2	12.9	12.1	9.5	19.2	10.8	10.0	7.1	17.4	8.9	9.8	15.4	5.3	22.8	11.8	9.4	8.7	13.0	14.0	12.3	14.7	17.5	13.0	16.1	14.4	13.7	13.7	14.2	14.1	34.0	227.6	83.6	22.9	147.8	86.0	61.7	37.1	56.3	25.1	23.9	24.4	30.0	11.5	40.0	36.8	47.9	54.0	68.7	26.1	23.5	26.2	67.7	45.0	44.0	36.3	18.6	32.0	61.6	19.3	20.9	52.1	32.1	65.9	70.8	14.2	41.4	20.8	37.4	43.7	43.3	16.4	20.3	40.6	169.5	37.4	14.0	100.7	37.4	32.8	207.8	12.1	38.1	27.6	42.1	41.7	14.5	12.0	178.7	26.6	8.9	65.2	30.2	27.5	19.7	55.5	57.7	20.8	24.5	48.7	47.2	54.3	83.8	44.3	14.6	53.5
PTPN2	"PTPT, TC-PTP, TCELLPTP, TCPTP"	ENSG00000175354	"Protein tyrosine phosphatase non-receptor type 2"	P17706	18	12785478-12929643	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 99.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015004, HPA046176"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA015004: AB_2669131, HPA046176: AB_2679569"	"unprognostic (5.83e-3)"	"unprognostic (8.50e-2)"	"unprognostic (5.85e-2)"	"unprognostic (7.21e-3)"	"unprognostic (8.94e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.37e-3)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.06e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.20e-8)"	"unprognostic (3.19e-1)"	"unprognostic (6.84e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.61e-3)"	23.4	15.2	10.0	32.8	10.8	57.2	23.7	21.0	17.1	19.9	15.6	22.2	18.9	16.0	20.4	20.0	17.4	22.4	14.7	11.0	10.4	17.3	25.8	26.3	44.4	12.3	10.4	26.8	33.1	14.1	18.3	19.5	11.8	17.6	24.1	20.2	29.4	13.5	16.7	21.0	19.5	16.9	10.7	28.5	18.0	13.6	10.0	99.8	17.5	11.9	43.5	37.2	19.9	14.3	34.8	20.7	23.7	7.9	26.5	47.4	23.0	22.7	50.2	47.5	42.2	45.4	48.8	54.3	37.2	23.6	53.2	20.4	39.0	62.2	62.1	21.2	23.5	38.4	17.7	47.6	36.4	91.1	35.1	40.2	57.6	43.3	85.1	29.2	24.6	58.1	37.9	71.6	38.6	39.9	91.3	74.5	28.5	141.7	24.0	30.4	37.3	61.9	40.2	54.6	42.3	22.0	46.0	26.7	41.8	25.1	22.4	51.5	18.8	59.8	58.0	45.1	49.8	22.6	24.5	77.8	28.3	49.3	25.7	23.7	52.6	39.2	37.0	47.7	50.4	54.4	43.7	41.4	62.5	39.5	31.6	34.9	19.0	64.1	46.7	53.0	57.3	40.7	10.0	10.8	21.0	17.1	11.0	10.4	12.3	10.4	11.8	10.7	10.0	14.3	25.8	35.3	77.0	38.5	82.4	59.9	106.0	88.0	61.5	44.1	37.0	50.5	15.0	47.1	84.4	14.7	104.3	54.1	130.4	32.2	13.7	55.1	24.3	51.0	44.8	32.0	32.3	40.8	81.1	68.8	52.5	38.1	24.5	78.7	56.4	53.1	20.3	27.9	51.3	15.2	60.5	35.0	69.2	99.2	92.5	23.2	29.2	93.4	23.2	44.0	137.0	17.6	128.8	22.6	55.0	40.0	45.1	25.6	120.2	126.4	29.9	23.1	55.4	84.5	19.7	35.4	33.8	23.3	61.3	40.0	50.2	81.1	84.2	65.2	39.5	152.4
PTPN22	"Lyp, Lyp1, Lyp2, PTPN8"	ENSG00000134242	"Protein tyrosine phosphatase non-receptor type 22"	Q9Y2R2	1	113813811-113871753	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Immunity"	"Hydrolase, Protein phosphatase"	"Diabetes mellitus, Disease variant, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.0;lymphoid tissue: 20.3"	"Group enriched"	"Detected in many"	4	"B-cells: 67.4;dendritic cells: 176.0;NK-cells: 108.1;Plasma cells: 79.6;T-cells: 151.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 69.3;HL-60: 27.7;U-266/70: 29.2;U-698: 37.5;U-937: 28.4"	"Region enriched"	"Detected in single"	11	"cerebellum: 5.3"	"Not detected"	"Not detected"			"HPA004912, CAB012209, HPA013350"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Vesicles, Plasma membrane"	"CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570"	"unprognostic (2.25e-2)"	"unprognostic (5.31e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.33e-4)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-3)"	"unprognostic (9.60e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.75e-6)"	"unprognostic (3.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-2)"	2.0	1.5	0.2	11.5	0.2	38.0	2.3	0.4	0.5	1.8	0.6	4.0	6.4	1.0	1.1	1.7	0.9	4.8	0.6	0.1	0.2	0.6	2.0	7.5	20.3	0.5	0.2	0.6	1.3	0.3	0.3	0.8	0.4	1.0	4.3	0.4	1.3	0.6	0.3	0.9	8.6	1.6	0.2	13.2	5.2	1.4	0.6	20.0	0.7	0.2	13.5	4.2	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.9	0.4	0.0	0.7	0.0	0.4	69.3	0.1	0.2	0.0	0.0	0.0	0.1	0.5	6.5	0.0	10.0	0.0	0.0	0.2	27.7	21.1	5.7	0.0	2.8	0.2	5.1	10.6	17.2	0.1	15.7	10.3	0.2	20.1	15.7	0.0	0.1	0.0	1.2	6.7	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.0	5.0	16.0	0.3	0.4	0.5	29.2	6.6	37.5	11.1	28.4	0.1	15.8	4.8	25.0	17.0	1.3	20.1	9.9	8.4	13.6	8.7	7.4	5.0	12.1	2.4	11.0	0.6	5.2	14.5	7.3	0.2	0.2	0.4	0.5	0.1	0.2	0.5	0.2	0.4	0.2	0.6	0.8	2.2	0.0	6.5	0.7	67.4	2.5	0.2	0.0	1.2	0.7	2.2	2.4	0.8	0.0	0.2	1.8	2.1	0.1	176.0	2.2	0.0	0.1	0.4	0.7	0.5	1.7	0.0	16.6	3.2	0.6	0.3	2.2	12.8	1.0	27.8	0.0	0.4	0.5	7.1	0.0	2.5	1.2	0.0	17.3	26.8	1.0	0.0	26.4	3.6	2.8	14.4	0.0	108.1	0.0	1.7	0.5	0.8	0.0	79.6	0.3	4.3	0.1	2.2	0.5	13.1	0.6	1.4	0.4	0.6	0.3	2.7	0.1	151.2	0.0	2.2	0.3
RAB37		ENSG00000172794	"RAB37, member RAS oncogene family"	Q96AX2	17	74670578-74747335	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.5;brain: 20.8;lymphoid tissue: 21.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 33.4;Excitatory neurons: 33.2;granulocytes: 50.7;Inhibitory neurons: 29.6;NK-cells: 87.6;T-cells: 31.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 269.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 269.7"	"Cell line enhanced"	"Detected in some"		"HEL: 50.6;HMC-1: 58.7;OE19: 25.4;U-266/70: 84.9;U-937: 34.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"				"unprognostic (2.10e-2)"	"unprognostic (7.04e-4)"	"unprognostic (5.95e-2)"	"unprognostic (9.80e-4)"	"unprognostic (3.49e-1)"	"unprognostic (7.04e-5)"	"unprognostic (1.74e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.62e-3)"	"unprognostic (9.47e-3)"	"unprognostic (3.05e-2)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (8.80e-6)"	"unprognostic (7.30e-2)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (7.80e-2)"	"unprognostic (4.01e-2)"	1.4	1.9	1.5	10.5	2.7	24.5	1.0	20.8	10.5	1.8	0.0	5.4	5.2	1.3	1.8	1.9	1.6	4.8	1.3	1.2	2.8	1.0	12.2	6.8	19.2	11.8	4.6	0.5	0.7	1.7	0.6	1.8	11.3	3.9	5.1	3.3	2.3	0.9	0.6	0.8	8.3	1.9	0.6	17.0	6.7	0.8	11.1	21.3	0.6	2.7	14.9	4.2	1.9	3.7	0.0	7.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	50.6	0.2	0.3	0.1	3.9	58.7	0.5	0.0	0.0	0.0	0.0	0.0	7.3	0.0	18.3	0.0	0.2	15.3	13.0	0.0	25.4	0.0	2.8	0.0	0.0	0.1	0.0	0.8	0.0	0.0	3.6	0.0	2.9	0.2	11.4	0.0	0.0	0.3	0.0	0.0	84.9	3.6	1.1	0.1	34.3	0.0	269.7	13.6	201.5	51.1	28.9	12.9	12.3	22.4	37.8	7.3	12.2	12.5	28.3	63.2	54.0	50.3	1.4	42.8	48.9	1.5	2.7	20.8	10.5	1.2	2.8	11.8	4.6	11.3	0.6	11.1	3.7	0.9	3.2	3.2	1.6	23.1	0.1	0.2	0.3	0.0	7.6	0.8	0.4	1.8	5.7	1.8	0.0	6.2	0.1	33.4	1.3	0.0	1.3	0.0	0.1	0.1	0.9	5.4	16.0	33.2	0.9	0.1	2.0	8.2	0.5	50.7	0.0	2.2	12.6	0.6	3.3	29.6	7.7	14.2	2.2	0.0	0.4	0.6	18.5	0.0	1.9	11.8	1.3	87.6	2.0	1.6	0.4	2.8	1.2	6.3	0.1	0.2	1.5	2.3	1.0	6.6	3.0	1.1	0.0	1.5	0.3	0.1	0.0	31.0	0.5	0.5	0.3
RAC2	EN-7	ENSG00000128340	"Rac family small GTPase 2"	P15153	22	37225270-37244448	"Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 411.9;lymphoid tissue: 387.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 329.0;dendritic cells: 381.4;granulocytes: 520.5;NK-cells: 717.9;Plasma cells: 287.8;T-cells: 419.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 522.5;HL-60: 734.5;HMC-1: 1427.9;Karpas-707: 684.5;U-87 MG: 618.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022946, HPA047820"	Enhanced					NA	Yes		3300000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB022946: , HPA047820: AB_2680167"	"prognostic favorable (1.03e-5)"	"unprognostic (2.91e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.82e-3)"	"unprognostic (6.74e-2)"	"unprognostic (7.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (5.00e-2)"	"unprognostic (8.52e-3)"	"unprognostic (2.65e-1)"	"unprognostic (7.65e-2)"	"unprognostic (3.81e-1)"	"prognostic unfavorable (1.06e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.50e-2)"	24.7	8.4	3.6	207.2	3.8	411.9	11.4	3.9	8.0	12.2	4.4	34.8	35.3	10.1	4.7	15.9	11.7	37.1	6.5	3.8	4.7	10.9	19.3	63.4	387.9	6.5	5.3	5.5	5.3	2.1	3.4	12.4	7.1	10.9	33.9	0.4	21.5	8.3	4.9	7.6	96.9	19.6	5.2	299.9	42.7	3.5	6.1	323.9	9.5	7.2	309.1	54.0	9.9	7.2	136.6	0.2	0.0	0.0	14.3	130.5	0.6	17.9	41.1	14.2	28.8	0.3	44.8	167.4	19.8	52.9	0.8	33.3	1.0	231.6	15.6	522.5	0.6	209.6	3.6	0.6	35.8	734.5	1427.9	96.4	32.3	25.1	84.3	0.9	239.7	159.1	50.5	684.5	1.9	0.2	218.9	291.2	2.8	13.1	87.2	72.3	0.7	193.8	22.6	0.1	2.0	0.6	0.9	23.0	2.7	0.8	9.7	391.8	258.7	0.6	23.5	1.0	2.0	307.0	171.4	176.6	618.6	316.5	35.1	1319.9	519.8	1602.2	972.1	695.5	731.5	761.7	768.6	858.9	494.0	672.8	584.3	759.8	1336.4	972.2	879.5	728.7	1163.4	1566.2	3.6	3.8	3.9	8.0	3.8	4.7	6.5	5.3	7.1	5.2	6.1	7.2	4.4	16.0	47.7	0.0	329.0	5.4	2.2	26.0	16.5	0.0	8.6	9.5	1.1	2.8	12.6	1.8	0.0	0.8	381.4	3.4	0.0	13.6	0.2	1.1	0.8	5.6	4.2	109.7	0.4	2.2	1.5	9.2	33.6	1.0	520.5	0.3	13.6	3.4	150.8	0.0	0.1	6.3	0.0	129.9	63.9	0.9	0.3	147.9	30.2	3.7	125.9	0.0	717.9	0.5	0.0	18.2	18.1	0.0	287.8	0.5	0.6	1.5	4.4	0.0	13.1	2.4	4.5	0.0	1.0	5.1	4.0	2.9	419.6	3.7	11.2	3.6
RANBP1	HTF9A	ENSG00000099901	"RAN binding protein 1"	P43487	22	20115938-20127355	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 754.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 2431.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065868, HPA065931"	Supported		Enhanced	Cytosol		NA	NA		1400000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA065868: AB_2685572, HPA065931: AB_2685580"	"unprognostic (1.25e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.43e-3)"	"unprognostic (6.55e-3)"	"unprognostic (4.35e-2)"	"unprognostic (2.50e-2)"	"prognostic unfavorable (1.58e-6)"	"unprognostic (2.83e-2)"	"unprognostic (2.21e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (2.40e-2)"	"unprognostic (3.95e-1)"	"unprognostic (4.44e-2)"	"unprognostic (7.30e-2)"	65.5	68.0	37.6	63.3	38.6	117.5	60.7	40.2	47.9	67.1	28.8	63.9	52.9	66.7	21.4	94.7	61.2	30.0	47.5	39.7	40.5	64.8	86.7	53.5	94.7	41.1	39.1	61.0	54.0	35.9	50.3	46.2	41.4	49.8	42.9	35.3	51.8	34.3	54.9	61.8	60.6	36.2	40.8	71.1	55.5	117.8	39.6	104.0	46.5	34.8	72.6	61.9	64.7	43.7	434.6	218.5	479.7	263.2	79.1	93.8	403.7	388.7	169.3	494.6	356.4	401.5	150.8	669.8	169.7	157.8	224.9	394.2	449.4	340.4	269.6	290.1	1071.3	562.6	218.5	426.6	120.3	913.7	294.4	103.9	158.7	393.0	139.2	114.3	227.1	300.2	2431.9	261.1	226.8	339.2	665.5	622.0	547.2	553.8	380.8	667.4	674.7	172.6	171.6	233.9	478.6	354.7	356.6	196.4	236.6	210.3	137.1	378.9	176.4	341.5	668.1	258.7	438.3	260.9	383.6	1066.0	186.9	405.9	292.7	21.1	94.7	75.8	71.3	101.6	78.8	123.1	101.6	91.1	111.5	119.1	101.8	77.0	9.5	90.8	93.6	103.6	115.4	102.5	37.6	38.6	40.2	47.9	39.7	40.5	41.1	39.1	41.4	40.8	39.6	43.7	133.1	35.3	37.1	14.7	135.0	274.4	195.0	260.6	109.3	44.4	142.3	175.6	47.1	104.4	104.8	90.1	6.2	409.2	103.8	106.4	277.8	188.5	394.2	104.6	131.1	143.5	117.6	259.2	22.2	112.3	754.9	156.7	72.4	86.7	64.7	187.2	93.5	169.5	268.7	37.0	21.4	194.0	209.5	85.5	223.3	236.1	145.1	95.3	177.9	6.5	140.6	103.5	87.6	7.5	23.9	150.0	109.3	136.9	179.6	338.0	107.3	213.7	93.8	39.0	98.6	110.9	289.5	505.1	435.2	220.1	294.9	194.7	119.2	176.5	273.6	218.2
RASSF5	"Maxp1, NORE1, RAPL"	ENSG00000266094	"Ras association domain family member 5"	Q8WWW0	1	206507531-206589448	"Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 109.3;lymphoid tissue: 83.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 119.3;granulocytes: 140.0;Langerhans cells: 147.7;Macrophages: 78.0;NK-cells: 118.4;T-cells: 97.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 90.9;Karpas-707: 192.6;MOLT-4: 84.1;RPMI-8226: 218.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070480	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA070480: AB_2686271"	"unprognostic (1.92e-3)"	"prognostic favorable (1.46e-4)"	"unprognostic (1.37e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.93e-1)"	"unprognostic (5.17e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.84e-2)"	"unprognostic (9.39e-2)"	"prognostic unfavorable (1.22e-6)"	"unprognostic (3.29e-1)"	"unprognostic (5.58e-2)"	"unprognostic (4.28e-2)"	"unprognostic (6.28e-3)"	6.8	15.1	3.4	48.1	2.9	109.3	4.9	1.2	3.6	10.8	0.4	8.9	9.1	3.9	1.8	41.7	10.2	18.2	10.8	3.2	2.9	4.3	14.0	26.4	63.4	4.1	4.4	3.6	10.8	8.4	10.3	5.3	4.1	8.1	9.3	1.0	30.3	7.2	14.8	28.8	17.7	6.7	2.3	56.2	17.3	1.4	5.5	83.1	5.7	3.7	60.0	30.3	20.7	4.6	9.3	4.2	0.1	1.6	3.2	1.8	0.0	0.6	4.9	1.7	2.3	0.4	19.5	32.4	2.5	2.1	0.3	13.5	3.5	2.2	1.5	22.4	12.7	35.2	1.0	0.2	1.2	59.1	90.9	2.2	8.9	2.0	2.4	3.2	0.3	76.0	14.4	192.6	0.9	1.1	84.1	37.8	1.8	0.1	3.6	39.4	4.6	218.8	0.1	14.7	4.7	0.3	15.6	1.7	0.6	0.1	3.7	37.5	0.1	0.4	6.4	8.0	2.1	67.7	52.8	30.2	3.0	34.1	1.0	211.8	40.3	268.7	112.3	53.7	99.7	28.4	82.6	117.0	43.9	26.6	112.1	105.8	157.2	131.2	84.0	34.2	78.2	154.7	3.4	2.9	1.2	3.6	3.2	2.9	4.1	4.4	4.1	2.3	5.5	4.6	2.1	38.5	27.9	1.6	64.0	32.8	16.6	8.6	27.9	1.8	7.4	4.4	7.7	15.7	11.3	0.0	0.0	0.2	119.3	1.0	3.9	8.1	0.3	0.5	0.5	4.4	2.4	16.4	19.4	8.9	0.1	11.6	9.2	0.6	140.0	0.1	5.7	6.2	12.1	8.4	16.8	1.0	10.2	49.0	147.7	0.1	7.5	78.0	14.2	6.5	54.2	0.1	118.4	2.0	0.7	8.3	2.6	9.1	41.1	13.7	0.0	0.8	9.6	0.2	0.0	2.1	6.8	0.1	0.6	48.6	27.3	0.1	97.7	0.2	2.1	49.6
RBM4	"LARK, RBM4A, ZCCHC21, ZCRB3A"	ENSG00000173933	"RNA binding motif protein 4"	Q9BWF3	11	66638667-66668374	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, RNA-mediated gene silencing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042174, HPA047849"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA042174: AB_2677885, HPA047849: AB_2680180"	"unprognostic (8.43e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.53e-2)"	"unprognostic (9.46e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.41e-3)"	"unprognostic (6.42e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.07e-3)"	82.6	111.5	60.8	71.0	63.3	131.5	75.8	81.1	66.7	90.8	69.4	96.1	67.8	87.1	90.3	100.3	79.4	59.0	75.6	61.5	67.1	119.8	82.3	77.4	97.5	59.0	58.5	103.6	115.5	77.2	86.1	72.8	58.9	95.9	62.6	74.4	89.1	60.0	96.6	80.9	83.6	69.1	61.1	104.8	98.4	74.3	69.5	109.8	85.7	72.4	99.1	84.2	84.1	65.4	127.2	163.6	246.5	136.4	90.1	95.6	153.9	128.6	106.1	134.1	97.3	281.5	160.9	161.1	174.4	132.3	120.5	136.4	263.5	159.1	142.9	162.1	138.4	220.7	163.5	170.3	173.1	152.8	91.9	138.8	134.3	158.6	213.9	136.4	184.3	155.0	180.1	115.0	147.3	263.3	252.9	157.9	309.7	246.8	176.0	234.2	224.6	181.7	180.7	199.5	204.5	149.5	227.1	168.6	379.9	163.8	315.3	154.4	180.9	140.4	124.0	86.5	107.3	143.9	162.5	258.8	109.9	118.3	205.8	210.0	119.4	131.3	135.5	123.2	122.3	119.3	139.8	149.9	116.2	130.4	147.5	149.8	137.5	155.4	144.0	103.6	194.3	159.1	60.8	63.3	81.1	66.7	61.5	67.1	59.0	58.5	58.9	61.1	69.5	65.4	19.7	28.9	42.2	8.1	64.0	17.8	61.4	36.3	112.7	58.2	24.2	12.7	4.6	15.7	36.5	20.2	93.8	36.2	48.7	16.6	15.6	25.1	39.8	26.6	28.0	28.5	34.7	42.5	23.9	23.1	30.1	33.6	53.0	30.7	36.8	38.1	25.7	11.1	14.5	62.2	21.4	15.5	32.6	18.8	29.2	9.3	27.4	27.5	19.6	7.5	28.8	15.9	69.0	15.1	18.8	19.6	23.6	20.3	60.2	62.6	32.9	10.6	41.1	90.0	19.7	29.7	28.3	41.1	40.1	68.6	22.3	43.8	66.3	42.4	24.8	65.5
RNF19A	"DKFZp566B1346, dorfin, RNF19"	ENSG00000034677	"Ring finger protein 19A, RBR E3 ubiquitin protein ligase"	Q9NV58	8	100257060-100336218	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 178.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011455, HPA023652"	Approved					NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"CAB011455: AB_2180446, HPA023652: AB_1847836"	"unprognostic (2.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.12e-2)"	"unprognostic (7.96e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.97e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (7.99e-5)"	"unprognostic (8.44e-2)"	"unprognostic (8.19e-2)"	"unprognostic (2.02e-1)"	"prognostic favorable (3.28e-5)"	32.0	18.8	29.1	32.7	28.7	57.4	28.6	22.7	25.5	52.0	17.6	25.9	24.0	41.3	16.4	21.6	30.5	43.1	25.0	25.3	48.3	30.0	49.3	34.7	55.4	40.2	36.0	27.4	25.9	16.1	15.2	26.9	33.0	22.0	26.5	27.2	22.3	18.7	28.0	31.8	37.9	32.6	37.3	31.5	27.4	53.0	36.1	34.3	18.8	31.0	43.8	35.9	27.3	40.7	26.7	16.9	14.8	16.9	27.7	23.1	18.7	23.4	22.5	22.0	19.9	9.0	17.3	15.7	41.6	24.7	10.2	18.9	11.6	17.4	29.6	65.3	9.4	26.1	86.8	13.5	22.8	5.3	15.6	23.3	26.1	17.5	33.1	26.9	34.3	17.3	14.8	178.6	21.8	13.5	24.6	9.0	5.4	18.2	15.5	9.8	10.0	30.7	60.2	41.7	11.4	24.6	24.5	14.9	23.3	30.6	13.1	20.5	33.9	25.3	19.9	18.7	14.3	85.5	59.3	10.4	16.2	17.4	15.4	26.3	8.6	8.1	16.3	6.8	10.4	15.5	13.4	12.6	5.7	13.9	6.9	9.8	19.6	6.2	14.2	14.1	14.7	5.8	29.1	28.7	22.7	25.5	25.3	48.3	40.2	36.0	33.0	37.3	36.1	40.7	70.8	51.3	51.6	106.7	101.7	40.1	83.4	56.9	18.8	29.9	44.7	32.5	40.6	110.1	83.6	44.1	60.5	11.0	184.8	61.6	7.9	65.0	183.8	165.9	78.2	66.3	20.8	124.8	76.9	40.2	14.5	62.5	67.8	242.1	43.0	172.0	32.2	42.9	23.0	58.9	69.7	25.9	42.7	30.5	41.8	259.4	58.4	39.2	21.4	73.1	24.1	43.5	65.9	35.7	39.9	49.0	32.0	68.8	161.7	66.3	50.9	54.1	106.2	48.4	19.7	77.4	46.3	77.8	47.2	26.1	60.4	8.2	204.6	46.3	21.8	144.9
RNF4	"RES4-26, SLX5, SNURF"	ENSG00000063978	"Ring finger protein 4"	P78317	4	2462220-2625320	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022047, HPA049356"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Microtubule ends"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"	"Microtubule ends"	"HPA022047: , HPA049356: AB_2680726"	"unprognostic (8.38e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.31e-3)"	"unprognostic (9.03e-3)"	"prognostic unfavorable (6.38e-4)"	"unprognostic (1.34e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.40e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.54e-1)"	30.2	30.9	24.0	36.0	24.9	46.4	29.2	26.0	25.1	29.4	26.5	27.9	29.0	29.5	28.3	30.7	28.5	28.3	27.0	24.5	25.5	32.6	25.9	27.8	49.9	26.0	25.9	31.0	31.2	33.6	26.8	28.4	25.2	28.2	27.4	24.0	28.0	28.1	27.7	29.7	30.4	33.1	23.9	40.3	30.1	31.9	26.3	50.1	30.7	23.2	50.0	35.0	26.8	25.5	60.9	57.0	57.9	42.0	50.6	52.2	65.6	73.3	83.4	77.3	70.0	65.1	56.8	77.6	42.0	76.0	101.5	39.7	63.5	58.6	72.7	37.6	38.5	92.4	54.6	62.6	76.6	66.7	77.8	61.0	69.7	72.3	59.4	53.6	73.1	64.8	50.0	103.2	80.4	43.5	105.0	92.5	89.8	52.3	70.9	76.6	55.3	40.8	52.6	74.5	54.3	51.0	50.5	40.4	52.1	62.9	63.1	50.6	60.0	65.8	32.0	64.2	115.4	131.3	189.5	82.6	64.6	72.7	69.5	44.7	70.0	104.6	97.7	95.4	97.2	85.0	82.2	97.0	84.1	59.1	78.8	80.3	77.2	99.2	103.8	56.5	98.8	128.6	24.0	24.9	26.0	25.1	24.5	25.5	26.0	25.9	25.2	23.9	26.3	25.5	31.1	22.4	17.5	17.0	36.0	27.5	18.4	17.7	31.3	11.9	24.0	16.0	20.7	12.8	21.3	22.0	16.7	21.3	45.9	16.5	21.5	22.2	14.0	17.0	22.8	21.7	12.1	15.4	15.9	23.3	35.0	19.5	23.0	23.9	14.5	22.7	16.4	20.4	19.7	13.5	17.8	16.8	8.2	34.0	28.5	22.4	17.1	27.8	7.2	18.7	35.1	11.5	43.3	13.0	16.3	29.8	14.3	20.7	47.8	27.1	23.1	21.2	17.6	17.7	26.3	18.2	22.0	31.2	48.6	27.0	32.1	21.8	39.7	16.4	18.9	32.9
SASH3	"753P9, CXorf9, HACS2, SH3D6C, SLY"	ENSG00000122122	"SAM and SH3 domain containing 3"	O75995	X	129779949-129795201	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 108.1;intestine: 36.5;lymphoid tissue: 120.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 69.5;dendritic cells: 66.3;Hofbauer cells: 51.3;Kupffer cells: 58.9;Macrophages: 40.0;monocytes: 45.3;NK-cells: 101.0;Plasma cells: 39.8;T-cells: 60.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 164.1;JURKAT: 119.4;MOLT-4: 120.6;NB-4: 89.1;REH: 88.5;U-698: 150.2;U-937: 117.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA001085	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA		14000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Nuclear bodies"	"HPA001085: AB_2184289"	"unprognostic (1.88e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.49e-3)"	"prognostic favorable (3.15e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.67e-1)"	"unprognostic (3.23e-3)"	"unprognostic (7.92e-3)"	"unprognostic (3.45e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.51e-5)"	"unprognostic (3.30e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.53e-1)"	8.6	5.6	5.2	61.8	5.6	108.1	4.3	5.4	7.4	3.2	5.1	9.4	11.6	3.1	1.8	3.6	4.9	10.2	2.7	4.8	6.4	3.7	5.9	21.3	120.6	9.6	7.0	1.8	2.5	1.5	2.2	7.5	8.4	4.2	9.9	0.2	7.9	2.2	1.3	2.1	36.5	7.5	7.5	100.3	13.6	1.3	8.4	120.7	3.9	1.7	108.2	15.4	3.0	10.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	164.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	41.7	0.0	0.0	0.0	58.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	119.4	0.2	13.6	0.0	0.0	120.6	89.1	0.0	0.0	0.0	88.5	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.1	24.0	0.3	0.0	0.3	0.1	0.1	0.1	35.0	150.2	0.0	117.2	0.0	41.6	135.4	245.5	192.2	195.3	159.1	79.1	108.2	178.9	121.5	90.8	76.9	120.9	128.0	153.3	209.9	55.1	145.6	343.7	5.2	5.6	5.4	7.4	4.8	6.4	9.6	7.0	8.4	7.5	8.4	10.2	0.8	0.0	3.6	0.0	69.5	0.5	0.1	0.0	0.0	0.0	0.5	1.1	1.0	1.5	0.0	0.0	0.0	0.5	66.3	0.1	0.0	0.1	0.1	0.2	0.2	1.2	0.0	13.5	0.2	0.0	0.6	0.9	2.6	0.3	22.2	0.0	3.3	0.9	51.3	0.0	0.2	0.1	0.0	58.9	19.1	0.0	0.3	40.0	0.0	7.5	45.3	0.0	101.0	0.0	0.1	0.0	0.0	0.0	39.8	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.1	1.3	0.5	60.6	0.0	0.1	0.0
SHCBP1	"FLJ22009, PAL"	ENSG00000171241	"SHC binding and spindle associated 1"	Q8NEM2	16	46578591-46621379	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.4;lymphoid tissue: 10.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 36.2;Extravillous trophoblasts: 28.7;Plasma cells: 38.3;Spermatocytes: 33.7;Spermatogonia: 23.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA048876	Uncertain		Approved	"Nuclear bodies,Microtubules,Midbody,Mitotic spindle"		Yes	Yes			"Cluster 19: B-cells - Humoral immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies"	"Microtubules, Midbody, Mitotic spindle"	"HPA048876: AB_2680542"	"unprognostic (2.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.96e-4)"	"unprognostic (2.26e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (4.47e-5)"	"unprognostic (4.81e-2)"	"unprognostic (2.22e-16)"	"unprognostic (3.59e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.66e-1)"	0.7	0.5	0.5	5.1	0.5	17.4	0.9	1.2	0.6	0.6	0.4	1.9	1.2	0.6	0.6	3.5	0.2	0.6	1.0	0.4	0.2	5.4	0.2	1.0	9.8	0.4	0.3	0.3	0.2	0.2	0.2	2.4	0.4	0.3	2.2	0.2	0.8	0.2	1.5	3.3	1.5	1.7	0.1	4.4	0.9	5.2	0.5	8.8	0.3	0.2	10.6	1.2	1.2	0.7	33.8	30.8	11.9	15.3	3.1	6.2	16.2	60.7	24.6	59.2	26.8	14.6	20.8	28.0	30.2	28.8	26.8	21.0	29.3	21.7	73.8	17.7	17.2	28.2	25.8	30.3	0.1	28.5	35.4	1.2	1.6	45.9	18.1	5.9	33.0	14.9	12.7	28.3	69.7	21.5	24.0	23.7	10.0	17.2	31.6	45.4	89.9	44.8	13.7	9.4	5.0	7.2	46.0	23.7	11.1	11.4	13.0	23.4	16.1	43.9	28.7	43.5	54.0	24.9	36.7	46.7	21.4	31.3	45.8	0.2	0.3	0.6	0.2	0.5	0.0	1.7	0.3	0.1	0.3	1.2	0.0	0.1	0.4	0.1	2.4	0.7	1.2	1.1	0.5	0.5	1.2	0.6	0.4	0.2	0.4	0.3	0.4	0.1	0.5	0.7	0.2	0.0	1.1	1.3	7.1	1.7	0.7	1.2	0.0	0.3	0.6	1.1	1.9	1.5	1.4	0.0	0.0	11.3	0.8	1.9	0.0	0.2	8.4	0.7	1.7	1.7	0.0	36.2	2.1	0.0	28.7	3.7	4.1	1.5	0.0	7.6	1.8	0.3	12.6	0.0	0.7	2.2	2.0	4.5	3.3	2.3	0.6	4.0	1.8	2.8	2.8	0.8	0.0	1.0	0.5	0.1	0.1	0.4	38.3	0.5	0.4	0.1	0.1	0.3	0.0	0.5	6.3	33.7	23.7	3.6	0.6	3.7	2.2	0.8	3.4	1.1
SHLD1	"C20orf196, FLJ25067, RINN3"	ENSG00000171984	"Shieldin complex subunit 1"	Q8IYI0	20	5750393-5864395	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 12.9;dendritic cells: 13.1;Distal tubular cells: 19.6;Exocrine glandular cells: 14.2;Hofbauer cells: 17.0;Pancreatic endocrine cells: 11.7;Proximal tubular cells: 11.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 55.7;U-698: 45.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040749	Approved		Approved	"Endoplasmic reticulum,Golgi apparatus,Vesicles"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum, Golgi apparatus, Vesicles"		"HPA040749: AB_10673093"	"unprognostic (2.03e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.20e-3)"	"unprognostic (6.15e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.72e-3)"	"unprognostic (6.66e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.59e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (4.05e-5)"	4.0	9.7	5.0	6.2	5.8	16.7	5.3	7.2	6.1	5.1	4.6	5.1	9.1	3.8	5.3	5.4	3.9	4.4	8.6	4.9	5.8	6.7	3.0	4.8	14.3	5.6	5.3	5.1	5.2	2.4	6.0	3.0	6.3	6.3	4.9	4.0	8.4	3.7	12.0	4.1	7.1	2.6	4.6	9.9	4.7	3.1	5.4	13.3	6.6	7.7	12.1	4.5	4.7	6.4	9.2	9.6	4.6	2.3	2.8	2.8	2.3	2.5	4.5	3.1	4.3	4.5	9.4	33.3	6.3	2.5	2.5	4.1	2.8	6.1	3.6	10.3	3.4	12.9	1.4	18.2	6.2	16.2	5.7	3.3	7.2	4.7	3.1	3.0	6.4	8.7	17.8	13.9	5.9	3.5	20.4	55.7	6.3	10.3	5.2	16.5	7.1	15.1	5.0	4.5	8.2	7.4	4.6	4.7	10.0	2.6	3.9	13.2	4.3	3.6	5.4	3.5	5.4	8.7	16.6	45.8	1.8	13.9	6.4	21.7	12.4	22.5	21.3	14.8	16.4	27.7	25.2	21.5	12.7	33.1	22.9	17.2	4.9	23.5	16.9	15.1	31.5	13.0	5.0	5.8	7.2	6.1	4.9	5.8	5.6	5.3	6.3	4.6	5.4	6.4	9.2	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	6.4	8.6	0.0	0.0	0.0	12.9	0.0	7.5	13.1	0.0	19.6	7.9	0.0	6.4	4.4	2.8	0.0	0.0	0.0	14.2	7.5	1.7	0.0	5.2	0.0	7.3	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	11.7	0.0	0.0	2.3	0.0	0.0	11.7	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	5.9	6.4	5.0	0.0	0.0
SLA	"hSLAP, SLA1, SLAP, SLAP-1"	ENSG00000155926	"Src like adaptor"	Q13239	8	133036728-133102912	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 97.4;lymphoid tissue: 156.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 224.2;Hofbauer cells: 67.4;Kupffer cells: 199.4;Macrophages: 154.2;NK-cells: 109.2;Plasma cells: 83.0;T-cells: 160.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HMC-1: 47.9;JURKAT: 201.5;Karpas-707: 129.2;MOLT-4: 35.8;U-266/84: 76.1;U-937: 55.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012296, HPA074192"	Enhanced		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear membrane, Cytosol"		"HPA012296: AB_1856946, HPA074192: AB_2686673"	"unprognostic (1.19e-2)"	"unprognostic (6.29e-3)"	"unprognostic (2.73e-3)"	"unprognostic (6.07e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.25e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.66e-1)"	"unprognostic (3.05e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.65e-1)"	25.2	13.1	9.5	82.9	6.4	97.4	9.5	6.1	11.5	11.1	8.2	10.8	7.9	5.2	2.9	9.4	7.0	20.9	5.2	8.2	9.1	6.4	16.9	25.9	78.6	12.0	8.4	3.0	5.8	3.1	3.1	15.2	10.3	5.2	8.4	1.3	4.6	3.6	1.5	4.0	20.7	12.5	9.7	70.3	12.5	1.4	16.9	156.6	27.6	4.4	71.0	22.0	4.2	14.6	0.3	0.0	0.0	0.0	0.0	0.1	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.9	0.1	2.3	0.0	0.0	0.0	6.3	47.9	0.8	0.0	0.6	0.0	0.2	0.0	201.5	0.1	129.2	0.0	0.0	35.8	9.3	0.0	0.0	0.0	0.2	0.3	7.8	0.0	0.0	0.0	1.0	0.0	0.1	0.1	3.1	0.0	15.3	0.0	0.1	0.3	0.2	0.1	6.9	76.1	0.0	0.6	55.6	0.0	0.7	110.2	203.6	87.6	123.1	110.1	41.0	79.7	88.2	79.8	48.3	75.3	77.4	262.3	132.6	148.4	6.3	124.4	158.9	9.5	6.4	6.1	11.5	8.2	9.1	12.0	8.4	10.3	9.7	16.9	14.6	2.4	9.6	19.1	0.7	36.6	2.2	0.3	0.0	0.0	9.7	0.9	1.3	3.3	1.5	10.5	0.0	0.0	0.4	224.2	0.2	0.0	0.2	0.2	0.7	0.7	5.9	0.0	13.2	1.0	0.0	1.2	4.5	3.6	0.5	37.2	1.7	8.9	2.9	67.4	0.0	1.3	0.5	0.0	199.4	15.0	1.0	0.3	154.2	5.4	14.0	36.7	0.1	109.2	0.0	0.1	0.0	0.0	0.0	83.0	0.1	0.0	0.3	5.1	0.3	6.6	1.4	1.9	0.0	0.1	0.3	2.7	0.1	160.0	0.1	0.1	0.2
SLA2	"C20orf156, FLJ21992, SLAP-2"	ENSG00000101082	"Src like adaptor 2"	Q9H6Q3	20	36612318-36646196	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.5;lymphoid tissue: 18.3"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 97.0;Macrophages: 21.8;NK-cells: 44.3;Plasma cells: 25.8;T-cells: 59.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"gdT-cell: 28.8;MAIT T-cell: 24.1;memory CD4 T-cell: 23.8;memory CD8 T-cell: 27.1;naive CD4 T-cell: 21.8;naive CD8 T-cell: 30.5;NK-cell: 39.2;plasmacytoid DC: 48.5;T-reg: 33.4"	"Group enriched"	"Detected in many"	8	"dendritic cells: 48.5;NK-cells: 39.2;T-cells: 33.4"	"Group enriched"	"Detected in some"	7	"HEL: 91.2;JURKAT: 51.8"	"Not detected"	"Not detected"							"HPA053746, HPA058217"			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		No	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA053746: AB_2682246, HPA058217: AB_2683641"	"unprognostic (4.16e-3)"	"prognostic favorable (7.36e-4)"	"unprognostic (4.52e-4)"	"unprognostic (2.30e-6)"	"unprognostic (3.37e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (6.77e-8)"	"unprognostic (8.48e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.45e-3)"	1.3	0.6	0.4	5.7	0.6	12.5	0.8	1.6	0.7	0.8	0.3	1.7	2.7	1.0	0.5	0.7	0.9	2.4	0.7	0.4	0.2	0.5	1.5	4.1	10.4	0.7	0.4	0.4	0.4	0.1	0.4	0.6	0.8	0.7	1.7	0.5	1.4	0.5	0.6	0.7	3.1	0.5	0.3	8.0	2.6	0.5	0.6	18.3	0.7	0.2	9.0	2.2	0.6	1.1	0.0	0.2	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	91.2	0.6	3.4	0.0	2.5	0.3	0.1	0.1	0.0	0.0	0.0	0.1	51.8	0.1	0.2	0.0	0.2	10.9	7.6	0.1	0.0	0.0	0.5	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	2.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.1	7.6	0.1	3.0	0.4	3.8	28.8	0.7	24.1	0.4	23.8	27.1	0.4	0.3	21.8	30.5	4.8	39.2	0.1	48.5	33.4	26.5	0.4	0.6	1.6	0.7	0.4	0.2	0.7	0.4	0.8	0.3	0.6	1.1	0.6	0.0	3.9	0.0	1.6	0.4	0.1	0.0	0.0	0.3	0.5	0.3	0.3	0.0	0.7	0.0	0.0	0.1	97.0	0.6	0.0	0.2	1.1	0.4	0.4	0.4	0.0	8.2	2.2	0.0	0.2	0.5	4.1	0.6	1.3	0.0	0.7	0.1	0.2	0.0	1.7	0.0	0.0	1.6	0.4	0.0	0.3	21.8	0.0	1.9	1.2	0.4	44.3	1.5	1.4	0.3	0.1	0.0	25.8	0.1	0.0	0.1	0.0	0.9	0.0	0.3	0.4	0.0	0.2	0.2	0.1	0.1	59.2	0.0	0.2	0.3
STAT4		ENSG00000138378	"Signal transducer and activator of transcription 4"	Q14765	2	191029576-191151596	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 23.0;testis: 29.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 139.0;Early spermatids: 275.1;Excitatory neurons: 85.9;Late spermatids: 66.0;NK-cells: 108.1;Plasma cells: 83.8;T-cells: 137.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"NK-cells: 76.6;T-cells: 121.2"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 58.8;U-266/70: 32.9;U-266/84: 12.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA001860, CAB013108"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"CAB013108: , HPA001860: AB_1080104"	"unprognostic (3.90e-5)"	"unprognostic (1.30e-1)"	"unprognostic (4.16e-2)"	"unprognostic (6.45e-4)"	"unprognostic (3.77e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.49e-3)"	"prognostic favorable (5.88e-4)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.07e-8)"	"unprognostic (2.65e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.88e-1)"	4.7	4.0	3.4	11.5	4.4	15.7	3.0	0.1	10.4	1.6	0.1	2.8	4.5	1.9	2.6	1.4	1.6	5.1	23.0	3.8	3.6	4.5	9.5	7.8	18.0	2.1	1.7	1.5	2.2	1.2	15.0	2.6	2.0	1.8	3.4	2.1	2.2	1.3	1.2	1.1	6.9	1.4	0.6	15.5	4.4	29.2	3.4	9.0	2.4	1.0	10.4	5.9	1.8	4.5	0.1	1.7	1.1	0.0	0.0	3.6	0.3	0.6	2.2	0.6	2.2	0.4	0.8	0.0	0.2	2.8	1.6	0.9	0.0	4.7	1.2	0.0	0.8	1.3	0.0	0.0	0.6	0.0	0.1	1.5	2.3	1.1	0.5	0.1	0.0	6.0	0.0	58.8	0.2	0.0	3.5	0.0	0.3	0.0	0.9	0.0	0.0	4.3	0.2	0.1	0.1	1.2	0.3	0.0	0.1	0.3	0.0	0.2	0.0	0.1	0.1	1.6	0.0	32.9	12.8	0.0	1.2	0.0	0.1	15.7	0.4	0.1	121.2	0.8	107.3	1.8	71.6	101.2	0.6	1.0	68.1	95.8	2.8	76.6	0.8	9.3	28.1	55.3	3.4	4.4	0.1	10.4	3.8	3.6	2.1	1.7	2.0	0.6	3.4	4.5	2.9	3.2	4.2	2.6	14.5	1.3	0.6	2.9	0.0	0.9	0.9	1.1	20.3	4.3	0.6	1.8	8.4	0.4	139.0	0.5	0.0	0.6	275.1	1.1	0.5	1.2	0.0	10.5	85.9	0.2	2.9	2.9	8.6	0.7	1.3	0.8	1.1	1.1	1.1	0.0	59.4	0.3	0.0	6.3	10.6	66.0	0.3	14.4	5.4	7.5	6.3	0.0	108.1	6.0	2.4	0.1	0.3	0.4	83.8	1.0	0.0	0.8	2.4	0.2	0.0	0.6	3.7	8.3	1.2	0.4	1.7	0.5	137.4	0.1	0.3	0.7
STK4	"KRS2, MST1, YSK3"	ENSG00000101109	"Serine/threonine kinase 4"	Q13043	20	44966479-45080021	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.7"	"Cell type enhanced"	"Detected in all"		"B-cells: 372.8;dendritic cells: 341.8;Langerhans cells: 606.9;monocytes: 367.5;Plasma cells: 336.2;T-cells: 414.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004038, HPA015270"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		45000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"CAB004038: AB_2144632, HPA015270: AB_1854150"	"unprognostic (2.77e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.83e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.28e-1)"	"unprognostic (5.70e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.18e-2)"	10.0	8.5	6.9	33.8	8.0	57.7	9.1	6.2	10.8	7.9	9.9	11.1	10.2	8.5	7.6	9.1	6.2	11.7	4.6	7.2	8.7	6.0	9.2	15.9	43.1	8.7	7.6	7.0	6.0	5.9	4.1	10.4	9.2	6.7	13.0	7.3	7.4	8.0	3.3	11.2	13.5	9.3	8.3	30.4	12.7	9.7	7.5	33.1	7.6	4.9	41.7	15.0	6.9	10.3	27.8	18.7	23.3	16.1	13.5	16.9	16.0	23.6	35.7	39.4	35.6	52.7	14.6	66.6	20.4	16.9	33.4	28.5	24.3	31.8	49.7	30.8	13.8	48.6	27.8	36.8	23.8	63.5	66.4	13.8	25.6	36.7	39.6	19.4	14.6	44.6	23.5	37.0	19.9	21.7	47.6	42.3	13.9	17.7	12.5	30.2	25.2	31.2	14.4	18.7	10.9	13.2	35.6	20.0	27.0	17.2	18.3	39.1	18.7	29.2	28.6	34.4	27.8	48.4	41.7	73.2	28.6	29.5	22.0	80.6	19.7	54.8	34.4	19.9	34.3	26.2	32.2	32.0	18.4	26.9	33.1	28.0	101.8	28.5	38.0	10.0	34.3	22.3	6.9	8.0	6.2	10.8	7.2	8.7	8.7	7.6	9.2	8.3	7.5	10.3	26.2	16.0	24.6	18.9	372.8	55.7	49.3	33.8	28.5	27.3	22.9	17.4	7.6	14.3	25.2	42.3	52.1	24.1	341.8	23.7	9.8	16.3	5.9	19.1	25.1	32.1	25.7	46.3	76.7	17.6	30.3	29.7	34.1	25.1	133.6	114.0	26.0	22.0	61.1	43.7	38.2	20.7	28.5	109.3	606.9	5.0	22.7	154.4	133.4	85.3	367.5	20.2	278.1	34.2	48.1	21.6	27.9	17.0	336.2	32.6	23.2	13.4	26.1	69.9	13.1	25.5	29.2	44.2	42.4	20.9	53.0	19.4	414.5	48.1	19.5	45.5
SUB1	"p14, p15, PC4"	ENSG00000113387	"SUB1 regulator of transcription"	P53999	5	32531633-32604079	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 1838.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 1427.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001311, CAB015351"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		120000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Nucleoli"		"CAB015351: AB_2197157, HPA001311: AB_1080123"	"unprognostic (5.19e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (5.25e-6)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (3.46e-3)"	"unprognostic (5.04e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.45e-1)"	142.0	98.7	88.7	130.4	100.7	251.7	122.1	72.7	152.6	109.7	69.4	110.0	88.7	85.4	83.3	108.9	66.0	74.1	113.3	104.3	98.7	129.2	135.3	91.2	159.8	80.7	87.2	68.3	62.0	107.3	88.4	103.2	94.7	73.2	107.1	83.6	76.6	65.4	105.2	69.6	83.7	79.4	86.0	144.9	97.3	71.1	92.6	204.2	69.2	108.9	137.3	124.0	73.2	85.3	199.9	161.8	315.3	295.8	187.5	329.1	197.7	340.3	245.4	300.8	275.4	236.9	307.3	101.2	231.0	236.5	307.3	132.4	266.9	278.9	402.9	420.2	244.1	337.8	365.8	450.5	264.4	594.6	441.4	233.3	235.6	321.0	228.0	166.0	228.9	378.5	399.4	1427.8	269.5	178.6	566.8	942.9	207.8	235.9	326.9	247.8	409.9	645.7	303.0	178.2	170.4	141.1	526.9	244.9	251.9	198.2	272.0	544.9	238.7	324.7	351.5	275.8	261.0	556.0	1035.0	180.5	297.7	634.9	202.4	650.7	135.8	326.2	164.7	142.3	151.4	330.4	215.9	219.8	265.1	214.8	168.2	195.2	163.7	155.2	133.4	390.1	344.6	326.1	88.7	100.7	72.7	152.6	104.3	98.7	80.7	87.2	94.7	86.0	92.6	85.3	298.9	144.2	163.4	27.1	638.2	584.9	588.7	709.9	324.4	118.1	459.2	383.9	196.7	244.5	320.1	310.8	43.8	493.0	613.5	342.1	1009.5	711.4	131.6	319.0	263.7	280.2	281.4	379.5	71.5	327.2	785.0	323.6	227.9	329.9	307.5	188.6	223.1	375.4	500.5	85.8	60.9	362.9	484.2	319.0	721.3	68.1	239.9	422.5	528.3	37.5	587.5	223.7	500.5	64.3	50.4	416.3	516.6	344.6	1838.8	536.0	342.4	921.2	291.9	79.7	203.8	224.0	468.5	447.2	439.9	411.8	565.4	836.8	575.5	357.7	394.6	645.5
SUSD3	MGC26847	ENSG00000157303	"Sushi domain containing 3"	Q96L08	9	93058688-93085133	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 57.3;testis: 77.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 32.4;Granulosa cells: 30.8;Hepatocytes: 66.6;Hofbauer cells: 49.4;Proximal tubular cells: 59.4;T-cells: 37.5;Theca cells: 34.7"	"Cancer enhanced"	"Detected in all"		"breast cancer: 50.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 150.7;Karpas-707: 32.6;MCF7: 36.8;NB-4: 78.0;RPMI-8226: 82.5;THP-1: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042310	Uncertain					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 32: Non-specific - Translation"			"HPA042310: AB_10796902"	"prognostic favorable (5.13e-4)"	"unprognostic (5.42e-2)"	"unprognostic (3.65e-1)"	"unprognostic (8.34e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.94e-2)"	"unprognostic (7.41e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.39e-3)"	"unprognostic (5.33e-2)"	6.1	1.8	4.5	17.6	3.9	41.3	15.4	4.6	4.3	16.7	4.4	3.8	4.9	19.8	10.0	4.2	35.4	4.2	1.3	4.3	5.6	21.2	27.8	4.1	57.3	6.4	5.7	40.1	1.0	1.3	5.4	2.0	6.5	2.4	2.2	6.4	11.4	3.2	1.2	3.6	18.7	6.1	6.6	36.3	4.5	77.2	5.9	31.8	4.2	0.6	30.5	4.4	6.1	8.0	7.3	0.0	0.0	0.0	0.0	0.0	0.1	0.8	1.5	0.6	0.3	3.4	1.3	150.7	0.6	0.6	0.1	0.3	2.4	0.1	0.0	13.4	0.1	20.7	0.1	2.4	9.5	0.1	4.6	9.9	0.7	0.0	0.0	0.0	0.0	0.0	6.2	32.6	0.0	36.8	0.2	78.0	1.8	1.1	4.6	6.5	0.0	82.5	0.0	0.0	0.2	0.2	0.1	1.1	0.0	1.7	19.4	34.6	0.5	0.0	0.0	0.0	0.0	6.6	3.8	9.7	0.0	0.0	0.2	0.6	16.7	79.1	24.0	15.5	27.4	88.7	124.8	43.4	41.1	70.1	214.8	87.7	5.8	11.2	3.0	3.6	182.9	68.3	4.5	3.9	4.6	4.3	4.3	5.6	6.4	5.7	6.5	6.6	5.9	8.0	2.6	0.0	6.7	0.0	32.4	0.6	0.2	0.3	0.0	0.5	24.2	11.0	0.8	17.2	0.2	0.0	4.2	1.0	2.4	0.4	9.8	0.7	3.0	0.4	2.9	3.4	0.0	2.5	0.1	0.2	2.1	9.0	1.1	0.3	3.8	30.8	1.4	66.6	49.4	0.0	0.1	0.4	8.2	10.5	9.2	11.2	5.6	29.1	1.8	17.8	8.3	1.7	2.1	0.5	0.1	0.6	0.1	5.3	17.9	1.4	0.2	59.4	0.7	9.2	0.0	0.1	1.6	3.4	3.9	0.1	0.3	1.4	37.5	34.7	0.7	0.2
SYTL3	"exophilin-6, SLP3"	ENSG00000164674	"Synaptotagmin like 3"	Q4VX76	6	158650014-158764876	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 334.2;granulocytes: 135.4;NK-cells: 132.8;Plasma cells: 135.2;T-cells: 230.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 232.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 232.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 23.9;U-138 MG: 18.9;U-2 OS: 19.1;U-266/70: 28.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030584, HPA030585, HPA030586"	Approved		Approved	"Nucleoli fibrillar center,Vesicles"		NA	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli fibrillar center, Vesicles"		"HPA030584: AB_10600196, HPA030585: AB_10601239, HPA030586: AB_10601226"	"unprognostic (3.56e-3)"	"prognostic favorable (8.84e-5)"	"unprognostic (6.37e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.45e-3)"	"unprognostic (9.33e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.83e-1)"	5.5	1.8	1.5	7.5	1.7	13.9	4.3	2.2	1.6	6.0	23.9	4.2	3.8	3.5	6.4	4.0	14.4	4.8	7.1	2.3	2.7	5.3	2.5	16.8	8.4	3.8	2.9	2.8	1.5	1.8	2.1	1.6	3.4	5.4	2.4	0.4	15.3	5.8	14.9	3.3	9.9	2.8	2.9	19.8	7.1	3.8	2.9	17.4	25.2	8.2	6.0	5.0	3.6	4.6	7.1	1.0	0.1	0.5	0.9	0.9	0.4	3.1	2.0	0.8	2.1	0.6	5.8	0.1	0.5	5.3	2.6	0.8	0.1	0.9	2.9	15.1	0.4	5.8	0.2	0.0	1.7	1.7	23.9	3.1	2.1	6.1	1.0	2.6	1.4	1.1	0.3	5.6	6.8	0.3	0.1	2.0	0.1	1.3	1.0	0.0	5.6	0.7	2.8	0.4	15.6	1.2	1.0	9.7	0.8	0.3	2.0	0.3	8.8	18.9	19.1	0.5	0.6	28.5	7.1	0.6	12.0	8.3	0.6	232.0	16.0	0.8	37.3	3.3	22.0	1.0	14.7	25.3	4.6	0.3	15.7	19.3	35.5	43.1	1.4	1.3	16.4	18.9	1.5	1.7	2.2	1.6	2.3	2.7	3.8	2.9	3.4	2.9	2.9	4.6	2.8	16.0	13.1	2.3	23.5	4.6	2.9	4.4	1.8	0.2	4.4	3.7	4.1	1.5	15.9	14.7	2.1	1.3	334.2	1.0	5.9	0.8	10.8	51.0	3.0	4.2	0.0	4.4	3.4	0.6	0.5	4.8	17.3	37.4	135.4	0.4	3.9	1.9	4.2	0.0	4.8	1.8	4.1	11.5	20.3	18.1	0.0	26.6	10.6	28.1	17.6	0.1	132.8	2.0	2.5	0.6	0.1	0.7	135.2	1.8	2.0	1.9	51.5	0.5	0.0	2.3	2.4	2.1	8.4	2.6	4.4	1.9	230.2	0.9	1.3	3.1
TATDN2	KIAA0218	ENSG00000157014	"TatD DNase domain containing 2"	Q93075	3	10248023-10281218	"Predicted intracellular proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA036822	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"		"HPA036822: AB_10671972"	"unprognostic (4.51e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.75e-1)"	"unprognostic (4.23e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.57e-3)"	"unprognostic (8.43e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.63e-1)"	"prognostic favorable (4.66e-4)"	"unprognostic (3.25e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.48e-2)"	15.5	15.8	19.8	14.8	20.9	34.4	15.4	18.0	21.4	19.9	17.0	15.5	12.7	17.4	15.5	19.9	15.6	10.3	16.2	20.8	17.3	17.8	14.0	17.3	21.6	17.6	17.2	24.7	19.9	17.9	17.8	9.8	17.3	20.9	14.7	9.0	17.7	12.3	15.0	20.7	18.8	13.5	17.4	23.9	16.7	8.6	19.5	32.5	20.8	10.9	22.1	16.6	18.4	18.3	19.4	32.1	16.9	14.3	21.2	22.9	73.3	23.2	22.5	28.8	18.8	23.6	17.0	45.6	17.0	32.1	30.7	14.3	29.1	20.9	22.5	29.5	36.5	24.3	30.8	24.9	13.7	34.6	24.8	17.6	22.9	40.2	13.6	18.8	23.6	28.3	27.9	40.7	26.4	37.2	45.4	29.6	23.9	25.2	31.9	24.8	18.0	26.5	18.2	26.8	18.7	22.6	19.4	21.8	10.9	15.6	22.2	32.4	18.8	33.1	21.6	28.1	41.6	25.5	43.6	80.6	30.0	35.6	23.1	1.3	0.6	0.5	1.6	1.0	1.6	0.8	1.4	1.3	0.5	1.4	1.4	2.1	0.5	0.9	0.5	1.3	1.7	0.9	19.8	20.9	18.0	21.4	20.8	17.3	17.6	17.2	17.3	17.4	19.5	18.3	6.3	6.4	11.0	4.9	8.2	12.6	4.6	4.8	9.1	4.4	9.4	6.3	6.9	7.2	4.3	11.0	6.2	3.8	9.3	12.7	1.9	5.1	2.0	4.1	7.0	7.9	16.8	6.1	8.8	9.2	4.0	6.8	5.1	5.9	5.1	9.1	7.9	10.2	10.3	5.0	5.9	8.7	2.0	15.6	21.0	1.8	7.2	9.1	14.2	6.5	9.0	5.2	18.6	4.5	5.0	8.6	3.1	7.5	8.8	9.3	8.0	5.4	2.4	2.8	6.6	5.8	4.7	2.1	5.6	6.4	12.4	2.5	10.7	8.7	10.8	7.1
TCF3	"bHLHb21, E2A, E47, ITF1, MGC129647, MGC129648, p75, VDIR"	ENSG00000071564	"Transcription factor 3"	P15923	19	1609290-1652615	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 467.3;U-698: 597.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018351, HPA049808, HPA062476"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"CAB018351: AB_675504, HPA049808: AB_2680892, HPA062476: AB_2684775"	"unprognostic (8.82e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.91e-2)"	"unprognostic (8.25e-3)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (2.07e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.29e-3)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (4.87e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.07e-1)"	"unprognostic (8.05e-2)"	23.8	17.9	20.7	49.2	20.0	72.8	26.1	18.1	22.7	33.4	21.9	32.3	35.5	29.6	16.2	28.2	25.5	19.8	22.8	19.1	17.8	27.2	18.9	25.9	86.6	22.0	19.3	35.1	28.4	10.2	26.2	17.9	20.4	27.3	18.7	11.0	26.4	12.0	19.5	32.9	48.0	14.4	18.3	62.5	27.3	74.8	20.3	68.4	31.6	12.5	61.0	27.4	27.4	21.8	83.6	48.6	146.4	139.8	18.6	49.6	50.4	51.9	48.0	67.8	60.6	89.8	68.7	421.7	53.5	50.1	12.7	98.4	87.9	69.2	42.8	253.7	52.4	43.2	71.2	115.2	44.8	105.7	56.8	34.0	75.1	52.4	39.2	64.0	82.5	176.1	163.8	146.6	46.0	158.2	301.1	107.8	187.1	65.1	49.2	467.3	61.7	104.3	46.5	78.5	119.3	175.7	50.1	55.9	70.8	53.0	63.8	191.7	103.2	87.1	90.5	116.0	94.1	353.5	173.5	597.2	63.1	140.3	80.1	3.3	1.2	1.0	3.6	1.5	3.6	10.0	2.1	3.1	2.8	10.6	2.8	4.3	0.4	2.8	3.2	12.9	2.2	1.7	20.7	20.0	18.1	22.7	19.1	17.8	22.0	19.3	20.4	18.3	20.3	21.8	17.3	6.4	9.1	14.7	33.9	13.9	5.3	10.0	4.6	12.3	16.6	16.1	10.7	4.3	10.8	1.8	27.1	4.3	26.5	14.7	1.9	11.4	8.6	9.9	20.4	13.5	16.2	32.2	3.9	6.9	8.9	12.3	14.8	16.6	7.0	27.8	9.7	4.8	7.7	5.0	5.6	16.5	16.2	8.9	12.3	5.2	13.7	9.4	10.6	6.5	8.1	9.2	10.3	3.0	7.3	17.6	13.3	10.1	31.1	13.0	16.4	6.3	2.9	13.8	19.7	8.2	16.9	5.5	46.2	9.0	13.2	2.9	12.5	10.4	20.1	8.5
TMEM131L	"DKFZp586H1322, KIAA0922"	ENSG00000121210	"Transmembrane 131 like"	A2VDJ0	4	153466346-153636711	"Predicted membrane proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 49.4;lymphoid tissue: 48.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 13.6;Alveolar cells type 2: 9.6;B-cells: 9.9;dendritic cells: 13.2;Exocrine glandular cells: 9.3;monocytes: 16.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 105.2;MOLT-4: 99.9;U-698: 122.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043472, HPA048443"	Uncertain		Approved	"Nucleoli fibrillar center,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	"Nucleoli fibrillar center"	"HPA043472: AB_2678496, HPA048443: AB_2680395"	"unprognostic (1.12e-1)"	"prognostic favorable (6.69e-6)"	"unprognostic (1.71e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.23e-2)"	"unprognostic (4.11e-2)"	"unprognostic (4.37e-2)"	"unprognostic (7.29e-2)"	"unprognostic (4.35e-3)"	"unprognostic (2.92e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.51e-2)"	9.8	1.7	1.6	20.9	4.0	49.4	7.2	1.0	2.7	5.6	1.0	6.4	2.3	6.3	9.4	6.7	5.0	4.9	8.7	1.5	1.6	3.5	20.7	6.6	47.8	1.9	1.4	4.6	31.2	1.1	3.9	3.9	1.9	5.9	4.6	0.4	8.1	4.8	24.5	6.9	10.9	6.9	1.0	24.6	6.1	4.4	2.0	48.3	4.1	6.2	45.4	6.1	6.0	2.8	5.8	3.7	15.7	16.5	9.1	7.9	0.3	8.3	4.0	5.6	7.1	25.8	3.7	105.2	2.0	11.1	6.2	5.7	12.1	14.3	8.5	9.7	8.7	20.6	7.0	6.7	5.9	22.9	1.2	7.3	8.7	7.4	6.9	6.3	14.4	19.1	19.7	0.4	5.7	10.7	99.9	16.6	14.0	0.2	5.4	34.3	15.2	6.8	3.8	2.4	11.7	9.1	6.5	14.2	8.6	8.0	5.5	16.6	11.6	7.5	13.2	9.1	6.9	11.2	12.1	122.4	2.2	13.5	6.2	11.8	19.4	21.1	12.3	36.8	16.7	28.2	15.5	11.7	20.9	27.3	25.8	17.5	21.0	24.3	31.6	2.1	20.9	17.6	1.6	4.0	1.0	2.7	1.5	1.6	1.9	1.4	1.9	1.0	2.0	2.8	13.6	6.4	9.6	0.0	9.9	0.0	0.0	0.0	0.0	0.0	5.5	4.3	0.0	0.0	1.8	0.0	0.0	0.5	13.2	0.0	1.9	2.0	0.0	1.3	8.2	3.2	0.0	0.0	0.0	9.3	0.2	3.7	0.0	1.1	5.1	5.8	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	16.1	0.0	0.0	0.0	0.0	3.6	0.0	0.0	4.8	0.0	0.0	1.5	5.8	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	7.2	5.1	0.0	0.0
TRA2B	"Htra2-beta, PPP1R156, SFRS10"	ENSG00000136527	"Transformer 2 beta homolog"	P62995	3	185914558-185938103	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 444.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011692, HPA063597, HPA064972"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		62000	"Cluster 6: Non-specific - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"CAB011692: AB_778565, HPA063597: AB_2685054, HPA064972: AB_2685396"	"unprognostic (9.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.22e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-3)"	"prognostic favorable (2.15e-4)"	"unprognostic (1.07e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.71e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.38e-1)"	"unprognostic (4.36e-2)"	38.2	41.3	18.1	35.2	19.1	46.3	30.2	23.0	31.1	25.2	25.7	41.7	21.5	31.3	26.3	38.7	27.1	16.0	31.7	19.6	22.3	41.6	37.5	21.5	38.7	19.8	17.2	25.5	28.3	28.9	20.3	26.3	20.4	25.8	24.9	18.5	27.0	18.4	34.1	25.5	27.0	25.2	17.4	36.2	31.1	22.4	19.5	47.6	23.2	23.2	43.9	28.7	26.8	26.3	145.0	44.2	135.0	67.8	30.3	27.3	78.2	101.5	71.1	117.5	90.2	75.3	67.6	124.5	134.4	53.2	79.5	94.1	140.9	104.5	120.9	117.5	89.6	122.0	40.1	92.7	42.4	133.3	101.1	26.5	44.3	75.1	51.0	36.5	90.4	63.5	120.4	81.6	79.6	66.4	344.9	164.1	191.3	113.0	85.5	201.1	109.4	147.5	94.3	58.9	98.0	104.0	73.3	90.1	117.8	66.5	101.1	138.0	52.7	81.3	110.8	68.2	170.1	159.6	444.0	272.0	78.0	151.0	130.6	84.1	39.2	33.0	36.3	33.1	32.8	71.2	36.1	34.0	35.3	64.0	45.0	40.9	44.0	41.3	39.6	73.2	36.4	21.5	18.1	19.1	23.0	31.1	19.6	22.3	19.8	17.2	20.4	17.4	19.5	26.3	236.3	64.1	122.0	46.4	201.7	258.4	196.9	136.6	157.1	107.8	206.0	148.2	67.2	140.2	104.0	69.9	196.0	188.9	196.6	156.2	72.4	126.8	156.9	152.7	284.5	181.6	227.6	233.4	49.7	109.5	230.7	147.2	92.2	274.6	197.6	155.9	189.9	93.0	174.6	72.3	53.7	259.8	85.5	280.7	283.1	46.6	127.7	228.1	135.2	74.0	196.9	115.5	167.9	78.4	67.0	97.5	129.1	117.4	152.1	218.3	121.2	59.1	66.7	219.5	105.2	177.0	214.7	168.2	151.5	141.3	260.7	214.9	212.6	89.4	232.4	163.7
TRDJ1		ENSG00000211825	"T cell receptor delta joining 1"	A0A075B706	14	22450089-22450139	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 54.0;lymphoid tissue: 78.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	77	"gdT-cell: 13481.1;NK-cell: 5148.7"	"Group enriched"	"Detected in all"	101	"NK-cells: 5148.7;T-cells: 13481.1"	"Cell line enriched"	"Detected in some"	15	"NB-4: 522.3"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 24: NB-4 - Immune response"																						21.1	0.0	2.0	10.6	1.5	54.0	3.7	0.6	2.5	3.7	0.5	6.3	9.9	22.4	0.0	2.3	4.6	4.5	4.6	3.5	1.1	1.0	15.8	24.9	18.8	1.5	0.7	2.2	0.0	2.4	0.0	3.2	0.9	2.4	13.2	0.0	2.8	0.0	0.0	0.0	5.8	1.3	0.4	56.1	2.0	3.4	1.0	78.4	2.0	7.6	21.2	3.1	0.0	2.0	0.0	0.0	34.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	522.3	3.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	2.6	13.6	6.1	13481.1	20.3	9.7	15.9	27.1	86.2	20.6	4.7	30.5	120.9	92.1	5148.7	11.2	16.9	62.4	2899.6	2.0	1.5	0.6	2.5	3.5	1.1	1.5	0.7	0.9	0.4	1.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TREML2	"C6orf76, dJ238O23.1, FLJ13693, TLT2"	ENSG00000112195	"Triggering receptor expressed on myeloid cells like 2"	Q5T2D2	6	41189749-41201149	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 14.4;lymphoid tissue: 9.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 5.3;Early spermatids: 19.1;Late spermatids: 37.3;Syncytiotrophoblasts: 8.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 23.3;neutrophil: 33.3"	"Group enriched"	"Detected in many"	15	"B-cells: 23.3;dendritic cells: 9.3;granulocytes: 33.3"	"Cell line enhanced"	"Detected in some"		"HEL: 27.9;HL-60: 6.9;JURKAT: 7.9;SuSa: 4.5;U-698: 8.0;U-937: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA		3400000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 31: Spermatids - Spermatogenesis"				"unprognostic (3.76e-3)"	"unprognostic (2.39e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.22e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.40e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.54e-2)"	"unprognostic (6.23e-2)"	"unprognostic (6.71e-2)"	1.7	0.0	0.1	6.4	0.1	14.4	0.1	0.2	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.3	0.5	0.1	0.1	0.5	0.0	0.1	0.7	9.5	0.1	0.1	0.0	0.2	0.4	0.0	3.0	0.2	0.0	0.3	0.1	0.3	0.0	0.8	0.1	1.1	0.3	0.0	6.6	0.3	3.7	0.1	6.9	0.1	0.8	7.5	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.1	0.4	0.0	0.0	1.5	2.2	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	5.2	0.0	2.6	0.6	13.4	0.4	1.2	0.5	6.0	1.0	0.2	2.2	23.3	1.3	0.4	33.3	0.7	1.4	9.3	0.7	2.0	0.1	0.1	0.2	0.3	0.1	0.5	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	1.1	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.4	37.3	0.0	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	8.8	0.2	0.0	0.0	0.0
TUBB	"M40, MGC16435, OK/SW-cl.56, Tubb5"	ENSG00000196230	"Tubulin beta class I"	P07437	6	30717435-30725538	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 2296.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005417, CAB012406, HPA043640, HPA046280"	Enhanced		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	Yes		170000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB005417: AB_2241191, CAB012406: AB_2210370, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (1.01e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (2.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (2.62e-8)"	"unprognostic (8.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.50e-1)"	229.5	164.8	74.6	243.5	81.8	541.0	186.9	46.2	367.7	228.7	87.0	250.3	87.6	333.0	174.5	246.3	227.0	158.5	245.3	73.5	119.7	137.8	236.6	205.3	369.2	80.5	74.8	467.5	138.1	74.4	97.0	194.4	99.2	145.2	194.4	82.4	160.2	194.6	185.7	211.9	159.4	371.0	57.5	195.0	172.8	77.8	94.0	620.4	142.4	98.6	487.6	222.3	213.8	63.5	2281.7	1027.3	2650.0	1458.4	733.2	1265.2	568.2	396.9	469.5	943.3	863.5	1329.2	703.9	1494.1	1105.1	1408.1	1877.8	805.3	2160.6	1968.0	160.3	892.5	1321.1	461.4	207.3	1306.7	345.8	2550.0	1223.9	943.6	455.9	416.0	443.6	967.1	1493.3	2058.1	1270.4	294.1	1844.8	1398.2	2719.0	249.3	377.3	604.1	948.6	102.6	708.5	911.6	1564.5	1071.4	940.8	1516.7	969.0	911.2	354.7	1625.5	1148.3	422.4	880.6	2712.0	1526.0	614.5	917.7	835.3	1735.4	2101.3	538.8	2494.6	3548.7	119.8	115.6	122.8	187.3	182.5	218.8	166.1	152.3	188.8	111.7	113.0	143.2	163.3	46.8	165.1	222.4	227.7	180.8	342.5	74.6	81.8	46.2	367.7	73.5	119.7	80.5	74.8	99.2	57.5	94.0	63.5	215.8	131.4	47.3	21.5	214.9	576.2	358.4	698.6	434.2	72.7	234.2	312.8	114.9	244.5	238.7	171.0	39.6	811.9	198.7	133.4	311.0	1091.0	9.1	69.1	261.6	370.8	163.6	1322.1	28.2	1061.1	2296.1	471.5	95.3	140.2	207.3	643.6	298.4	267.8	955.2	109.4	25.0	185.3	376.4	454.5	689.6	24.4	402.6	295.8	321.9	30.9	774.0	192.6	246.1	20.1	23.0	1087.0	90.7	237.3	304.6	199.5	117.9	245.9	66.6	65.4	118.3	124.0	838.6	58.0	126.5	447.0	430.6	220.4	244.0	224.9	253.2	229.0
U2AF2	U2AF65	ENSG00000063244	"U2 small nuclear RNA auxiliary factor 2"	P26368	19	55654146-55674716	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010910, HPA041943, HPA043562"	Supported	Supported	Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA		73000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"	Nucleoplasm	"CAB010910: AB_262122, HPA041943: AB_2677760, HPA043562: AB_2678555"	"unprognostic (2.37e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.12e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.94e-2)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (9.46e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.00e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.19e-2)"	"unprognostic (4.80e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.08e-2)"	74.2	80.9	70.3	101.9	73.0	147.7	70.2	74.6	82.4	92.1	75.4	83.7	85.1	87.4	56.7	98.2	82.8	54.0	69.3	70.3	70.8	79.4	80.2	74.2	119.3	76.2	71.5	98.3	75.0	70.1	93.7	63.6	73.0	74.9	54.0	46.0	72.0	65.9	67.3	80.0	92.3	62.1	72.0	115.7	75.4	81.8	72.1	132.5	78.9	45.9	93.7	78.2	80.7	82.4	244.5	394.0	235.9	191.1	108.3	109.8	249.3	191.9	174.1	314.2	305.3	231.3	222.3	284.5	149.5	164.9	160.5	193.0	299.3	268.3	149.1	218.0	501.9	245.2	176.1	221.5	176.7	287.4	263.5	148.8	161.0	239.5	166.8	120.0	190.8	195.9	293.1	181.3	169.9	239.2	388.0	261.1	260.4	217.1	307.2	414.5	149.7	233.0	189.7	290.0	270.6	211.0	208.6	197.1	125.7	134.6	190.5	296.9	161.5	279.7	203.7	130.0	415.9	165.0	239.3	344.5	124.3	279.5	245.2	0.1	1.1	0.8	1.3	1.5	1.0	0.8	1.1	0.9	1.0	1.1	0.8	0.8	2.1	0.6	1.2	1.8	1.1	0.9	70.3	73.0	74.6	82.4	70.3	70.8	76.2	71.5	73.0	72.0	72.1	82.4	31.0	3.2	9.1	10.4	46.0	45.4	41.4	34.8	57.5	41.8	29.7	21.3	2.7	24.3	20.6	27.6	31.3	58.5	34.1	44.0	19.6	33.0	6.4	33.8	36.0	31.4	45.5	32.6	6.8	23.8	63.0	29.4	51.0	40.9	34.3	30.4	27.5	26.8	37.6	35.3	7.6	42.4	30.5	22.0	32.3	8.4	44.4	31.6	19.6	11.2	37.4	25.3	30.9	4.0	12.0	31.8	29.3	34.3	62.4	41.9	31.9	21.3	15.3	52.0	0.0	26.1	46.6	22.5	32.0	53.5	39.2	71.8	42.7	30.8	43.6	44.9
UPF2	"DKFZP434D222, KIAA1408, RENT2, smg-3"	ENSG00000151461	"UPF2 regulator of nonsense mediated mRNA decay"	Q9HAU5	10	11920022-12043170	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067008			Supported	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"	Cytosol	"Cytoplasmic bodies"	"HPA067008: AB_2685762"	"unprognostic (1.99e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (5.48e-2)"	"unprognostic (5.68e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.01e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.48e-2)"	12.8	8.1	12.4	14.1	13.7	21.0	12.7	15.8	15.1	12.0	12.5	16.2	10.0	14.9	10.7	10.9	11.0	8.9	10.6	12.5	13.6	10.9	16.7	10.4	18.9	11.8	12.2	16.2	13.7	14.8	7.9	14.1	11.6	13.5	12.9	14.8	11.1	12.2	22.0	12.9	11.4	12.1	11.9	14.8	11.3	19.5	12.7	21.5	12.8	21.4	17.7	13.4	11.8	13.2	35.9	22.3	18.8	23.5	14.0	17.9	21.2	27.5	12.7	19.2	23.0	21.2	28.6	51.4	9.1	23.0	15.8	29.4	27.2	24.9	27.4	32.5	15.7	61.6	18.2	19.4	15.8	28.1	39.8	13.5	19.0	24.3	16.4	18.2	23.8	27.1	37.1	25.7	22.2	17.7	34.8	16.4	18.0	27.1	11.8	30.4	22.5	25.3	18.2	14.2	12.1	13.0	21.6	23.1	23.8	18.7	27.9	37.1	25.5	15.0	31.4	31.1	21.1	23.4	19.8	41.4	24.0	26.9	12.1	13.7	4.2	10.2	4.3	4.2	4.2	10.7	4.9	4.5	3.0	10.6	5.4	4.5	29.5	5.4	2.9	11.5	3.8	1.8	12.4	13.7	15.8	15.1	12.5	13.6	11.8	12.2	11.6	11.9	12.7	13.2	74.8	25.6	34.6	32.0	133.3	71.9	35.0	46.9	64.3	66.3	53.8	38.6	69.6	52.9	39.4	49.7	102.2	47.0	79.6	97.7	39.2	47.7	70.1	99.3	86.2	62.6	66.3	108.4	36.1	44.8	51.7	48.2	58.1	88.7	58.9	71.8	64.2	89.5	41.1	52.2	31.6	90.2	48.8	71.4	125.3	116.9	86.3	56.0	53.4	31.9	89.0	45.5	98.9	37.2	45.4	53.7	78.9	59.0	121.2	38.7	70.6	34.1	41.5	97.2	98.6	54.3	60.1	182.9	149.8	47.3	81.8	56.5	73.6	35.9	65.5	36.3
USP20	KIAA1003	ENSG00000136878	"Ubiquitin specific peptidase 20"	Q9Y2K6	9	129834698-129881828	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Endocytosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 95.9;K-562: 60.2;MOLT-4: 56.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006287, HPA007008"	Uncertain	Supported	Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA006287: AB_1080510, HPA007008: "	"unprognostic (2.64e-2)"	"prognostic favorable (8.01e-4)"	"prognostic unfavorable (2.48e-4)"	"prognostic favorable (4.01e-4)"	"unprognostic (4.69e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.89e-2)"	"prognostic favorable (1.54e-7)"	"unprognostic (2.09e-1)"	"prognostic favorable (5.65e-5)"	"unprognostic (1.76e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.24e-2)"	8.1	12.0	8.7	13.5	8.0	22.6	8.3	4.8	8.7	12.5	2.5	13.6	8.2	12.5	4.2	7.9	12.1	7.7	7.5	7.8	10.6	7.6	7.4	8.4	18.3	10.2	9.1	13.5	10.9	8.4	18.4	6.7	10.0	14.8	4.9	6.7	11.4	13.2	10.9	12.1	12.5	8.2	5.4	13.9	9.9	10.0	8.9	32.3	18.7	7.5	11.8	14.9	10.1	6.5	6.0	5.8	10.0	13.4	12.8	10.8	14.1	9.5	7.9	7.1	4.9	4.7	6.5	8.1	8.0	9.3	8.0	14.7	6.0	6.7	2.9	43.4	7.9	14.9	17.0	3.3	8.8	14.2	10.6	9.6	9.8	9.3	7.0	12.4	7.7	95.9	60.2	9.9	4.4	15.9	56.4	33.6	7.9	12.7	13.6	9.4	11.2	14.0	5.5	6.5	2.2	11.0	11.0	13.9	9.1	5.9	14.4	19.9	11.5	7.8	3.5	10.5	6.3	9.7	15.3	5.7	15.5	18.6	7.4	1.0	1.9	5.4	8.6	1.5	9.1	3.7	8.7	8.3	2.6	3.4	9.8	8.9	2.8	10.0	1.5	2.1	11.5	6.3	8.7	8.0	4.8	8.7	7.8	10.6	10.2	9.1	10.0	5.4	8.9	6.5	3.0	9.6	6.9	16.3	9.2	2.8	2.2	2.5	4.0	7.8	6.4	8.0	7.7	4.3	3.0	1.8	4.2	5.9	9.4	6.2	3.9	2.4	2.1	4.1	6.3	4.3	8.4	12.8	17.0	4.0	2.5	4.6	8.2	5.7	1.3	6.8	6.4	6.1	3.3	10.1	21.1	4.6	4.1	1.6	3.8	3.3	6.2	6.0	3.6	11.2	3.1	5.3	11.3	9.5	14.3	2.7	5.0	4.9	6.7	3.0	4.1	2.9	5.0	6.3	0.0	4.3	5.7	12.1	6.0	4.8	2.0	6.2	19.3	2.9	5.2	1.6
VCPKMT	"C14orf138, METTL21D, VCP-KMT"	ENSG00000100483	"Valosin containing protein lysine methyltransferase"	Q9H867	14	50108632-50116600	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001146, HPA076561"	Uncertain		Supported	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA001146: AB_1845558, HPA076561: AB_2732312"	"unprognostic (1.58e-1)"	"unprognostic (2.87e-2)"	"unprognostic (5.05e-2)"	"unprognostic (3.86e-1)"	"unprognostic (3.54e-1)"	"unprognostic (4.74e-2)"	"unprognostic (9.97e-2)"	"prognostic favorable (2.40e-4)"	"unprognostic (8.20e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.90e-2)"	"prognostic unfavorable (4.75e-4)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.27e-2)"	2.9	4.1	1.7	3.4	2.1	5.1	2.3	2.4	5.3	3.7	3.0	3.3	1.7	3.0	2.6	4.9	2.9	2.3	2.7	2.5	2.0	2.7	3.9	3.1	4.3	2.0	1.9	2.6	2.9	1.9	3.3	1.6	2.0	2.7	1.6	1.5	2.2	1.6	2.3	3.9	3.2	1.5	1.5	4.8	3.6	2.1	2.2	4.7	2.6	1.8	4.4	3.0	3.2	2.5	4.2	4.4	4.0	4.9	2.6	3.1	4.4	4.0	4.4	4.4	3.3	2.8	4.8	12.8	2.7	2.8	1.1	7.9	4.9	7.0	4.4	6.4	3.2	2.5	1.7	2.8	3.6	6.4	3.3	2.0	3.9	4.8	4.9	3.0	5.5	4.6	3.0	5.3	3.3	5.5	13.4	6.7	3.9	6.1	7.2	9.0	7.4	3.4	5.6	6.3	6.7	7.9	5.9	1.6	7.1	3.6	4.0	5.7	1.4	7.2	5.6	2.6	4.5	5.1	11.4	5.0	2.5	5.2	3.5	12.1	2.8	0.0	9.3	4.7	10.9	27.1	9.1	11.5	3.8	21.4	11.2	12.4	0.8	11.8	2.2	5.4	7.8	4.8	1.7	2.1	2.4	5.3	2.5	2.0	2.0	1.9	2.0	1.5	2.2	2.5	11.5	12.8	9.8	7.8	38.0	30.3	17.3	7.7	30.1	6.5	12.8	10.8	3.6	8.6	9.7	7.3	10.4	10.2	25.7	5.6	9.8	5.8	39.4	14.1	9.8	8.3	5.4	9.5	12.6	5.7	8.4	9.3	7.7	17.1	17.7	7.2	6.8	7.7	5.1	1.7	11.0	8.5	12.2	7.5	16.4	10.2	7.5	8.7	10.6	3.7	9.5	3.5	15.5	10.6	17.5	5.3	8.0	4.9	48.2	15.5	7.8	6.7	8.6	8.1	0.0	9.1	9.1	14.4	16.6	24.9	37.4	11.5	22.4	10.2	7.1	17.1
VHL	VHL1	ENSG00000134086	"Von Hippel-Lindau tumor suppressor"	P40337	3	10141778-10153667	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Congenital erythrocytosis, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 146.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031631, HPA031632, HPA068954"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA031631: AB_2673968, HPA031632: AB_2673969, HPA068954: "	"prognostic unfavorable (9.02e-5)"	"unprognostic (1.10e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (3.55e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (7.84e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.28e-3)"	14.0	13.7	11.5	21.1	11.0	27.9	14.7	13.6	12.1	11.8	6.7	14.8	15.7	14.1	9.8	12.3	13.4	11.5	7.9	11.8	14.9	12.6	14.1	11.8	29.6	9.4	9.4	12.6	12.7	11.7	9.0	14.1	9.3	14.0	15.7	8.9	14.5	10.2	11.4	14.2	17.2	12.8	9.6	22.5	16.0	13.4	16.6	23.4	15.8	7.7	29.7	12.5	10.9	12.5	19.5	18.2	39.9	24.6	36.0	27.7	146.5	16.8	24.0	21.1	24.5	21.5	23.7	67.9	22.2	23.0	29.9	16.4	37.2	23.6	25.7	33.0	33.7	52.7	30.5	30.6	34.3	47.3	41.3	28.1	26.3	28.0	35.1	28.4	24.6	42.5	48.3	50.3	21.1	35.0	45.5	40.9	26.7	21.1	23.4	57.3	34.6	34.6	25.5	48.7	15.0	49.4	35.0	18.7	21.0	23.9	37.0	59.1	21.3	20.8	27.7	19.6	26.8	35.7	78.1	105.6	23.2	55.3	19.4	4.6	3.2	2.3	2.6	2.2	1.9	2.5	1.8	2.2	2.0	3.3	1.7	1.8	5.6	3.0	2.0	2.3	1.7	1.2	11.5	11.0	13.6	12.1	11.8	14.9	9.4	9.4	9.3	9.6	16.6	12.5	12.4	12.8	12.5	9.1	38.7	14.7	17.8	14.3	24.5	14.7	10.7	6.1	6.1	20.0	9.6	16.5	18.8	16.8	21.9	10.7	7.9	11.8	9.6	13.1	26.1	14.8	14.4	30.5	15.9	5.1	18.7	12.8	20.9	19.9	5.1	18.4	18.9	14.3	14.9	18.5	14.2	11.3	16.2	27.1	45.8	7.3	14.0	32.3	12.4	7.5	31.9	9.1	28.8	12.1	14.9	10.7	11.7	11.3	33.3	23.8	12.3	9.5	9.7	15.3	6.6	17.4	11.9	15.4	24.0	26.7	20.5	17.2	23.5	21.4	10.2	25.9
WRAP53	"FLJ10385, TCAB1, WDR79"	ENSG00000141499	"WD repeat containing antisense to TP53"	Q9BUR4	17	7686071-7703502	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	"Chaperone, RNA-binding"	"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 29.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023026, HPA028130, HPA029928"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA023026: AB_10963931, HPA028130: AB_10961728, HPA029928: AB_2673257"	"unprognostic (1.45e-1)"	"unprognostic (3.50e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.86e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (4.70e-4)"	"unprognostic (8.69e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (8.26e-4)"	"unprognostic (2.68e-2)"	"unprognostic (5.67e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.93e-2)"	"unprognostic (4.04e-1)"	4.1	3.7	3.4	4.5	3.5	7.6	4.0	3.4	3.5	4.3	5.0	4.2	2.7	4.5	2.3	4.5	14.5	3.0	4.2	3.4	3.5	4.0	3.6	4.1	6.9	3.9	5.0	3.3	4.5	3.1	4.1	3.4	3.8	3.0	3.5	3.4	3.6	3.0	6.2	4.4	4.7	3.9	4.0	6.9	4.3	5.2	3.5	8.0	3.5	4.5	6.5	3.8	3.6	4.0	22.7	40.6	28.9	29.5	9.2	8.0	16.5	14.3	14.9	45.6	42.1	24.2	13.2	23.3	15.0	13.1	18.7	24.0	33.8	24.5	35.2	14.4	41.4	12.0	22.6	20.5	7.9	8.1	14.7	6.8	9.3	39.9	8.9	6.8	28.8	27.4	12.0	7.7	18.7	21.1	27.0	22.2	15.4	16.7	20.5	35.0	19.3	14.0	17.2	7.7	13.3	19.4	23.1	11.9	12.1	14.0	16.7	10.3	10.1	17.4	19.0	0.1	36.6	5.3	15.9	13.1	16.8	15.2	21.4	29.4	5.8	5.0	5.3	6.3	6.1	3.0	4.2	6.2	5.3	4.2	3.8	4.2	2.5	5.0	2.8	7.4	8.9	3.8	3.4	3.5	3.4	3.5	3.4	3.5	3.9	5.0	3.8	4.0	3.5	4.0	4.6	3.2	3.4	2.3	7.0	3.8	5.2	12.9	2.8	5.6	4.1	4.6	3.6	2.8	7.0	11.0	6.2	12.3	9.2	4.5	3.9	10.1	3.9	22.4	3.4	5.8	3.0	10.8	2.0	10.4	17.0	4.4	4.1	4.1	1.3	7.3	5.3	4.6	7.7	1.7	2.1	5.6	18.3	7.2	3.1	1.9	2.5	5.4	3.6	1.0	8.7	7.2	12.3	5.0	2.8	6.9	3.7	2.2	8.8	2.2	5.2	6.5	51.0	6.3	0.0	6.4	6.3	13.3	6.7	3.5	4.5	4.1	5.7	5.8	7.2	2.9
WRAP73	WDR8	ENSG00000116213	"WD repeat containing, antisense to TP73"	Q9P2S5	1	3630767-3652761	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026893	Uncertain					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA026893: AB_10603459"	"unprognostic (3.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.12e-1)"	"unprognostic (9.44e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.40e-3)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.19e-2)"	"prognostic favorable (3.49e-4)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.00e-3)"	13.8	14.3	12.0	10.7	12.9	23.8	13.4	13.3	16.1	14.2	12.5	14.7	13.9	14.2	7.9	15.7	13.4	9.0	14.2	11.7	11.5	13.6	13.5	13.3	17.6	12.1	12.4	14.0	18.1	10.1	17.5	9.6	12.4	13.6	9.0	8.4	13.5	7.8	16.3	12.9	18.1	8.8	11.9	21.5	16.7	15.9	12.8	14.3	14.6	9.6	14.1	13.9	13.5	14.0	30.5	17.4	17.0	33.1	22.4	14.3	16.8	14.9	14.6	24.8	21.5	27.5	39.4	33.5	27.5	19.0	20.2	22.6	50.0	29.8	12.8	59.3	75.8	19.1	23.7	31.3	24.0	22.5	29.2	13.2	20.7	20.1	25.6	13.8	22.2	39.7	31.8	19.9	18.1	27.2	47.6	33.7	23.5	30.4	36.7	29.3	24.5	17.9	13.1	12.6	43.7	61.1	17.3	23.5	43.1	14.4	23.3	35.9	17.9	19.1	19.1	32.6	21.7	27.0	34.7	68.7	9.8	45.8	8.6	57.3	23.4	70.3	21.7	22.5	21.6	22.2	22.7	21.1	24.3	22.4	19.9	21.0	28.8	24.2	33.3	20.5	27.3	19.3	12.0	12.9	13.3	16.1	11.7	11.5	12.1	12.4	12.4	11.9	12.8	14.0	15.4	3.2	13.4	12.1	18.3	7.0	10.8	22.3	12.0	23.5	8.7	9.4	7.9	10.0	12.9	14.7	35.5	21.3	21.0	15.4	13.7	13.1	12.1	11.3	9.4	11.2	10.3	5.9	9.0	14.2	12.5	12.0	14.3	8.7	4.5	14.8	10.0	7.0	18.3	42.1	7.9	13.8	16.2	11.9	6.8	25.7	12.5	13.5	12.4	9.4	14.8	17.6	15.5	6.0	10.3	16.6	7.8	9.8	16.5	14.2	30.3	9.4	14.2	26.9	6.6	9.8	15.3	38.1	15.8	12.3	6.8	14.5	20.3	15.4	13.0	9.6
Z82206.1		ENSG00000225528	"Novel protein similar to translation machinery associated 7 homolog (S. cerevisiae) TMA7"		22	39960397-39964718	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"bone marrow: 1.3;lymphoid tissue: 4.3"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 7.9;granulocytes: 3.8;Proximal tubular cells: 3.2;T-cells: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	4	"K-562: 12.5"									HPA047397			Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		Yes	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Nuclear bodies"	"HPA047397: AB_2680029"	"unprognostic (8.48e-4)"	"unprognostic (2.95e-6)"	"unprognostic (3.67e-1)"	"unprognostic (5.90e-2)"	"unprognostic (4.27e-1)"	"unprognostic (6.95e-3)"	"unprognostic (3.74e-1)"	"unprognostic (5.41e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.18e-3)"	"unprognostic (8.77e-2)"	"unprognostic (6.53e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.58e-3)"	0.1	0.0	0.0	0.2	0.0	1.3	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.0	1.1	0.1	0.1	0.0	4.3	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.4	12.5	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	1.1	2.7	2.9	1.3	2.5	2.3	3.5	3.2	1.6	2.0	3.6	4.4	2.4	1.3	1.2	1.7	2.6	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	7.9	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0
ZNF22	"HKR-T1, KOX15, Zfp422, ZNF422"	ENSG00000165512	"Zinc finger protein 22"	P17026	10	45000923-45005326	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 184.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016736, HPA054893"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"HPA016736: AB_1859133, HPA054893: AB_2682632"	"unprognostic (2.87e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.77e-2)"	"unprognostic (3.50e-3)"	"unprognostic (3.42e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.31e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.11e-5)"	"prognostic unfavorable (8.06e-4)"	"unprognostic (1.39e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.58e-2)"	28.3	13.5	19.8	21.9	21.3	25.7	41.1	20.5	26.1	22.8	18.1	21.0	18.9	30.6	23.5	10.9	25.7	17.6	23.9	19.1	21.0	25.2	38.7	23.1	36.1	25.1	20.7	35.8	39.6	13.3	8.6	40.0	21.5	22.8	21.6	19.2	22.7	19.6	21.1	8.4	18.2	23.9	21.4	27.1	22.8	9.0	20.9	70.4	23.9	25.7	35.1	18.1	10.9	22.9	46.7	7.4	63.3	39.3	32.1	23.2	0.5	21.6	44.5	54.7	58.8	25.5	38.6	48.4	33.5	32.5	12.0	7.8	62.1	23.2	77.3	30.3	1.1	50.3	11.3	0.3	68.8	98.5	17.0	41.6	33.3	22.3	0.9	0.5	87.7	127.8	67.8	84.9	43.7	1.4	184.0	148.5	38.0	26.8	12.9	133.8	87.8	69.4	43.0	39.2	60.5	52.7	19.3	38.8	32.3	57.5	8.4	96.7	48.4	39.2	72.2	27.2	73.3	48.0	51.0	46.4	24.4	3.6	42.6	28.2	28.1	37.6	51.7	27.5	62.5	42.2	33.6	53.8	37.8	54.4	45.3	56.6	2.9	70.8	18.3	64.7	21.1	38.1	19.8	21.3	20.5	26.1	19.1	21.0	25.1	20.7	21.5	21.4	20.9	22.9	69.3	28.9	27.4	5.9	45.7	19.2	65.5	34.1	42.1	33.6	51.2	68.6	9.9	68.6	25.2	33.1	10.4	71.7	48.0	7.0	56.7	58.7	6.3	22.1	48.7	72.9	40.0	67.5	5.0	43.3	55.8	49.5	21.4	25.4	33.5	59.1	91.8	58.6	49.3	38.7	7.6	37.2	38.7	28.7	28.4	3.6	44.4	32.7	19.6	4.7	61.4	57.2	89.6	7.5	11.3	35.7	15.1	51.1	31.9	57.9	6.9	54.6	28.4	32.7	32.9	77.1	48.4	40.1	37.1	23.9	13.2	53.2	36.4	58.7	34.7	27.6
ZNF830	"CCDC16, MGC20398, OMCG1"	ENSG00000198783	"Zinc finger protein 830"	Q96NB3	17	34961540-34963777	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024754, HPA027211"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA024754: AB_1859464, HPA027211: AB_1859465"	"unprognostic (2.87e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.70e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.39e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (2.01e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.22e-2)"	"unprognostic (8.63e-2)"	8.0	7.0	5.9	9.5	6.3	11.1	8.4	7.9	7.2	7.9	6.3	8.3	8.6	9.4	6.8	8.7	8.9	6.8	7.0	5.9	6.1	9.0	10.4	6.5	13.9	5.9	6.0	12.8	8.2	8.0	5.5	7.8	6.1	8.1	6.4	6.3	7.8	6.7	8.0	8.5	10.6	6.5	5.8	14.7	8.9	10.1	6.1	13.7	9.0	8.5	11.8	9.4	7.5	7.4	7.9	15.2	13.5	12.5	14.1	10.9	9.3	9.5	9.6	12.2	12.0	11.5	10.5	14.3	8.5	9.3	12.7	18.2	14.5	8.6	13.7	8.7	19.7	16.9	15.5	14.5	14.3	25.4	23.2	10.7	19.9	10.2	19.7	12.3	11.1	17.4	24.6	20.5	11.1	6.1	23.2	28.5	8.9	10.6	7.4	15.4	18.3	19.1	11.3	10.6	15.9	13.6	9.3	5.7	15.4	12.9	13.2	27.5	11.7	12.8	9.4	9.5	16.7	22.6	18.5	19.1	11.0	13.4	11.7	30.8	12.3	40.7	16.2	12.1	16.2	13.1	17.3	18.0	13.5	13.0	26.2	20.9	11.6	15.8	8.7	14.4	16.9	12.3	5.9	6.3	7.9	7.2	5.9	6.1	5.9	6.0	6.1	5.8	6.1	7.4	27.6	38.5	21.3	4.2	35.3	24.0	45.3	26.7	25.0	19.9	23.3	18.7	8.3	17.2	30.9	12.9	14.6	24.5	45.8	25.7	35.2	19.0	7.1	14.1	27.3	23.6	18.5	20.2	5.1	13.1	16.7	23.2	23.0	17.3	17.1	20.4	15.4	10.6	14.4	10.1	4.8	21.1	22.4	11.5	16.7	3.8	26.8	15.8	21.4	6.5	18.3	20.4	51.5	4.5	11.6	13.4	25.3	27.4	21.3	27.7	26.5	22.4	15.4	31.8	26.3	27.2	22.6	44.8	46.4	18.6	24.2	26.7	36.3	22.6	28.2	34.3